var title_f38_23_39280="Febrile ulceronecrotic Mucha-Habermann disease";
var content_f38_23_39280=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Febrile ulceronecrotic Mucha-Habermann disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hemorrhagic nodules in febrile ulceronecrotic Mucha-Habermann disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39280=[""].join("\n");
var outline_f38_23_39280=null;
var title_f38_23_39281="Patient information: Ventricular premature beats (The Basics)";
var content_f38_23_39281=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/13/24787\">",
"         Patient information: Echocardiogram (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?34/28/35266\">",
"         Patient information: Hypertrophic cardiomyopathy in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/2/32803\">",
"         Patient information: What can go wrong after a heart attack? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?43/17/44305\">",
"         Patient information: Dilated cardiomyopathy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/49/18197\">",
"         Patient information: Hypertrophic cardiomyopathy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Ventricular premature beats (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/ventricular-premature-beats-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H4313444\">",
"      <span class=\"h1\">",
"       What are ventricular premature beats?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Ventricular premature beats (called &ldquo;VPBs&rdquo; here) are extra beats that happen before a normal heartbeat. The heart is divided into 4 sections, called &ldquo;chambers.&rdquo; VPBs start in the 2 lower chambers, called the &ldquo;ventricles.&rdquo;",
"     </p>",
"     <p>",
"      VPBs are caused by a problem with the heart&rsquo;s electrical system, in which the ventricles send abnormal electrical signals. These signals cause the extra beats.",
"     </p>",
"     <p>",
"      VPBs are common. They can happen in healthy people. They can also happen in people who have different types of heart disease. VPBs are very common after a heart attack. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4313459\">",
"      <span class=\"h1\">",
"       What are the symptoms of VPBs?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people with VPBs do not have any symptoms. A doctor or nurse might find VPBs when he or she listens to your heart during an exam. Or doctors might find VPBs if they do a heart test called an &ldquo;electrocardiogram,&rdquo; also called an ECG or EKG. &nbsp; &nbsp;",
"     </p>",
"     <p>",
"      If you do have symptoms, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Feeling like the heart is beating hard, beating fast, or seems to skip a beat &ndash; These heartbeat changes are called &ldquo;palpitations.&rdquo;",
"       </li>",
"       <li>",
"        Feeling dizzy or lightheaded",
"       </li>",
"       <li>",
"        A pounding feeling in the neck",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You might be more likely to notice VPBs when you lie quietly in bed at night or lie on your left side.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4313474\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your heart often seems to beat fast or hard, or skip beats, talk to your doctor or nurse. VPBs are common, but you might have another condition that is causing the symptoms. VPBs can also be a sign of a more serious heart condition. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4313489\">",
"      <span class=\"h1\">",
"       Is there a test for VPBs?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The doctor or nurse will do an exam and learn about your symptoms. He or she can also do the following tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An electrocardiogram &ndash; This test, also called an &ldquo;ECG&rdquo; or &ldquo;EKG,&rdquo; measures the electrical activity in your heart.",
"       </li>",
"       <li>",
"        A Holter monitor &ndash; This is a small, portable machine you wear that records all your heart&rsquo;s electrical activity over 1 or 2 days.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have VPBs often or the doctor thinks you could have a specific heart condition, he or she can order other tests.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4313504\">",
"      <span class=\"h1\">",
"       How are VPBs treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on what is causing the VPBs and whether they cause symptoms. If you do not have symptoms, you might not need any treatment. If the VPBs are caused by another heart condition, doctors will treat that condition.",
"     </p>",
"     <p>",
"      Possible treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines to control the speed or rhythm of your heartbeat",
"       </li>",
"       <li>",
"        A treatment called &ldquo;radiofrequency ablation&rdquo; &ndash; This treatment uses heat to destroy a small part of the heart that is sending abnormal electrical signals. You might have this treatment if medicines do not control VPBs.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4313519\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/2/32803?source=see_link\">",
"       Patient information: What can go wrong after a heart attack? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/28/35266?source=see_link\">",
"       Patient information: Hypertrophic cardiomyopathy in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/13/24787?source=see_link\">",
"       Patient information: Echocardiogram (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/17/44305?source=see_link\">",
"       Patient information: Dilated cardiomyopathy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/49/18197?source=see_link\">",
"       Patient information: Hypertrophic cardiomyopathy (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?38/23/39281?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83178 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-62FEFCC119-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39281=[""].join("\n");
var outline_f38_23_39281=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4313444\">",
"      What are ventricular premature beats?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4313459\">",
"      What are the symptoms of VPBs?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4313474\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4313489\">",
"      Is there a test for VPBs?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4313504\">",
"      How are VPBs treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4313519\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/17/44305?source=related_link\">",
"      Patient information: Dilated cardiomyopathy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/13/24787?source=related_link\">",
"      Patient information: Echocardiogram (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/49/18197?source=related_link\">",
"      Patient information: Hypertrophic cardiomyopathy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/28/35266?source=related_link\">",
"      Patient information: Hypertrophic cardiomyopathy in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/2/32803?source=related_link\">",
"      Patient information: What can go wrong after a heart attack? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_23_39282="Head-tilt chin-lift maneuver";
var content_f38_23_39282=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F70710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F70710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Head-tilt-chin-lift maneuver",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 310px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE2Ah4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA4W88Xa6/iDWtP0fQ9LuINNuEtmmu9UkgZ2aCKbIRbdwABKB97selRXXirxbbQmWTw3oBUdduuTH/2zqDSFz4u8cH/qLRf+m+zrZmVXRkYZUjBzXJOtKMmjWME0ctJ8S/EEZ+bw3ov/AIOpv/kSiP4l+IJPu+HNE/8AB1N/8iVg69ZtaXckTdD8yn1FZVvIUkwelbRqXVwcEd/F468Ty/d8OaF+Otzf/IlPbxr4pXr4c0H/AMHc3/yJWBps3TmtRzkCodSSYciLY8beKDjHhzQef+o5N/8AIlWh4o8WkZHh3w//AODyb/5DrIi5dP8AeFbsSnbntUzrSitAUEVz4r8WDr4d8P8A/g8m/wDkOmHxd4rH/Mu6B/4PJv8A5DqWYHJ9Kqv70lWkw5EWF8VeLW6eHfD/AP4PJv8A5Dpk3i/xXCcP4c0D8Ncm/wDkSohP5ZxUV3Os0JAPzChVp3BwRP8A8Jn4pxn/AIRzQf8AweTf/IlIfGvikf8AMuaD/wCDub/5EqhExHBpx5H4Vq5tEqKLh8beKP8AoXNB/wDB3N/8iUh8b+KB/wAy5oX/AIO5v/kSqQ5pjHFZ+2kXyIuv488TJ18OaF/4O5v/AJEqH/hYniP/AKFzRP8Awdzf/IlZd03bvVKQ4JPc+9UqjYnBG5L8SfEMalm8OaLgDPGtTf8AyJTNP+JviK+XdF4Y0hV9X1qUf+2lc1enMLAdSMUmjGa2T7PcDZNEdrD+taKVyeVHdw+MfFUrKq+HdABbpnXJv/kSrDeJvFy4z4e8Pf8Ag9n/APkOsWzkLx/IfnXkVqxz+bEG55FbKNzNuxMfEvi4D/kX/Dv/AIPZ/wD5DpD4n8Wj/mXvDx/7js3/AMh1CGds4qeKNzjNXyEczJIvEHjCX7vh7w7n312f/wCQ6kOs+Mx/zLvh3/wez/8AyHT4lZcHoRWhDMSgzzWVSEl8JcZJ7mX/AG54y/6F3w7/AOD2f/5DpDrnjLH/ACL3h3/wezf/ACHW0/zR7gCD71VJJrhqYipTdmdEacZK6MKfxf4rhlMb+HNA3D01yb/5DqL/AITXxT/0Lmg/+Dub/wCRKNSJN02R6VTP6Vg8ZUD2aLn/AAm3ij/oXNB/8Hk3/wAiUf8ACbeKP+hc0H/wdzf/ACJVI0hqfrtQfs4l3/hNvFH/AELmhf8Ag7m/+RKz9f8AiZ4h0TR7rUbrwzozw267mWLW5SxGQOM2gHf1p1ct8Uf+RB1n/riP/QhThjKjkkxOmrHVp8SPETHA8OaJn31qb/5EqUfEDxKR/wAi5of/AIO5v/kSuWt/vDNX15IxXoxm2ZyjY3B4+8Snp4c0P/wdzf8AyJR/wnvibOP+Ec0PP/Ybm/8AkSsZGAIHbNX4LZWG4HrRObQoq5fXxv4obp4c0L/wdzf/ACJVr/hKvFpGf+Ed0D/weTf/ACHVBYQK04SDGDWbqyRXKiu/i/xWnXw5oH/g8m/+Q6dB4t8WTEhPDugZAzzrk3/yHTb3pntUelv/AKUQe6H+Yp+0lZsmxafxP4uTr4d8P/8Ag8m/+Q6YfFfiwf8AMu+H/wDweTf/ACHV2flciqTng1gsTM09mhjeL/Fa9fDugf8Ag8m/+Q6jbxp4pUc+HNB/8Hk3/wAiU1yT1qrKc1SrzYciLf8Awm3ijGf+Ec0L/wAHc3/yJTJPHXidBlvDmhf+Dub/AORKrH7v0qjeN8hHrWntZCUEaSfEDxI/Tw5of/g7m/8AkSpB478TEZ/4RzQv/B3N/wDIlYdvwuasDhaTrSHyI028eeJgOfDmhf8Ag7m/+RKrS/EnxDGcN4c0Qn21qb/5ErPmbYhJNYlwck1SqSFyI7eHxz4nmiSRPDmhbXAIzrc3/wAiVAfiF4jFwYX8OaGrg451ubH/AKSVU03/AI8Lf2QfypNQsku4uPllH3XrGOJd7SE4o3f+Eq8WcH/hHfD+CMg/27Ng/wDknSR+LPFkmdvh3w//AODyb/5DrJ0O9c25tb0ElDt5610NnbpHnZkIvJzXoxSauYSbTsLFrnjKRQR4d8OgEZ512Yf+2dRR+JvE8j7I9K8Ju3oviKUn/wBI64bxf4hutXvpNP06WRbFDtfYOZWB5/AVxWqaVexurLbSMg7gc1zVnVX8KNzso0IyV6kkmz3Y6v40H/MveGz9Nen/APkOoZPEHjGNgreHfD2f+w7P/wDIdePaL411nwpLGkglu9Oz88Epy6DuVJ5/CvaNH1nT/EekpfaXOs0DDgg8qfQjsfauB4yrF2krGk8LybmfceLPFkGN/hzQOfTXJv8A5DqH/hNfFP8A0Lmg/wDg8m/+RKW/l83acY5PFUj70njaqMvZxLf/AAmvikf8y5oP/g8m/wDkSj/hNvFH/QuaD/4O5v8A5EqmfrSVP16qL2aLv/CbeKP+hc0H/wAHc3/yJSf8Jt4o/wChc0L/AMHc3/yJVI0hpfXqvkP2US9/wm/ij/oXNC/8Hc3/AMiVr+EfFWp6vrMun6tpVjZEW5nR7W/e53YYKQQ0MePvD1rmjWh4K/5HQ/8AYPk/9GR1thsXUq1FGRM6aSuiPTJQnjDxwD/0Foj/AOU+0rdDq44NYGnR7/GHjj1/tWL/ANN9pWukbDpWtVXkyoPQz/Eumm+ssxjM8XK+47ivN5fkkyK9fG7HI4rgPGelfZLn7TCP3MxJIA+63cfj1/OlSlb3WNlXTZsMOa3VkBUVy2nP09a3Y3+UVpIRfhI8xe3zCtyKYKuK5u2fMq+ma10bcRzUTV0JF6Tn6VWuMBM1YMkYi5IrNvLlTkA1ESirK+/Ip9vbk5JHFFugLZPNTiTBIFaxJYwoFPNULu9SAHJ59Klu7jahz271zly5lmOTV2uSkdDa3Czx7lxmnP3rP0z5OKuyN8jE+lZyVmWilM+WOaqM2e3FSSPUROFq0BVvD8lbmoWfnYmj/wBev/jw9KwrzkV1S9B6VnUk4tNEspWN4iOpzg981vQhVkDBgY5O/oa5/VLQOhmiGJF5IH8X/wBenaPesilJcvC4weeR7iu+jUVRXRhOJ1yIi4JIq/b/AGdhzJXK3H2kqDE5kiPRh/Wrlmk0SLnJ3c1u6ba3M07HTiGFvuNU8cSoDisi0WV2CrnNb9rADEBIdzCsKkXFblxkmys43dxVWQbSa1nt4yDgYNZ11CyEsDuX+VeTXszsps5rWV/0kH1FZxzWprY/eRt6iss1yS3G9xDSUGg96lgJXLfFD/kQdZ/65D/0IV1Jrlfih/yIOs/9cR/6EKqn8a9QewqSYYe1aMLZAIrJb71XrR+lezDsYyLb57VZtbox4GeKqSE4OOtRoGzVtX3IWh0kNwsgGKuW8gAxmuetN69TxWpBL831rCcbFrUuXPKE1U01v9NQeuR+masO2VNUrI7b2P8A3v6Gph2Bo6Fl+SqUqcmrSydFNRSjBNc3U1M6TioGGWNSyHdMQKTGG5rSJLInIx1rKvHy4WtKU4B9qw5333ZHYcVoCLUPCc9alB+XFRKMLSu+1Cc9qQyrfSDOzOaz5eRn0qQsXlLHvTZfuVpshI6HTf8Ajxg/3BVvNU9PP+hQj/ZFWga4WS9yO6kECiYD5h3q3danJ/YN5dQDMjoVQH+/jAH5kVD164qO7cf2c1uCBucNjH5/yr08uq8840pHNifcg5ox7O2S2gEcQwo6t3b3NR3YZVyvm8f3SMirxwFwKibP4V71WXu6bHgRvOV5O7Zzt6zXQMUhB9pYypP9K4/Q9TuPh546t75TJ/YeoN5N1H2Q5xnHqOvuM16ZPGsiYYAg9jXI+JdJS5tmt5hujJDox6gqc4/TH0NedXhCvBwkj1cJWlRkl0Z6rfkeeShBjb5lI6YIBqtWb4Zvftvh2yLHMkIMD+vy9P0xWlXyzv1PZkrMaaDS0hqRCd/ekzS0hqRiVo+Cv+R0P/YPk/8ARkdZ1aPgr/kcz/2D5P8A0ZHXVgv4yIqfCT6DGr+K/HJJwRq8X/pvs63WRFzxWHoP/I1eOf8AsLxf+m+zrbmPFenV0uzOPYr3EwwQBwaz722iv7SS3uBlHGM9wexFXGTcc04R5+lcbbvc2SPKmtpdP1GW1nA3o2OO47EfzrVjb93xXQeM9LE9ql5Ev76D72OpTv8Al1/Ouat2BUZrpT51cmxZtnInFWLmd15jYD3Pao9Ph8662ZxkcVJq1i6QlIgTxnPc0tL2EUYLyRpwrSk7ugI4Na0dq8i75ePQVm2sFzcTQEps8ogk444rWtxKzYfOB0JqpWvoBYiXYvNV5WCkkVZcYBFZt3JtU801sSzOv5s8VQiG5wakuGyST3plvySauI9kaNrwRirNw+2FuarwU67bMQ9c8ms5fENbFB2+fFHP1piksxNPJP8A+qgCtddBXTxnKj6VzFxXSRH92p9qxrbolomBqo9uscwKcI3b0NWQadgEEMMg1NKq6UuZCceZWL2mKkMypJKoJOAta1qA52fxA4rkJbNt5khlbf1w3+Nb2jtLKn2pwRIp8t/f3r16VaNbWLOacXE6NHitYnZ2VUUFmdjgADqfpXnPiH4j3k87QeGysVup/wCPsqGaT/dDAgD3IJPtXOfFbxcdV1mPwtpkh8iFhJqLDjeeqxD1Hc/gPWptN0iNIUa5yWxkRg4/M1o6M6r5IL1NI1KOHiqtd+i7kF9488XWcivHqauT/BNBGyH64Cn9a7LwN8T7HX7oaZrCJpus44iZ8xz/APXNu/0PP1rm9QsLGeArcWPyjoynJH41wXjPwpb39gf7MuMXERyqy/K2fTPGP88159XKql7Jm8cywlZaLlf9dj6C8RoEMe3gEmsPNcn8NvFE2r6EulalJI9/Yorh5CSzIeCCfUHj6GurHFePJNO0tzVrUO1B/Sik71DASuW+KP8AyIOs/wDXIf8AoQrqelct8UP+RB1nH/PEf+hCqp/GvUT2ZGGHSrFscHg1VdemadFIFA5xXsRdmZtGxEVI5qxGq46d6z4JAQDk4q/GQRWjMywOnSp4DzVYNhSAeKmt2FZz1KRfzlaqQnbdpz/GP51YRvlNUixF2nb5gf1rOG42bnmAPknpUd3dowwhyfaqN5ICuNxH0qrYQ5kKMdu7nk54rFrqaJFyHLEsetOlGDUoA/h6UyXP4U47iZQumCgmsKLLy5PUmtTUXxG/qRWZa/fB9K0QF8DA/Cq16+1DjvVljx+FZd6+5wKIgNiA25ps3QYFSxL8oqKfrVPYSN3Tz/ocX+6KtA1TsTi0iz6VZBrjZPUlzgZPQdapO5lJc9+lS3LYhx0ycVCCo4yM45r3cooLldV77Hj5nXs1T+Yxs9ab160rOucU3eM16Enc4I7XYwjms7U7cyQsQRlfm5rVyGHNQSrjINcVROLud1JqRR8BHYb2EsSHRZVHbIJB/Qj8q6rrXFaKw03X0RzsjL7cn+63H+fpXauCrMD1Bwa+axEeWbR71+ZJifSiikNYAFNpTSVIwrQ8Ff8AI6H/ALB8n/oyOs6tHwT/AMjof+wfJ/6MjrqwX8ZEVPhJtCOPFvjnJ66vF/6b7Ot0sC2DyK5bT3K+MfG4BI/4msX/AKb7Stg3DRsATXtThdanNGVmaYjUjgUvlgDIqrDc5IyetWQ+4HmuOdPlN4yuV7kK6MpAIIwRXnt9Ztp180LZKH5kY91r0N0Y8is7WdM+32ZUACZOY2Pr6fjWVOfK9TRo5TTzi53Z7VryzHaCOorHsVaO5ZJAVdcgg+tawXIrSa1JQ1LiSXAboKnDcdPxpmzbyKY7lelJAE0uFwcZrFvZSeAav3D8HNYlw+XPtWqFYrzHkVNbLxmq0hJfFW7cEAZrWImXIelNvSBEcU0vsQGobmTfETWT3GtiKMcU84zTYeRxT2XNAFSfrXQxf6tfoKwJl57mtyBgYkI6YFY1dWEticGng1ECKcDxWDEiYHir1lchbORj8qpndj0HNZwPSqms3f2PQdUYdXi2rn1b5f612ZfOMaln1M60XJaHkHw/t2vfEeralM5n8y5kkWRur5Y4P65r1uFCsYz161xHwv0SXTbC4e5wQ0pEP+6O/wCv6V3RzjvX0tG6p37ts8PHzU61r6JJEE8e9SNzAHjIOKxb3Tpy25ZRcIAfklUA/g4x+RB/Cugbp7VDIoxx0rmqSa1JppPQ5TwfaeR4xadCQs1s6kHj5gRnI9eMn3r0I1zNnaf8VLbzrkAJITj1IxXS96+ax6Xt211PoMPJypRuFIaWk7Vws3EzXMfEv/kRtW/65j/0IV09cx8Sv+RG1b/rmv8A6GtVT+NeoPZlzxDafZNRkAH7t/nX+tY5Feg+JNP+2WRZB++jG5ff1FcC3TivUpyuiGie0krVgf5RWHESr9K0oJOB6fWtU+hDRpRnJAqygCc1XhIGCagu7xY+AelTIEjYhbdjFQzgC6jPYsP51Rsb0tjf3q9ctvWNx2NRZqQy9fWDGFTF8xzk+9QW9pIPmlyDjAzV5pSI+KghLu5ZyT6Vg7miJkTC471BcnAqy3TnrWffPhTVLQlmNqT5BHrVe1GFzjmictK7Kqk4PYVZit5Fjzsb8qtbAJI+ENZTndJWncxybeEbp6VRjtpmc/uXAPciqQD0+7UEvLVpLZSlRwBn3FQSWRByzqKUnoI0LL/j0iHtU4NQWeBAoByF4zUveuUhrUbdDMQx2YVUbEYxku56D1NW5T8h+tQMvU9zxX02Tt/V2n3PAzRL28fQqSSeX8i/vJTyfasvUtSW2kCM4Hdj2AqzqEzxwsLYKoPWQ9T9BXnH9pJd+JJ45mJjgfYqj+Jh1P511xjzO5gloemaZcPcIH2lUPTd1/GtCRNyZ7isvRyslujCF8Y6vV6afy+lLE0lYKFR3MnWYCZIZAOc7T9P85rsEk82OOQfxKCfrisCGWOeRFkwRuFb/wDDgcCvlcwioyXc+jwtTnh6C03vS5pM815rOoO/WkPWj60makAJrR8Ff8jo3/YPk/8ARkdZprS8E/8AI6H/ALB8n/oyOurBfxkRV+EbpwX/AISrxxnr/a0XP/cPs6vEhgQDzVPTFY+KfHJUEj+1ohx/2D7OtWx00vMJn3IgPfvX0ThzRRwqVpMrQwO5HB5q+gMS45x71c81SMbAAOBiq1w4xkcVlNXWpcXqPVs8ilbHeqKSszbY1Oa1Le0kZR5hyR3FcFSlpdHVGfc5nXbLbOLuNeo2vj9D/SqcbAAZrtbqyjkiZW5yMEVxF5E1ncvC/wDD0PqKiL5lYolkk3LxVWWTAPNIZAFyDVG6n7CqURBcy5DEVlsTtzmp3fcjEd6gn4iOa1SArp97Jq/G6mPp0rNjwTVyILuUZ68YrQlmwljbXEY3TtGw4wV3f1FQ3mkYT9zcRFevzAj/ABqyRBKA0Eqg9xmoZZGRdpBPuKzGUktwgw0qYHpk/wBKsJHD6M2O/SqrN83TGetTW8gxjnjqcVDbuOw+VIVHyRLu98mprcloVJ61VlPPHK9+atW/MQx71jN6ilsS5pwNRinA8VmyUSg1R121+26XPCBl8bl+oq2D1pwPWlCXJJSXQox9MAitokHG1QK0VwRmsiKTyZXRiMoxBz6A1qQOJIsrzX3ainTTWx8dNtVHcHJUZKkgdxUe9GXKHOakZhjJ4H86528uDFqUDQtw24Mv5VxVIqWh0wk1qbsB23KMODnH4GtSsGKUuAa24nEkSsO4r5vMqTjJSPdwNTmi0PpM+tFJXlM7wNcx8Sj/AMUPq3/XNf8A0Na6Y1zPxJ58Eat/1zX/ANDWqp/GvUHsenuARXnniSxNjqLlFxFL8y8fmK9ClxG2zOax/EliL7TnKj97H8y/1Fd0XySJ3R5+eDmrdu/AqsynbSwkiukk2Q7tDiIZcjFULmzuEG6QYq3pk/lzDPI6VvOi3EWCByKlz5WCRzFoWwK1ll3wgdxWfJD5ErqBT43wK0a5tUI6sYK1MqYANQQ8gVY3g8Y6Vxy3LWwyXp1rF1KUBeuBWleShIz61yuu3Xl2Ur9yMD8eP61aVwHaIZ3HnrkqzN/6Ea3xcswwxINc/oMs9vp8bxgFGycEe5rQa8aQ/MgB+lNxC5amc5yDVVnOcihpCR0FU5pmyQpx9KGhIug/L1NVJWwQD3pkeRySxPb2pjHOSetJrQC/Z4EZA9alNQWP3Dn1qc1jYiW5HMwVQT0yKqTTqPlILMeijvU90oaLnPXPFUxDcOpcOtup6IFyxHuf6V9Pk6X1d+v+R89muldehT1KT/R5CFLMAePU15tpGmxjXJJBcExZLZUjls//AK69O2GSSGE7ihcZLcFvXj04riLPRYpNevVvM/aIX2ohGEx6j1rtoTgpSp310ZlJS9nz9NjuoHENohBGMcHPWs27u8sRTHYRJsZiWHQBcY9qyDc+ZcbR1Usp/L/69KtqyaMS5a3h89Tnvmu9tpPNto37soNeZaSkl3e21tHkyS47fdHUt9AP6DvXp8arHGqIMKoAAr5rOOVOMep72BT5W+g+kopCa8NnoCmkopKQwNaXgn/kdG/7B8n/AKMjrMrT8Ef8jo3/AGD5P/RkddWC/jIzqfCWdAuFh8V+OdwB/wCJvEf/ACn2dbU98JDwcCuUth/xVfjdh1/taIf+U+zq08qqCd4De9fTRj7qZ5sn7zNoXEefvDmmi3e7YFD+6/vVl6ZZSX0gkuVxB1Uf3/8A61dHBttMkcsazqQuXGdmWbOxit4wT+dWJHBUhRgVTa7B+Z+BXI6z42VzLZ+H0S5uFOx7hgTDEfqPvN7A/UisY0J1fdihzrRprmkzpdR1Sy0uEy39wsSZwM8lj6AdSfYVw+r+I7PVLlYobG9icZKTOqhSPcbsj2yKy1t5JpGnvZGnuW4Mj9ceg9B7DiiSJQMgYxWsst9mrt6mEcyUp2Ww6WchSazppix5zT7hnDcjjsahCEnPNcfLbRnpxkpK6FjcgAHPWi+bCjBpSAJAP0qtetlgBStqMW2XPWr1qoEwHbqaz4pQnBFaelBZJm3nC4xkCm9AQ11CvlSR9KXexGOatXsCoflOaptgCpvdBYM5OBVlcCPAqtCpLVaYFeCPwNY3V7GjhJLma0InPGKuWp/cCqUhq5a/LAorOe5EtiU0A0hNJ3rNkIlB96cDxUQPSnA89qhlIw/EsbQKLuJcqeJPb0P9Pyp2hXaXNoCuc+vrWxPGk8LxSDKONpH1rD8PwNZLcW8vWKQgHsRgEV9Tk2M9rS9jLeP5Hg5rhuR+1j1NSQHB2/41yuuOyapFGGOQhJwCep/+tXTm4U5w6jvzXO67E73Nu9vOkQ+bOYy+7p7jFdM9JanJDbQ1dOAMQ5/MEfzrX09iAyduorEtJGSFQ7qzAfeUbQfwyat2V1i5XPfivPx1L2lN2O3CVeSojb70lGaT618oz6AWuY+JX/Ij6t/1zX/0Na6XNcz8Sv8AkR9W/wCua/8AoYqqfxr1B7HorM8j5NSxhs+tSxRYFWFTaOldrVybnn3iHTjbai3lITHJ864HfuKxShjYhhgg4xXousQGdCF+8ORXBaim27YewNb0pc2gmrBA3ze9dDpsm5cZ5rmoyVNbWmyLkYPNOogRLq0QV9/rWcnJrc1JC9rkdRWFGfmIp0npYUkdRbvwBntUxcAEmqSvtA5qK4nwnWsZLUa2K+pXBJKg1zHiKTIghzwxyfw//XWw7FnNcvqtyH1oIeVjAX8ev9auCGdfo6bdLhHbB/malkiz9adpj402IcYx0/GiWTAJFLqIrTt5a471SBy1PuJC7ZzTYwTQwJhwtMbk04jikxzzQ9gRbsxhW9KdczrCuWxn3NLbjEf1rP1yye5iV4Rukj52ZxuHpVYNUpVUq3wnNinUUG6W5Qu9XmimQso8nd8+PT1qxe6pBsRgVIYZHzYzXLNcvC/kXKMjp2PFQ2lidQuDGuREGBZx0AHb8eK+0o4anGFqVkj5erUnKd6u5swatbxQzXXnQi4G6O3iznDepqrpcB+zmWTd5rnLE9c1J/YsNv8AvNh2qMDnOB71Xur1IhsBO0DjPauH2KpTlJO9zr9r7WKiloiTUtQWO3keV8eWPm5/I4rG0ZZG3Sz/AH2Bdsep/wDrcVCIzrt4EUn7Ihyzf3iOmPoa6rRbNbi/iAwY0B8wY9DjH5ior1VSg5voaUqblJQRueEtK/s7T0eZMXcqjfnqoHAHt2J9/pW8ajzzTs18VWqSqzc5bs+ihBQiooWij+VJmsSwJpKM0lIYdq0/A/8AyObf9g+T/wBGR1lmtTwOf+Kzb/sHv/6MjrqwX8ZGdT4QsML4m8cuyggatF/6b7OnWemS6pMZSmIA2Of4qo20jyeOPGNmpASXVoix7/8AHhaZrs0dbWJYoSNor6mF+RWPLm7SY4f6PCsS8gcZqvPJHDE8szhY0BZmY4AA6kmoNU1a2sbV57qRURRkkmvF/GniOfxEtxB5jpZEHZGDjOOhbHX6U1G7syYqT2NTxD42k8U6n/Y+gCSPTg3766VtrSr3C8fKvv1PbFdDbWqQQJFAipGgwFUYArnvAGhJp9gsjLmaQbmY12JAxjvXsKlClHkijwcRiJVZ+SKJGOO9V5hxkVekjPXpVSTByO9YVVpZl03fUzpxwRQFCxqQeoouxsBNQ237yLqSFYjH614eJXU9/AyesSGRv3zHJqjM26Q81bnZVdue9VI4ZJnOxCf0rmTS1Z6Vm9EKpAxmtfSW8tWYDg8VmmymI2lQHHQbhzWpZq8VuAw+fHIqJTi9mV7Oa3RNcyDnPOaq53dBxUhXnLdR0FL5eY8jqe1JW6nZRw6j709yNHWKVd2Mg1Vsrx59WvbdxhItiqc8kkbj/MVQnla0vXeQlgTkD0FEs8MeqDUIX5mVUli9WGAG+uOPwFcuJ9xqaPRVP2sHBm44y4UVoKMIB6VUjj3kOhKk1n6nrD6bdRW0yB2nOY2zgYHXNLm5meU8HUlpHU2yfam5NVLC7a5iDvGEJ6EHOatE1LOapTlSlyzWo4GnZrH1HVI7acws5R8A5xWPcapfQt5sEwdeu1uQRXp0corVqaqJrXY86pmFOnPkaeh2QNUb1P34IwuV59CR6/nVbR9Zh1ABCPJuMcxt39x6irt86xRrI/RW2/nx/hWeAjPC4yMais9vvKxnLXw0nB3M+QliUghkuVXG4lgi5/r9Kq30e5EaePyX3fdDZIH4VsPcxJH8shAA/hFc/qtypkjWNg3zbm7Y7fj1r6astT5+i20NM3lDGcgetNs7otex44AYcVkyXQedhn5U5OD6CtbwjYy3Nz9rlUiCM8EjG9vb2B7/AP18cWKnGjScpHoYam5zSR22aM8UmelITXxbPohc1zXxI/5EnVf9xf8A0Na6T1rmviPx4K1X/rmv/oYqqfxr1E9mexCJV59KguJBtwKmdvlJFUpQ7E4FehU00REdSvjdIK43xbZm3vVkUfJL09j6V3Uds27npWf4osVudKkCrmSP51+o/wDrVFOXLK5T1R50vBrRsSC2DxWbyDVq3bawOcGu2S0M0dTARLDtb0xXNyDZcSKDnaxFbmny5j564rn2O66kxzmQ/wA6wp6Notm877V5NZ1xP5kmxe1TXDMcBcktxUDWkkEmJMbz2zyKTBDGwiFmwAOtctpWnXWpXEt4oCxs5bLHGee1dBqpZrZ4ovvP8mfTPFT20kVnDHH0VQBiq1UW4m9Ckqj97Ys2YaK2CHqBg1DdTY4XrWRcXc+m6rL5qSNp9yweOUDcEY4yp9Oc/nW1EIZhuR92OtY06nNutTSrg5Qd1sUR80m3PPpVlEIHNW2hjfaWUbh0YdRVS+ldTmQAKB94DAquazszOdCy5olZLxXuDDEpfBOTmrDSorEuQoUZINY3hNjcCa5X5og7ojAcMA5GR69K3J4FmB3rnmoqz5ZWOuWFptLlFWWSaPKNsUdMCqs81zb8h92OzDrV6BCi7cVDdQtIMe1RKa6B7GD0sUmNnrEflXcCibGBnqB6g0s32TTbZYYVCoowM/560l7B9l097pB++h+YY7juPyritW13zXbEm6bOBGOmPrX0WT14+wfK9bny+cYSSxCX2bF3XNWVI2eVgiDgANzn+tc8kdxq0vzeZHbj+Enk/X/Cljhe7nQlPMmJwqqM4J9BXWaf4ZuWQG4lECn+BeW/Gumti6dHWbMKeGlLSC0K1ncQWkCQxIqkDHy967TRLP7JafMuJJDvf/Cq2naPZ2O1o4g0o/5aPyf/AK1aymvn8fj1iFyQVkelhsKqL5nuSg04VGCM04GvIZ2jxRzTc0ZqRik0neikpAJWr4G/5HNv+wfJ/wCjI6yq1fA3/I5t/wBg+T/0ZHXVgv4yIq/CZdjqH9n/ABR8YSMf3TahCj57A2Nrz/Kun8Q6hBpVubqZ8Rt90DufQVw2oru+IHjTH/QRh/8ASG1pNTtf7REC3UkjJCNqrngV9FCso6M4J0edqSOd12/vPEN28hQrDGCQgPCgdz71T062iLJsAdnIGTXXfZoY7KSKEBRtIwO/Fc54VQzX6J2Rsn8K1w9T2tRJdx1UqVJvyZ3dmoSNQoIUDA7Ul5eRQAtIwAFPLBIyR6VyeuXHmbvSvdb1uz5GEebQ3BqUc9uZIz8pOBWa94zE7ax9BuVljntpG2iFtxJ/uEE/0NayKQil49rsN2zP3R2B9gOvvU1oJq5tSfLKxWvbglDuPSqGl6vCtq6AmSXeSVA6dMc/hS65L5FnNLydiF+fYZrmfDQZbeMHlmG5j6k8k18xmVX2aSjuz63JsOqt5S2R06CSd9zDAJ6Vt24EUS4H4VmWOfTj1rYjQFRivLjJyd5H0HJGCtFHn3iu5nHiO08lnQb1BIPA5/8ArmuzS+fbt8sl8YzWR4n00M6XKruKMCwxzitGzAe1jlOW45qK8IqcZPYdJ6NDL3UlsIWnuwVjXqccCp9L1S31GES28g2k8H1rkPiVqTf2YtnbxlpLlggx16ip/BVjLHEkPJAwS2K6HNKKXcSTvc7G+sIr+LbICG7OKzLXwusN1HKZHdE5Ck8ZrqIYNiYPanqDu4Iz6GuabsdcG7aFdIyigAHArnPG9rNLa2k8EbSNbzBjt5IUgg/zFdcxRXVGfDt0HrSSRp3HWs/a63MleDujJt02afFH3CgGq8IuWumEkhdc/L2GPwrWktwoO0kCoUhIcEHNZqbvcTSerWpla1oovULqzLKqkK3UiuLiu30+5NnfDY4B2nsRXqZ4GM9q4Lx3pSXkCtlkZGADJ1GTj+te7leZypTVKesX+B42aZbTrwdSKtJFFIhqUscMCLIMs20H2Ayfb/PcVu/YPsemiCS4llC87WYlVyMYX0qPw/a22kWIWEHewG92OS31NQ6rqibWwFYdyGxg/Svrfax0bR8V7ObbjEqNNKqOnmvg4zg/07ZrJvb2WPMAdmmlY7W64GBn/wCt9arSanJcSBLNCwb+NhgD/Gr1lY+UvnzAyTF1I9Sc44/CsKk03dnRGHIrJ6mh4d0k3LrAQQhwZD6LnkZ9T/WvRVUKoVQAoGAB0ArO0Sx+w2m1h+9c7n9vQfhWjmvi8xxf1mrpstj6PCUPYw82KaSjNOjjeVgsalm9BXnHUJ17Vz3xFiZvAurv0AjX/wBDWuyi04oQZjn2HT86wPicCfAGsgD5REvT/fWt6NN86bJk9D0QNgbT1705ZD+FQ3B2ufami4VR83X2r1qtK70OanPTUsl+4qCbBBBNSxxPK2RlRUslnxljXBNWOlNHlGoW32e6li7oxA+lV42KnBNdZ4n01YrxZhysnB+orClstxynFddOomtSGi5psuVqhbqDLIe5kP8AOprISQS4kUgetZcV3IdVWDAVd5/TJqeXV2GtjUvrh7QJIrAO2QB3HvVC3lZ5t4yARyfU1av1RyNxJNQxqFGcYFJIdyQruk3EcJzWVqlrcTqPKYgqc1roQsZJ6selTYDAHaK2UVynfS9xI5ZNTvrX92VZscYx1rS8PwXr3lxLLGY4nI2j8K3I0VsfImfXFX41KAACuWaUZc6R2qfPHlI1hOAT0pxh9elWVPXkH0pFLEfvAA3t0rmnUuRyJFVYowCoHHtR5foMCrEkfGR1oUEr6cc1lzD5bbFORCehPXtQcgYbpVpl4/rUU2CpHFZzloCiUbtBJC8bDKsCpz9K5nTfBml2yq84e5lIyS54J+ldNKCeAetRwkhNp6itMLiKlNOMXa5w4+kp2k1sQ2Wn2liP9FgWM9N3U/nVsGm5pc1cpOTuzhirDwalVqgp4NQyidTTgaiB4pwPpWbKJc80U0GipGKaTvTkVpHCoCzHsBWvaaHI5BuGCL/dHJpxg5bBexkxRvI+yNSzHoBW54TtGtPGSiT7zafITjt+9jrThs4bSPEKjnv3NRaQpHjmPd302TH/AH9jrvwlHlmmzKpK6OGu/wDkoHjX/sIw/wDpDa1LcD5T2qG9OPH/AI1/7CMP/pDa1M5ypr0pbmcdioncZrL8EQg314WAJXA+mT/9atTgIeeKz/Ckiw3N9uONxU/zrvy9fvjhzFtYeVjp79wkeBXHauVAJOPrXR3r+aeMnArmtchQwMSD9c17UlqkfOUdDK8NPHN4oEIwytAxZfXDKf8AP1rs74pCcTMu9uSO7H6egrzzwMV/4WAiDy1ItpH2hctj5RknPv6CvQdQmVHcLIuD1G5QT9ctmtKnw2Bx5Zo5rxKpk0i9LHJML84x/Caw9ExsHbtXR6u8b2EyAAM6kffBz+G6uS8Oyh40x3wa+SzKF6kT7TJJ2pSR3FiAEHrWojcVkWcyqoA4q+s4yAG4rz6kbHsqVx11GJEYMMhuMVW0+IwRvCQWUdKkMm5xjP8AjVhCpI45rCbclysqOhjXGix3d7E8icIcgehro9Pso7dchQMDtTo1xzUu4euKVP3dym3ImZtozikxyDioTJgHFR+f2qKjuWnZFwkED2pWxt561RExbpzT1lYcHpWJaVydDuXJB/EVHKOO9EcmOPWnSOoHXmpuTJWZXB2/KOAKwfE7BNOmcjgYJxz3Fa87jII61h69btqto9lFL5LykASYztwc9PwrbDNKrGUtrowxD/dSS7M5a71cxgRgnfjKhcEEdjWRJ510xe7kyp/5ZpwPxPeumtPAywyZk1KR4+OBEFb88muk03RNPsMGG3VpB/y0k+dvzPT8K+nqZtTj8Gp8pHAvrocLYQSTECxt5Zm7bFyB+Ndh4e0e4SUT6kgTbyke4E59Tjj8K6WGKSX7oyB3PAqQrFEfncOfRa4KuYV8SuSCsmdNPCUqbuJnjil7ULqCRtiOJDj2rQtNQkdxsjTP+5zXDLCTirtnUpp6ILDT3mO+UFY+vPetM5hHlwqFA9KydZ8VaXowH9salDAx5Ef3nP8AwFea4zUfi5bq5TQ9Gub05wJZj5an6AAmiFNpbfM0UJS2R6ekbPHhsZ/kK5r4p24X4b64y4+WEZ/77WtLwPD4m1KI3fiaK2sw+PKsoU5Qerkk8+1T/GK2WL4Xa9tGCIB/6Gtb0oJNGFSVnYvyGS4l2RKWrX07Sljw8nzN79BVixjjjjUlVQ9xVkyljx0r0Wjk5uxHKFhHyrzUMp3oSe1ZniXxBZaMIkuJd1zNnyoEG53x14Hb36VyV7qV7qWfNkaK3P8AyyU4z7H1qI4Cdd3Wi7kzxsKCtJ6mr4kuLOSDyftMP2gHcibxk/hWHEgVQznioZLSHIYRrleQSORVe9eQRFUbBx3onl06S0dx0swhUdmrEGq6iCwijOFHpVSS3A1SK4X7rRlvx6f1rGuXcSkPkMDzWpZzl0jQn7qn9SP8DWEqfLax3Rdy9IPMfGM1IsIKgu649Aar6pbvJpcscbFXYZyK5LwfdPbPNZ3zuCWyp6isZqajdHZSoxv7x18z7j8nKr6VxcPiO6j8Q3dlP8qD5kXviu4PyQBVHGOMV5/qWj3EvjJLpf8AVSR7PoavntDR3Zuoc0tT0Pw9L9ojEnXNbb7cDHFZWh2gtLcKOwrQd16deayqaouD10JV+XmmvLjoRVd5jjjpVeWbHOa4JHQvMtmZif8AClEnzdapCYbTnik88Z4pGisaJfK1Xl6Gq6XAPfFTI6ycAVhO5L0IcZkAqZ7YMuV60Kh8zPWrKnbWSk09CJRUlZmW4KHDDFIDzWqyhwdwFVpbMYyhrpVVPc86phGvhKoOKfmkaJ06iiNWdgqAkntV3vsc7i46MkBp6AsQFBJ9BWhbaaqqGuXwT/AvX860LZoYBiJAPfufStoYac9XoiHNIzodMu5MERED1Y4q0uh3ZwW8sD/erShEj8s2FHvWfqPiqx09XW3331yP4Ien4seKt4aK6ji5S2Rsadp0Vmv96Q9W/pU9zLDbRmS5mihjHJZ3Cj9a8s1bXvFOrb0guYdKt24CwDfJj/fP9BUvhv4TnVLyO+8RTXVxCDu2TSEtL9fQVUeVe7E2lQ5VzTdj0zTL601VPN02eO6hDFDJGcrkdQD3xT7WMx+O4Aev9mSf+jY62tOsILC2jgtYkihjUKiIMKoHYCsxuPH1v/2DJf8A0bHXVRWpxTdzze9Td488ant/aMP/AKQWtSFcDmnXC58c+Nv+wlD/AOkFpT2Xit5PUa2KTw/KWzXOaawiuGY9GOP04/WumvJRb2sjEAgevrXNWaGQBF+/IwUH3Jxmu/ASaqp+ZyY2N6Mk+xurOr2+8kAep59qwtdlYwMApUe/X8a27IQv54jw0cD+UnoMAZP1yTWDr7bldE2s/fjhfr/hXv1UfMUdzj/B12ll8S9OjnZQ17HKgz2G0lfzIwK9fmtCzFjNMo7KrDH8q+VvFVzdaf4pjvILhhdROJo5O6sDkfy6V7f4Q8eweJLJFeeO3v1H7yAnv3K+ornjVU249UdmIw8lGNRbW1NjXkW3sbh2YkLGzEn2Gc15H4W1HMEfOCAB1rX+JPjiD7DdabZXST3EgMTFP4QeG/TNea6RdvA42nkdvUV4uKjzS1PfyuTpwd+p7VY3rMpKuquOCp6Gopdbntp1Drjv7EVyNpqLSqro/OOMHH4H8aS+1ETWodCcZ4z2PcY7V586d3Y9iM9Lnpen6utwgOVz+Va8MwYcV5FouthW2s5A7V1UWvhAAGXPrXE6Ti7M6o1YtXO+FxjntSm5HTP0rjIdeSUYLc9etaMGoeYM5zUyi0awkmbpuDnB4NMMhI96z45iefzqyj7gM8GsJI1fkWoXKnJOT+lSecD/AI1UYtg7SM9s9KYGO8cilyhFmkkvQj0pZX4qgjFWGMfhVkAuvPWs3Gwpsq3ExHHftVNg5kRl+8DkVqfZCxOetILQ7uBgVHPYzaT0EhlEg/ut3Bq9awhyC5wuarC3TA3KCR3p6lkAVJGx6HmtqdaN/fOGphH9guXVwVjCp93HQdqoHfIxGcfWlO8+mfpUN5BdTQlYLhrdm6yKgLAegzwPrXpQxlFLRnM8JVvsR3WpWen5R2MtyOfKjwW/E9BWRfalqWoL5UVz/Z9uR8y233z/ANtD/QD61Yj8PrAMqzux5Z3PLH3rS0fw7PqV2sFqu5v4mOdqD1NYVMU6jtE66eHhSXNM5rSPClpcXax21obm5c/ecl2J9STXsHhDwHZaUUurmKOW8HKnb8sR9vU+9b3hzw5Z6Jb7YhvnYfPIRyfp6CtuqjTtrLVnJXxLn7sNENjjVBha4z40j/i1/iD/AK4D/wBDWu3ArifjWQvws8RE9Bbgn/vta7KcerONmwSWbPT1rzP4gfE1dJmk0zQlWe/5Rpc5SI/1P8qNf8UXuqtLaaYfJtM4aZT8zD29K841Tw3HaXCz2xZkdvmDH7p7kf5717VCFOU7TOCopxhzI67wbbSTrNqGoStc39ww3TSHJx6ew56CuwjiAHXPvXN+Gbdvs6biQuOB6CupjChABwBXrTSWx87OblJ3IpIxz2zWZeDGa1bqRYhzWPczo5PfiuHEL3Tqw71Oa1dVJDjhs07Sj5lydnIUAH8M/wCJrP8AFkzQWU7xthtp2n0PapvDUypCgB6jk+9eJX0kkfW5fHni5PodiqhoxkZ4rD1TRIpX82FjHL1yBWxBJlPaifDYBrByaO+2pladdSxHyLxD7N2NaItopJQ5XoeKrELv5ORVpJAvfiuSUVzXRvfQv/KFwKhdwoJ7VDJcDHbGPWqctweeciiTui4RLMs+eARUDE5y3SqRuAH4x+dSLKzE5IP41ySjqdOhZLHnHNQ/MFDPgH0HOKkDn/GgITIWJPIx14qXoCAYbGe9XIWIPtVXABxyTViPjFZPUl66GhH8wGBUgHrUds3HIqYt8vHrWDRKEPFNB9KVn9ai2+nBJppMdiQkHGQDnvRERBIXjC7unIpgU+tLgd6uLad0ZzipKzRK92WP3fwBp8V8sak+SWbtzgZqv8opkkiqD0ro+t1bWbOf6pS7GfqNzqOoMVnfZF2ij4UfX1/Gqi2jBgnJdjhUXkmtDdLPKI7dC7scAAZzXoXhXw2mnRrc3gEl6wzk9E9hVwU6z1HUqQw8dEUPCfhNbZUutRUNOeViIyE+vqa7MAAYApTSCuuMVDRHk1KkqjvIUVhP/wAj/b/9gyX/ANGx1visCT/kf7f/ALBkv/o2OuymrGbPPpT/AMVv42H/AFE4f/SC0p7Abqr3jMvjbxrtVT/xM4eT/wBeFp2pJZJNmC/PsAP/AK9U46lp6Gbrsu/MY6Lx+NZEPmoD5AzKB8g/2jwP1NXrzknPXNM08A3sanG0nFd+DSU437nLi7ulK3ZjvDtlLb21zFLKxUyb944LAgDj0HFVtajC27KqgKOwHSt6WVY710OMuuR+H/66yNfiaSBwDtOK+graq58pRfvHzr49A/t7g5O3OB9azFZoTHLCzJImGDKcH2IrX8awPF4nYMCQVGOevr2FZiKGQoeWTkH+8vcV4NWVptn1mHV6aITGJm80nMmck/3qtW6qCDnjsaRIzGRtG4DoMdR3FSunlFWHKOAwNYOzOlaFuG5NvIpLZjPB/wAaLq48qRwGyr1lXLsrMOwORTGmLIA3Ud6hq5anbQuJdlG4PGcg1rx6mWhUE844rmN2cj2qdJSsK+tS6aY41Wjp9O1RvtCqTxniu30G6Z4sE52+9eV6Uzy3KBck5r1Hw9askByDnpmuLFKMWehhZOWp1VnKSwPUf1rWXkcDmszS4S5zg8Vq+XMFyIm2+p4rjlY7thr/ADptywB44OCPxoBG7396hknCuFbG72NM3hjn86nluDZfibPXkVpWq56dKyYWG7A7VqWsmFGOKxmrkmgsYx7UMoA7YqIzAL1ppmGc54rBwGhpQljnAHanBAOopjTqOhpjXIIzS5bDbJ/lHOPzprShc4ptnHcXr7LSGSZu4QZ/M9q6jSPBc85EmqSCKPr5cZyx+p6D9a2p0ZTdkjGpWhT+JnOabpl5rNz5dupWIH55Oyj/ABr1TRtMt9Lslgtk2qOST1Y+pqWxs4LOBIbaNY4k6AVbr1qGGVNXe55FfEus/IYRSYqTFJirlS1uc9xAa4f44c/CjxIP+nYf+hrXccVw3xvP/FqfEfH/AC7j/wBDWnFtaAefeWsSBUAVR2FV5YvNVlP8QxV6VaiC813RbTuRLazNDSRthGTyODir8t0EXrWXbEorKPrUGoyP5fyn3r6GE1OCkfKV6Ps6rihbi/8AtRUxsSGxikiGUznk1ytrdtY3aQ3H+qLfu39PY11FkD9niJ67R1/z9ampTurlRfJoc743tXl0e58oEuoEgA74IP8ASsDwxehlTDfrXoN1EJgwP3SMV5XJbSaFrjWjk+Sx3xMe6+n4V87jKTjJS7H1uT104Om99z1C0n3L1xipZZ+B+vNc7Y34EJwR0pbvUcx/JuJ78VzSjc9W9jaMo37icD0pBcL61wF9rFzbybn3j69Kji8ULnEkhQ+5rnlSaZcZqx3txfxRKdz4rFudXjBOHyAfWuN1PXHlBKSA/j1rnn1hlm5//XVeyYe2PU4b4SLkNkfWrtpdZbBNcH4cvzNJsU5BxXWWrEEcfSuVq0rM6YvmVzp4nG3LHAp7T4wqRs5PTCmoZriLT9JuL+UK/kRNJsJ64BNZngXxQdftLkaiFt54yGXb0IP+FZTg3qti46mrNJLEqtNEyKe57UR3ik/e5q7cPEYWjLiRH4P0rkNOeQgh2xg1EqaW5rKFo3R2MFwDj5qupMMYJGa5+3kwAc5yKtJcY781lyGDZsBwTjNM83Hfisz7aF781XlvwDjP50nAEzaF0oPJxSmZW6MK5mW/U/xfrV7w7a6lrN2IdPhaRR9+RuEX6n+lSqblohSkoq7NZmyo+bINOtbO4v5xFaRNLJ3A6D6ntXWab4HRcNqFyZT3WMYH59f5V1tlZW9jAIrWJY0HYd67aODk/i0OGrjYr4NTG8OeHItLHmykSXTdX7L7CuhxxQKWvThSjBWR5kpym+aQ0ikxT6SolTQrjawX/wCR+t/+wZL/AOjY63qwX/5H63/7Bkv/AKNjop/FYGeezrv8ceNfQanF/wCkFpUV3gcd6mmbHjnxr/2Eof8A0gtKrXILSsa36lLYxr09cDmq9sxSVGGcgg1ZvhzVVcqCfQV0xlyLmRDjzaMv6q7bYp4wGdSG9iP/ANVP1CLdGepBqOyXztP2ckpkH+f9anSRZbFckZA2n8OK+k5va0lJHyE6fsazh2Z4T8ULbyNVsphkHJUn8q5qa3ZZAUGCV3p9O4/z2r0n4sad5unpcxAb4H3/AId64aEfaNPJi+We3/eLz1Xv+R6+xz0FfP4n3Z3PqcC1OlbsUwm0ZUYx2x0Pp9KYJVUlHGUfkZ6g1LcsskG5FAdOSM9V/wDrfyxVaMLcRsjHDfwn0P8Aga5eY77EEwWQFf4x07Zqo33eO1XZo9yHIKzRcSD29f8AGqPVmI69xVJmTBRnn2p24lgPeliUMsgHUAH8qbzvyOgOKq4jqvAdkbjU1UJuZV3n0GeBXudrokcVliMgMB17Zrh/D2iyaR4fX7OMX12qyyyd1B+6o9MDFT2ugXeoRyxPPPDOFMkZDkFj/dPPevDxLVWfNzWR9FhaHJTStqaL+MItIvpLKbTrrcACHUKQ30yad4I1jVdW1+ddSmH2V4yyR7RtTngZ61Vs9HeezFtqDMzpyrsc/rWnYQtau7RIBsAUkDqc0JRlGxtyWOlvbUXCGCdQHTJjcdVz3+lczbSyniT7wODjsa2LzVvLtsSE7gOBWLHIqqDnk8n604wcNBVbJLua9uxwOauLPgD1rE+2hQSTxTH1FR0an7O5yuVjoWuj6896q3OogZ+bp6Vz8upnbxWbLemUsFbOD0qXSSBSNy41gg8HivUPAvhQXNjFqGtqxMvzR2xyMDsW+o5xXmHw70f+3PFMCTLutbf99KDgggHgEd8nH4Zr6PswNgP4DHatKGGU3zS2RxYzFOHuRJre3igjCRRpGoGAqLgD8KlbpRnijOBmvRUVHY8tyuKBgUZ5pm7J5xQXA/jUfWqsSmSU0kZxnn0puSR/A3pTGcIDkMnvjIqJFJjySOoP4c1w/wAbTn4U+I8YI+zjv/trXZCZyPk8uQeqtiuG+NTGX4WeIywQFbccZ5HzrWV7Mo5KRcHFNEfzdKe08K/ekUN9c05bqFhkMfwBr0IxZjJjljwrMemKqzxF1NT3GpRrCVVSzHjJ4qc7GiBHIIzXsYTWnyvoeJmEeWop9zkNasFktnDYyOQau+D78ahYPG3+vtz5b/0NaN3bCZTnge1cvEF0HxDHIfktboeU/oGzwx/H9DXVT1Tizjm+ZXR1crLGxC5x6nvXFfEO1ebTjdRJ+/tjvX1x3H5V3DQuzkIjOT12nA/Fv8KqalY4tXV1XBGCAcjFcGKoqS1OvB4h0pprc8o0nWBPAG3kcDvWhLq0sceI3WQH+FuDXB3i/wBla7fWRzsSQlR/snkfzp8t5IVKxtx/davI9lY+s9uppSXU29Q1WOeIxufLf0YcH8a5e6nKMQeR79qVrvzV23A4PGaozDA+Vsj+VQ1YfPfYkS92sFYnbVe7nbP3sn1qtJycU0k7VBPTvSt1M3NnZ+B7oeewY84BH517XYacLu1V1wuRke9fN+kTPHcx+V1aQKB654/rXueo/wBpmGOxtPMS3iUByDjf+PpXlY2DU007Hr4F+0hZmd4lsjeagLZtaDKpANon3fxx/WrFnpMmnTRS2yfIRtfB6jNT6X4f0+ZS0MBguR1BPB+npWytpJaxlZGCoOCM5qaT11Z3OFtEhvlyRK6GQnHI+lZSyFRuHANW767DJK6jG7CIPX/OazXfbCA4wKVR3sOr7qUWXIrt1Ayc96sHUDjr2rDW4VcqGBNV5bvBJDdKUUmcTkjoJL3LE55rO1DUTEhYBn5wAOtZwvAw6/T3qrPOSTzmm0gizf8AD8M+u65aadbkh53wW/uqOWb8ACa+l9E0+10ywjtLGJYoIx0HVj6n1NeL/AWxQy6pqj8uCttH7fxP/wCyV7lbn92uMYrrwtFJc7PJx1ZynyLZE9B5NNzyBQx5wK7bHC5C7vSlH4U0fhQSfY0WBSHE8U3d/ewPamsw6lTx6VEZMnCOp9mFZTKTJz7VgE58fW/tpkv/AKNjrTfb0dCnup4rIix/wndvtCY/syX7vf8Aex1nD4iuh5/cnHjrxr/2Eof/AEgtanljDISKguj/AMV541/7CUP/AKQWtTTS+Wg7ljiuicdEOLMO6QHPFZ8nyrgdSa2LlcMQRWPeOFkA7USl7pUVqSaTMq3TRPjDjj2I/wDrZq2ieXdyxMVCsN2T2+n6Vyep63BozpdTnKqwyoGSR3xXV6ijbhMhiYpggBslh9PSvoMsnz0eV9D5zOKXJWU11X5HM+MbdZtNnjbkFSMmvGLaV4I4pUIDKSpz/eHBH0OK9d8X6xaLYTyNKqYyDGSN46dB3614rp5MluQ5+8xLD6muLMIW3PQypu2uxakIR1mh5U8hW5+oPr/Xg9+K7hY9skfMLggr3X1H8qequjlQTg0mMbhk7GI3qOcEdGHv1/UV5S0PaaH3CmdBPCx+1xD5hj/WL6/X1rLmjHE8H3CcFf7p9P8ACtGMPFIpRuVOVZfX/P8AhTp4E+a4gTKNxLF6H29u9OLtoTKN9TOhKqwkA47j+YpZYSshHcEGrIthk7DlJB8p/wAfcd/zpxBaDfjLR4Vh3I/zxV3uSlY9+t5UvdKt7qFh5c0aOpX0x0qYXwiZDKMleh74ry/wD4yTRf8AiW6vubTycpIBkxE8/ip/SvTTPpOpQrNZX1vIuP4ZV4/WvGnSlSnaS0PqMNXhVimnr1Ld1c2twu/lG68VSa5jFuQgKxZyzH+I1g6nrej6cxRLhbucHGyM5UH3PSsZ/Ei3GXkkAA6KOgraFB9FoKriqdPRO7Ny/vPNbdnp2qhLqKIDlga5PUfEO522twKxpdaduhrqVFvc8mpiVJ3bO1l1Zt3Bwv1q1aztMMlsmuBh1BnYDPFdJpF2Tznj0zSnBpCjNS2OkZsECq0m1Msijc3YDk0zzg3PrUZuFByT9K5rM3R6j8EZAk2rF8b2ERH0+evbbJ8wJ718/wDwjn8zU70xk7Qig/Uk4/ka95sTiNfTAxXfh1+7PFxv8Vml94j0pHYbsGhPu5ppP+1j61qcjY7eq9x9BSq24ZGPpmmgt2K/lUMuSDuhV/oc0WHcklaNGGQd7cYXr+lRMzJ0kYezDcP8agMkUZJAeBvUD/DNR+fIT+6uIpMdmXn9KmSKTJXJLAvERjo8VcT8aJFk+FviFfMSQi3H3hhh8y/57V1jTzO2bpmRB0MYyv4964/4xMkvwv18rIsg8gck5I+dfyrG2pqmcqLYjgCoyjr2PFdGYFqN7ZSTwK74ya3MWkzmJ1JPSrMN1shVWz8vGa15LFPTpVaSwTkdDXXQxChK72OXE4f20OUiRzJgDkngVh+JbEX9lL/dwSpx+Rq9IJLWV0kbHykgj+dW7jaLckDIA4Hv2r1U72lE8KUXTlyyOe8KeLbMS/2TqkuzULYKm5zgS8c49weD9K3tS1KM20rqo8pFLM7HAAA5NebfEDwuJrczQpl8ZJHXPrXl9trur2kE+nPez+UQUZHO4FSMEc1z4mrFLVbnZh8Kqj5oPUh8Q6wNQ8TXd3BzEzYU+oAxmla5D+o+tZhtNjAr0q3ATkAqG+vWvHvdu59BGPKlFCzMSvXNRLkcbquxxRPnLYOPunvUEi7TjFZTNUVyTn5hSldyqRznvS4ydpIP8xShmjc8fKeo7Gs2OwtnN9nuoZSMqjq2Poc19M2dyt/YxXVoQyTASKR7180NGGBZB/vA11vgzxtf+HEWAj7TYg58tuCnrg1w4yhKqk47o9HAYiNFuM9mexzPKjFkUBv7wFU9l1dPhmO0nk1kr8T/AA+0e+VbiOQjlPKz/KuT8T/Epr+N7fR7doImBDyMfnYeg9KxpUqj0krHqzxdKCvdM2Na1uBLto4nBig+QMOhPc1hap4pTyf3Z/KuIl1N3Bw31BrNmnOTgnntXZHCp6s8atjXJ3R1zeI5MowJ9DzSrr7OxVj1rjY5fl61IkpD8nnFa+wj2Ob6zI7qz1MudxPPerpvA0pHeuOtJipPNWjenzxz2rnqUFfQ7aVe61Poj4G6gBZ6haZ+7KsmD/tDH/ste6Wr7o19hXzf8A1d4r25IIWWVUU+u0f/AF6+jbZSqg+vzH6100Y2gkeTi2nVbRcHXNNHXOaXtTTn2P1rQ52xxye4prMw6Jn6GkJx1Q/hUEjIDgmRD70Bcc0x3fvW8tew/wDr01mSXgyIV9+aheQ5wlwv0YZqnPk8PAjg9161nJFxZaMsaSFYZXIHXjIrMtWLePISQuTpsnKjGf3sdSpMsahIn8vn7jj+VVtOdn8dRF1Uf8S2Toc5/ex1mo2lc0ucLd/8j540/wCwlD/6QWtMv3xJEv4069OPHvjT/sJQ/wDpBa1S1qXyrmP02f1rpeiQR1bLN4oEW9jwBzXFatqAjDSkFsnCIOrH0ravLuW4txBEC8j/ACqoos/C7eYLi8/eT4woA+VB6D/GuSUraHQonkOsaTrmo3ovJQgX+GIN92u78J61crax2WpW7bo4/LWRccqPug49K6650JUi5Hzeg7VjDT/s7HaOT3Irpw+NnRb5TGvhqdaPLNHm3xPti8sGEOJGJLY7DH+fwri5Yj9qcEEyj7yjjfnnI+o5+v4V7prugLqumNG3Eq/Mhx3ryvV9DlTM0QKXNvlXjPUqD/Tp9MGtKmIlVleQUaEaUeWJjBN5C5DEj5T03j/H/Ch85XP+sGcEj7/t9atNslhDrkJnJwOY27ke3qPxqOWPzP3U2PNI+VgeHHYj3/8A1fTma1OuL0KrjKnYMex7H0+lTQtucOi5yMFTxvHcfX/9dRxtsk2T5443/wBD/n/69gw/K2xcg87c9fcUvIq3UZLF5ab1+aJzkEdcjvjsw7/4U2VDGRLjMTDa+30/z+tWYJk2usoLo33scZ9/Zh6/gfeMkWbiOQiW0k6EDGR3+hHcdqpXIasULyBkiDcM0eAcdGU8g1nEDIx91hx7VuyxeSDBI26Mr+7cfxKe39axZF8ssjdAeK0iyJIRblx0OGHFDXbBmIJAPUVWlOJM5+tQu3JrVJGDky35xIJJyKTfnAB5qrvwi1NGu50A/iAoYJ3NawjZ2AUE11Ol2d0wCxQO5PpjNTaDouyK3lbHI3Z9/SvTtFuRBF5ZYpITgKwwT9OxrmmpT2OmFT2aOBl07VoIfMl067Ef97yjiqAuMkg8MOoNew/2iycbq47xXo8OpXUd0j+UzMFkKjr71jGLvaRvHE90dt8H7DytK88qA9wfMP8Aujgf1P417ZYkeQg4yAK818EbEiRUG2MKqgDsBXfwSlRjPTiu2EOWNjy60+ebZrocL3NIXGQMHnuRVT7UDncBz6nvSxuTknj6MWH60+UwZZfYANw+Y8DA5qJ4gflUyKfZv6VGQu4MIwf9pDz+VQtLhsC5kU+65/nRYaY+dpY2KidAwHQqf6VSmdnO2WGOUeqdT+Bwan8phCxjdJSxyWY4NUfPkicsLZWZen71TUspDm2xj5Xnh+qkqP6frXHfF8s/w115iIZR5I/eDqPnX/PWuySV2+eWQxyN2YFR+B6GuQ+MFup+G2vSMRu8gYYdT847jrWbRaZUMkvqKQvLirBs5OwNTQ6dKx54r1OVHLzGc00obGKWcSLB5p6d634tMjiBeY/ia5Lxl4ht7eI2FkN8p+8R2rOpyxjdmkOaTSRy/iDxRDY6ja2zxtMZH2SY6RoeMn8+laWj3Mk7tBMMCJuCf4gM/wAjiuWuNJM6mRjiRuTkdTXTeHHMkLRScToBk/3veujLMWpp0pb9DkzXCNRVWC23Ne6gWaBgwyCK8M+I/hS5trk39nDuAOXReuP617qsw37W4NVNSsEu4WVgOa7cRR5lY8zC4h05Jny+gJj8yPBU9QalhUMMsCMdsV2XjTw6dGvTdW0RNtIT5qgcL71gRxxSnNsdj9fLPf6GvEqpwdmfTUKiqx5olIKrDDjOf0q3DBJgrCVlUj7kg60SrG74mjZD0LKP5inJC6ofszpMo6qOv5GuKcjtil1KF5bxhsTRvbv/ALS5FV0gnHMbLIvqDn9K2TeyeXsfO0fwuNy/r0qForWQ7hG0LHvGcj8qXtGlqg9n2KEcbscgbZB0xUsigtiVTG4/iA4NXRBIR8kqzqOzDn/Gmn5DtlRwvoecfnzS5hqNii1uGGCArHo38JqpPE0bYmXb6MK2khibmGcIx/hPI/GmXMUioRNEGX+9Gcj8u1VGWonHQwZY9wznn1qs+cYPUVoTIoz5bcjseKzpz3HFbxZzzRHuwT71MrhlU9xmq3U0+H73JwKdzNGr5vlsvuKJxIj+YDuB9KrZ81lPQZxmup1DTkt9NtbqNwxOA49D2rOTs0jaLdrn0H8D7IW/hu3R/vqOfqSS388V7dbygqBkda8a+DDsvhmzmcZDZBz9TXqkDErweOlXBe6jkqu8mbO7KAjP4UwNySSfYHis/wA3nBxgmrKuFQ5IAHXNOxmycyNvO9SqD05zUTXUKqS7kgdsGmk4O5WK57jkVGJGZ8CWNj6EYoaAilkLxh2jjw3IXANV0hUlnJMKqM5DcflVjUYvkLG3yfVTWM20kB0uFGeMnIqGaRLu8kcSK6nsy9aqaPgeOU+QJ/xLpOh4P72OrsTiQYV0Y+jDaaq6Zu/4TqMMm3/iWyd85/ex1Fi0zgtQOPHvjT/sJQ/+kNrVLW9PvdU1Gwt9Oj3tIrb3PRACOT/31WjNZ3OofEjxlb2kZdzqMJPoo+w2vJPavR9I0yLS7ZIE+eVvvyEfeP8AhXQ480YkqfI2c1onhOHT48sfMnI+eRup/wAKmuhDE5SPHua39WcpAyRD/eYVy00LhtzA4NZyoq1kXGo3qyCeDeOOay57EZ+Za1XEgHy80JDK55Xj3pRwr6FOt3MQWY3Yxiuf8XeDBqMf2zTHMeooOVzgSj+jenr0Nd7K0cS4Ay3sKrMHlBIHWuhYd2szL22t0fM80H2e7dlQx3C5EsRBGfXjr/UU6K1tr2MFG/d8gx94z6g/0/8A117R4j8JWevSN9pBt7oY2zoOePX1/n6GvPNV+Hmv2t00liiXZ5HmxOoLD0dWIz+GfrXNOhNHXCvFnE6jYTW4ImUyx/wzocnHofX/AD9KpwXBtgAwEkR5+n0re1WTUtJzHq1nPayA4BliZVY+xI5/zzXKX17DK7NGhjY/3cFT+VSoN7mvtEtUWriWNyTE/PY9z/jVNb5lUxvhoyc7T0JHp6GsmV3djtB/Cpbe0ubgKoQnPT6VfKorVmbqOT0Rfa+XyjEx3R9VPdT/AEqjPcb1wTlhxn1qaHSpXMyENuRT+hAP866PSfCiSxaXczsEguA+c9TtbaaidSFNXCMJzdjjJJCxBH401UeQ4XkntXT3PhWddVlt4ugchTnimPo8lsqNITuIEkTDow/xFP6xDZMX1efVHOCKV84Rjjg4HSuo8MeHrzUJVk8h1gXgyMCB9Ae5qXw7qB03WRN8oWUEOuOCM+n4V3Vtrb3LjsOygZOPf/AUp1HsEadtTdtbYW+CgBVcKR26D/GrRuVVGUqhQ9jWNFf/AHvnABPTPtULzNLIBF+dCnoNx1NSS8GT5bsvtnP86pyX3PzsSPemR2tzM2FjOTU8vh+8aEtt59M0laQbHq/gRkm03ehznGK7i2Yqo3DIIxmvH/hZfyW7Tafc5WSIggHupzXr9pJ8uDyDzg11xWmpxVFaROWyODyP5Vajk+UHPPTGR1/H/GotiOQVJXvz0pVikjIIIIPoaDPctJkrlmy3rjFRsxcZWVimcYK5H9KjLiN/mABx6gZqRSJF7nPTBI/UUNAh0sYeHJtw/f5c/wAqw7lNjHEFyo9Vz/jW3bSDzTHI3OMAbs1Sv4/Llz5bsOo+XisZ6GkOxBBKABiWVUP/AD1jJB/HArlPi/Cp+HGtMIoiPKB3RnA++vaulgkkacvIkgYnsVIH65rA+LggPw31xmcCTyVxkFSfnX86E7oHozqhaKD90UstvHBEZH4A6VprEGYGnFEMoZgGcfdHYV0+07GKOL1LT9U1Y+XbEWsB6yOMnHsP8a5q88N2FiSsQae4zl5nOSTXo+tXLRxGOI/MfvH+lchKjFzu61Ek5GsJW1OSuNKkz8oOKrw2U8Mobow6V2LL2CnNLFYea25l/GnHD8r5kU691ZnPTRNLCSV5PvTreQkFJB8w6H1rppIraEbVAZqyb3TyQXiXjrj0r26GI51yVNzwMTg+RudLbsYuq2MN1EyOgIPXNeNeNPDB0mdrm0Ui1P3lH8B9fpXtoPlf64HYM9OuaytZt47q0bIyGHT1qMRhuZBg8XKlLQ8DMz7FMg3qejdf161Gqo7japDe/wDjTbpRpWuXdi5JiRztYfw55xVhSrruX7nTIFfO1aThKx9bSrRqRTBlKnDEgH++M/r1pjISQYyuR6GrCyEJtjnA/wBlv/r1ARIrFjHG3fgf4Vz6nRZMaruc748fhkVMt6yLtc7l9Cc/zqMXQRcNGV+maRryIqdwc/jStfoP5kc89ucloUBPdSRVF7pUP7tnX23ZpLy6jGdqZ+tZWXnk2xpya3itNTnnLWyJ5rh55Ni/MxOBxVweH7oxB5AR+6EpH16CtfQ/D58ia6nGDGg59GbhRXU30wmuLryVAj8tUU/h/QLWFSu7+5sXChf49zy1ognyiI7z6mpreCQgYQgHuBxXbwW9s09qHhQF2DZP93gf5+tVrKe3k2W3lgFl8oN3DEYB/PBqlWctkJ0IxerOZlgeF0DDnIbHZq07e/e6tPIYExKO9QO/mymI4LfeQj+VR2mdzJGpaRjwoHWtfUhpX0Ppv4KXsV14Ms0BG+MsrfUMa9Xt1OzMRyD2r5m+B+rtpmozabdkoXO8K3HPevpGwuAyKQc+hrohrE4KqtIt5OeeoqzHJuTqDjtSxNvXc2HH60n7sPkIwx3zTsZ3Jg7bWCnDY4PWmueFLZYd+M1AX5OzIGc1MrqyENyDQ0IkmRJYSVMnHHBrE8lvOJSV1A6kkGtm3YxuYmOA3TFZmpQYZgfOYHt0FY1F1Nab6DLeUyEjcHX/AGl61Hpgx46j+Xb/AMS2Tvkf62Om2++Nh8sgA9WBqTTZDJ45hzjjTZP4cf8ALWOkndFWtIr+GWjh8SePJSoDtq8Sk9yBp9ngfqfzrSQyXl0DkiNTWFo5ZvE/jhF76xF/6b7OuttLbyohxyea3g7IiSs7izojcMoJPc1nzWUbcnP0PNaEgYnpTWDBc7c1aIVzmru3a2kLRhcZ9P6Vi6hcahFueOzkmj6jy+f/AK9dXfENkYpLFFQD0q1Jp6F201PMrrxJjKS2N0jg9Nmf0BzVZPGMdtJiWGcIeRvjZf1Ir1u60mw1DH2q2ikI6FhyPxrPuPBuiy/8uqqfVWI/rSdeqtkikqb0aPOL3x3pkkYEsckRAyeM1jXXjvTUAFvc+U2fvMMYr0m8+Gnh+6BEltJ9RM4/ka5+++B2hXJLRXN/B7LIrD9VJ/WhYqot4opQo92eF+OL1/FmqRxR38bW6AbRvzg92x1qJ/C+laPDHJcTJPL5YJSJs/OecE+39BXrt1+z7al99prU8TDkFoFYj8iKzb34A6w5zD4jhc5B/eWrLnAx2c9q56k3Ud5I1i4R2Z5DYaTZTZkJCw7j8uASeeT/AEFdBNbWmm6FPfbUN27IirjhVJBI/IY/Guv/AOFC+LYcC31TSJFB6O0i/QcIaLz4H+Obq2WKS70Vh5vmMftEmCcf9c/auacU3dm6qxtZM8wsiI7eXeQD5aQqT3Zsu35DH5VMl+bjTbONDgWt3IoXPRXIb+pFegS/APxrIU3X2iKqljjz5eSepP7uo4fgD4ytomSO/wBEJYhiTNLyR3/1dD5WhqqrnL3t6q+ZIMHY/wB70+4D/M1gX8zXVoQDhkZmTP05H4jA+oFehTfBjxxDAYQmnTrj+C6PrnPzKKjsPgr4zM+bpLGGIkk/vt5H0xWEIRhqjaVZS0ueUtaXF2YntYJJCAdwRScHNdFoul605VEgMee7rk/lXvHhz4WtpFt5bJ5jE5ZuOT+ddDF4ReHBFsD+IrXmlLZGLlFO54vpPha93q1xKCfTFdbY6BHFyx3NXoa6DOvSEKKa+lSoclfyrSNPuZupc5i205Ix9z9K0YrNWGNuB9K1fsjAcgj8Kljt2B7VvGKRnKRx15prW+pR3dsQky9DjqO4Ndjo2tLIqpMdkg/hJ/lSzaaJl5HNZ1xoUpPyjNdkOSSszlnc7e1uwVypVh6ZqbzEYgntXnZGr2ePJm3KvRZBn9etTQ+JLyAgXtm+B/FEdw/I1To9jPmO8MqA4SQk9xginRSYJyTjt3NcpD4msJwoE8cbej5Q/k1advfLJjZiQH+6c1DpNC5jfDF0+VvmHv1FJdBbmHeC5I4IR+hrLjvwr8ZU+hNaVpcxynJOQR8w5rOdN2KjNXMwwgAN5WB6vIR/jXL/ABUdj8N9dHIHlL0fcPvr6jNdvfxOXyzRKoHAwTj+VcN8Vcr8PNbwWIMQzhMD76+vNcifK7HQ1dXPTSRDHlj81UraeSa6JUYjHWnX5eRtq81ZtoPJjHHNdCaSOe1iC6tUk68nORWZc6WkmScfhxWy24t0oZAFOVqlKwanLpaJDLtkXI96Wa0c8hvl7AVq3aBjjFTWyDaAa3VSxMo3ORu4GQ5wfwqtHeiF8TKSvqBXe/Yo5PvAYqKXSbZwR5ajPtWkcTBboycJdDzvVoorr95bFUGDxjqa5K+YEtC4kRhnDE4zgZJFew3Hhq1lUgbl+hrn9S+HcN2CBdyqO3tXZDHU1GzOOeBcpc2x8meNLFLXVlliYsshO7dye3NZCloTuRSUP8SHpX0jrXwIW/JK6vKCem6MHFc9N+zzqMZza65GD23Qn/GvJxE1ObcT2KHuRUWzxkXCP18ts9m4NTLEpI+RhnpsevVJv2fvEDH/AJCenv8A70bClT9nvxGTxqVio7Y3/wCFcUkjtjVR5abZcn9/Ko9DVa5hjReJZDXsK/s++JgMHWrLb6FWNQ3H7PHiBwf+JxZk46bXFZpJPVmjqprQ8WgsjdRvO2RAjBSzdM/55rU0yztY7o+UQVyME+/+f1r0W8+BPjGKyFtaSWEseSSPOK5J+o9qpQ/BLx1Cf+PazJJ/5+R/hVNprcmMkmZN3epFotxDFg7po3PrjoB/Os9Z98TKpIwPLUf3mbg/oSPw967QfBbxzIW8yPTxu7G44H5LVu3+CPjBAC0+mxsvK4kY49/u9axUbaI19rHc83lnzcO6kBIxtUj17Afj/KslxNDOs8fJVg/HbBr2zTPgBeKu7V9ZYDOQltHj9Wz/ACrcg+Deg2zbp4J7sjvJOw/RcCtoq2iMpVUz5z06zuri6Jhj3uT27V6Z4R8LNax+ZLDi4cYJPJr12Dwbo9onl2+nRQgei1o22jQxcImBVuDnuZe0SPJLvwzJ9vS5jLRyIdyuvBBr0bw/4lmtkSLUF5AwZF6H8K6L+xopFwUGagk8MJglRiu2kopWZy1JOTN2x1q2njBikRj6hq0Y70N90gmvPbnw55bEx7kb1UkVCqazZ/8AHvc7wP4ZFzW3sU9mY37npLTsH+fAPsMVJFN2Ucewrz2LX9TiIF1Yhx6xt/Q1eg8TR7v38F1Fjvtz/KpdFoVzvVdZVHOGHSnTxm6i4LBxwecVxlv4ltGbicD/AH+P510Wm6xb3AH7xCTweetZVKLsOM7MiuI4wxUYbH8THqai0PH/AAm0WCP+QbJ0/wCusdatzAoXcnlqp6EDJrM0cH/hOkzu/wCQbJ97/rrHXCrp2OrRq6H+EYVfxR46du2sRY/8F9nXVsv5VzHg/wD5GPx3/wBhmP8A9N1nXUGtUS9yMRjNLIoC9KlAwKimbijmFYzZ7dZH6VItghHBxViOPJzU+AOKcZMbtsVVs1UfeNRtbOG+Vs1f28cU0pxT533EkUlhkHXmnBWHWrWMUYzRzsLESkDqalV0A/8ArUhUUbPepbHYeJEzinhwahKc04JSKHll9aYWUdcUFKQrSdgQgZCeKU7SeAKYY+aeg5qVYqwjAdlphUntx9Ks4FGParsibsptDkHNZ1zbqD92t7bxUM0IYdKLgjlJowDginLbow5GPpWteWmQSBmqqR4HPFVFpsGRxWyj3qwtuCuMZpyDBqdOnvWqZmzPuNPSQfdFZ0+krz8nFdIabtB7VpGo0S4pnG3GiwvnfCD+FUZPDVoxysKq3qODXf8A2eJuwphsIz0NbKuupk6b6HnZ8OXCEm2up4/beSPyNPSx8SWeWtLyFx6TR5/ka9A/s/8AukUn2FxwACKr26Zm4SRheH9cuZk+ya3DDbXQHyyRtuRvpnkH2rE+MUO34fa0WzkRry3++tdJquhSzRlkUbhXF/E7ULg/D3WLa/jPmiJQJNvLfOvX/GuWtSjL3oHRSm1pI9djiBbeQPapCKdSdTXMaNDQo9KRwMc1JjFRSnsKGw5Sm0Cu/tUq2oHSpY0I5PWpcU4yYNIhEOBwaZ5bg1aI4ppFPmZPKQbWxyKAMdRU5o20cw1EiyKcCtLspPLqXIpRFDJmnhlpgjpwjFK4xSykdRUbOvpxTymPSmsoqXYaGqyelO+U9qb5fPFSIKSaGxh9hTShPWrAFLiq0EU5YMrWVc2+CcKK6HANV5oA2eKbYI5R4xvwRz71KtujYO0Vp3loR8wFRLHgdKqLTCQyGBewqwIOKSMetWFODWqZkynNaK/UCqMumqTnaDW4aQH1FVGbjsJxuc0+m8/dFRNpqtxsH5V1m1T1XNH2eM/w1qq/cydM4x9Chk4ZB+IrNv8AwXaSKWQvGx7o2P5V6KLWM+1J9iU9zVLEJC9nLocZ4dvLjSStjezPNak8SSHLJ+PcVsacF/4TuIoQVOmyEEHOf3sdWdS0FJxmNsN7isvw9Yz2PjZIp2yP7OkK85wPNjrnr+zl70dzalzLRjLafWdC8S+KXTwtq2pW2oX8d3BcWc1oEKi0t4iCJZ0YENE/8OOnNaH/AAk2r/8AQieJP+/+nf8AyVXWUVzm1jkz4n1gjjwJ4k/7/wCnf/JVM/4STV+/gTxIf+2+nf8AyVXX0UBY5H/hJdX7eBPEn/f/AE7/AOSqP+El1j/oRfEn/f8A07/5KrrqKdwscj/wkusf9CL4k/7/AOnf/JVO/wCEm1j/AKETxJ/3/wBO/wDkqusopBY5I+JdXP8AzIniT/v/AKd/8lU3/hJNY/6EXxJ/3/0//wCSq6+igLHI/wDCSax/0IviT/v/AKd/8lUf8JJq/wD0IviT/v8A6d/8lV11FAzkR4l1gf8AMi+JP+/+nf8AyVTh4m1cf8yL4k/7/wCnf/JVdZRQFjkz4m1c/wDMieJP+/8Ap3/yVSf8JJq//Qi+Jf8Av/p3/wAlV1tFAHJf8JJq/wD0IniT/v8A6d/8lUf8JLq3/Qi+Jf8Av/p3/wAlV1tFKwHJjxNq4/5kTxL/AN/9O/8Akql/4SfV/wDoRfEv/f8A07/5Krq6KYHKf8JRq/8A0IniX/v/AKd/8lUv/CUav/0IniT/AL/6d/8AJVdVRQBybeJdVbr4D8Sf9/8ATv8A5KqH+3tS7eAvEn/gRp//AMlV2VFKwHF/23qXUeA/Euf+vjT/AP5KoOu6r28CeJP/AAI0/wD+Sq7SiquxWRxf9vatj/kRfEn/AH/0/wD+SqT+3tX/AOhF8R/9/wDT/wD5KrtaKOZhZHF/2/q4/wCZE8R/9/8AT/8A5Kp3/CQ6uOngTxH/AN/9P/8Akquyop8zDlRxo8Q6wP8AmRPEf/f/AE//AOSqcPEesf8AQieJP+/+n/8AyVXYUUuZi5Uce3iPWD/zIviT/v8A6f8A/JVc98QLjX/Efg7UtKsvA+vJc3MYVGmuLAKDuB5IuSe3pXqNFFx2Ryf/AAk+sf8AQieJP+/+nf8AyVQPE+r/APQieJP+/wDp3/yVXWUUgscmfE+sf9CJ4k/7/wCnf/JVN/4SXV88+BPEh/7b6d/8lV11FAWOT/4SfWP+hE8Sf9/9O/8Akqk/4SbWP+hE8Sf9/wDTv/kqutooCxyf/CT6x/0IviT/AL/6d/8AJVL/AMJPq/8A0IniT/v/AKd/8lV1dFAWOTPibV/+hE8Sf9/9O/8Akqk/4SbV/wDoRfEn/f8A07/5KrraKAscn/wk2r/9CL4k/wC/+nf/ACVR/wAJNq//AEIviX/v/p3/AMlV1lFKwzk/+Em1f/oRfEv/AH/07/5KpR4n1f8A6ETxJ/3/ANO/+Sq6uimByZ8Tav8A9CJ4l/7/AOnf/JVH/CS6t/0IniX/AL/6d/8AJVdZRSsByf8Awk2r/wDQieJP+/8Ap3/yVR/wk2rf9CJ4k/7/AOnf/JVdZRRZAcp/wk+r/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXV0UWA5X/hKNX/6ETxJ/3/07/wCSqT/hKNX/AOhE8Sf9/wDTv/kquroosByZ8TasRg+A/EhH/XfTv/kqmnxFqZ/5kHxH/wB/tO/+Sq66iiyA4/8A4SDUs5HgHxH/AN/tO/8AkqkPiHVf+hD8R/8Af/Tv/kquxoosBx58Q6r/ANCH4k/7/wCnf/JVH/CQ6t/0IniT/v8A6d/8lV2FFMVkcePEWrD/AJkTxJ/3/wBO/wDkqj/hI9X/AOhF8Sf9/wDTv/kquwooCyOR/wCEk1cf8yL4k/7/AOnf/JVA8SauP+ZE8Sf9/wDTv/kquuooDlRyJ8SavkY8C+JP+/8Ap3/yVS6LLqWpeLBfXmgajpNtFYtAGvJbZjI7SK2FEMsnZT1xXW0UBYKKKKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The head-tilt chin-lift is used in any patient in whom cervical spine injury is NOT a concern. The clinician uses two hands to extend the patient's neck and open the airway. While one hand applies downward pressure to the patient's forehead, the tips of the index and middle finger of the second hand lift the mandible at the mentum, which lifts the tongue from the posterior pharynx.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39282=[""].join("\n");
var outline_f38_23_39282=null;
var title_f38_23_39283="Marshall Marchetti Krantz";
var content_f38_23_39283=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Marshall-Marchetti-Krantz procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 392px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     In: Gynecologic Surgery. Mann, WM, Stovall, TG (Eds), Churchill Livingstone, New York 1996. p.716.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39283=[""].join("\n");
var outline_f38_23_39283=null;
var title_f38_23_39284="AP xray of transverse fracture of little toe";
var content_f38_23_39284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F70754%7EEM%2F82505%7EEM%2F61555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F70754%7EEM%2F82505%7EEM%2F61555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nondisplaced transverse fracture of little toe: AP view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 423px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Hatch, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Nondisplaced transverse fracture of little toe: lateral view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note how difficult it is to identify the phalanx on the lateral view, let alone recognize that it is fractured and minimally displaced (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Hatch, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nondisplaced transverse fracture of little toe: oblique view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Hatch, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39284=[""].join("\n");
var outline_f38_23_39284=null;
var title_f38_23_39285="Systemic onset juvenile idiopathic arthritis: Course, prognosis, and complications";
var content_f38_23_39285=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic onset juvenile idiopathic arthritis: Course, prognosis, and complications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39285/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39285/contributors\">",
"     Thomas JA Lehman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39285/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39285/contributors\">",
"     Marisa Klein-Gitelman, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39285/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39285/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/23/39285/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H401605\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic onset juvenile idiopathic arthritis (formerly called Still&rsquo;s disease or systemic onset juvenile rheumatoid arthritis) is a subset of juvenile idiopathic arthritis (JIA). It is sometimes called adult-onset Still&rsquo;s disease when it occurs in patients over the age of 16. The clinical course, prognosis, and complications of systemic onset JIA are discussed in this review.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, and treatment of systemic onset JIA are discussed separately, as are pauciarthritis and polyarthritis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21046?source=see_link\">",
"     \"Systemic onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/9/5274?source=see_link\">",
"     \"Systemic onset juvenile idiopathic arthritis: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/56/35717?source=see_link\">",
"     \"Classification of juvenile arthritis (JRA/JIA)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24056?source=see_link\">",
"     \"Pauciarticular onset juvenile idiopathic arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/25/24983?source=see_link\">",
"     \"Polyarticular onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H815997\">",
"    <span class=\"h1\">",
"     COURSE AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course and prognosis of systemic onset juvenile idiopathic arthritis (JIA) are highly variable. This variability has prompted many observers to believe that it is not a single entity. Nevertheless, the typical child with systemic onset JIA experiences a four to six month period of spiking fevers and rash, with varying degrees of arthralgia and arthritis. This is often followed by a relative quiescence of the systemic manifestations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H816540\">",
"    <span class=\"h2\">",
"     Arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arthritis resolves completely in approximately 40 to 50 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/1\">",
"     1",
"    </a>",
"    ]. The child who appears well after six months has a substantial probability of remaining well, whereas the child who continues to have active disease (eg, fevers, arthritis, elevated platelet count, continued requirement for glucocorticoid therapy) three to six months after diagnosis typically has a more difficult course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. However, some children have recurrences even after years of appearing disease free. Thus, many patients who present with systemic onset arthritis in adulthood may, with careful questioning, give a history that suggests initial onset in childhood.",
"   </p>",
"   <p>",
"    Children with systemic onset JIA who fail to respond adequately to therapy have a significantly poorer prognosis than do children who achieve disease control. The percentage of such children is unknown. In the past, more than one in three children with systemic onset JIA developed permanent joint injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/5\">",
"     5",
"    </a>",
"    ] and more than half required substantial steroid exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/6\">",
"     6",
"    </a>",
"    ] The number of children experiencing severe protracted disease is lower, probably under 20 percent, with the availability of newer therapies, including biologic response modifiers such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"     anakinra",
"    </a>",
"    . As an example, a series of 46 patients treated with anakinra as part of initial disease-modifying antirheumatic drug (DMARD) therapy suggests that early and aggressive treatment could markedly reduce steroid exposure in many children and achieve arthritis remission in up to 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Manifestations of active disease may take several different forms in children who remain symptomatic with systemic onset JIA:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some children continue for years with fevers and rash, but little progression of their arthritis.",
"     </li>",
"     <li>",
"      Some have persistent systemic manifestations with progressive arthritis.",
"     </li>",
"     <li>",
"      Others show resolution of the fever and rash, but have a destructive arthritis of both large and small joints that proceeds relentlessly. These children may ultimately require multiple joint replacements.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H816547\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although previously significant, the mortality rates of children with systemic onset JIA are currently low. Cohorts of children with juvenile rheumatoid arthritis (JRA) followed in the 1960s and 1970s, approximately 90 percent of whom had systemic onset disease, had death rates of approximately one-half to 1 percent per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. By comparison, a more recent population-based cohort study of children with JRA was notable for the absence of deaths during childhood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/10\">",
"     10",
"    </a>",
"    ]. However, there were two deaths among those with systemic onset disease who survived to ages 18 and 29, both of whom had deficient antibody production. Another study examined mortality outcomes in 49,023 pediatric patients diagnosed with rheumatic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/11\">",
"     11",
"    </a>",
"    ]. The subset of patients with systemic onset arthritis did not have a significantly increased mortality rate, but this study may have missed hospitalized patients at highest risk of mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H816554\">",
"    <span class=\"h2\">",
"     Issues in adulthood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adults whose disease began during childhood may have residual problems. In one study of adults with a history of JIA, 52 had systemic onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/12\">",
"     12",
"    </a>",
"    ]. Among these patients the mean duration of disease was approximately 29 years, and the following disease related features were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leg length discrepancies of more than 2 cm were found in 31 percent, possibly related to hip replacement surgery.",
"     </li>",
"     <li>",
"      Restricted jaw opening was present in 54 percent.",
"     </li>",
"     <li>",
"      Severe disability, as indicated by HAQ scores of 1.5 to 3.0 or by modified Steinbrocker classes of III or IV, was present in 62 and 65 percent, respectively.",
"     </li>",
"     <li>",
"      Amyloidosis was present in nearly 20 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results illustrate the importance of proper therapy and the inadequacy of the therapeutic modalities used when these adults were children and developed systemic onset juvenile arthritis. The improved effectiveness of modern approaches to treating juvenile arthritis should result in significantly decreased morbidity as these patients reach adulthood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H816465\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macrophage activation syndrome, severe growth retardation, and osteoporosis are the most common complications of systemic onset juvenile idiopathic arthritis (JIA) or its treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H401611\">",
"    <span class=\"h2\">",
"     Macrophage activation syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macrophage activation syndrome (MAS) is a severe and life-threatening complication of systemic onset JIA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The clinical and histopathologic characteristics of MAS are similar to those of hereditary lymphohistiocytic hemophagocytosis (HLH). Children may present with spontaneous bleeding, bruising, or shock. Unremitting fever, lymphadenopathy, hepatosplenomegaly, and rash are also common findings. The hemoglobin, platelet count, and serum fibrinogen typically drop precipitously secondary to consumptive coagulopathy. MAS typically occurs within the first few days or weeks, but can occur at any point over the course of the disease. Triggers may include viral or bacterial infections or new medications, but often no inciting event is identified. It is thought to be caused by the activation of T cells and macrophages, resulting in the uncontrolled release of inflammatory cytokines (\"cytokine storm\"). This syndrome and its treatment are reviewed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/5/41050?source=see_link&amp;anchor=H33#H33\">",
"     \"Hemophagocytic lymphohistiocytosis\", section on 'Macrophage activation syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H401617\">",
"    <span class=\"h2\">",
"     Growth retardation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The key to preventing growth retardation is effective disease control. Profound growth abnormalities with obesity and short stature were common when glucocorticoids were one of the primary treatments of systemic onset JIA, and resulted both from therapy and from incomplete suppression of systemic inflammation. With safer and more effective therapies allowing more judicious use of glucocorticoids, these abnormalities are now less frequent. Short stature and failure to thrive may still be seen, however, in those with chronic unremitting disease, even in those who do not receive glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is preliminary evidence suggesting that the administration of recombinant growth hormone may ameliorate these complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. Issues of cost and appropriate dosing are barriers to the widespread use of growth hormone in this setting. In addition damaged joints may grow asymmetrically in response to growth hormone, exacerbating deformity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H401623\">",
"    <span class=\"h2\">",
"     Osteoporosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention of osteoporosis is extremely difficult in children with systemic onset JIA as a result of prolonged glucocorticoid therapy, decreased weight bearing, and systemic inflammation. Measures used in adults to treat osteoporosis are frequently ineffective or are poorly tolerated in children with systemic onset JIA. Options for prevention and treatment of osteoporosis in children with systemic onset JIA include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Glucocorticoid administration should be minimized in patients with systemic onset JIA, because one of its major side effects is osteoporosis.",
"     </li>",
"     <li>",
"      Growth hormone may have a beneficial effect on bone mineral density [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/22\">",
"       22",
"      </a>",
"      ], but its use is still considered experimental and subject to the concerns expressed above. (See",
"      <a class=\"local\" href=\"#H401617\">",
"       'Growth retardation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A poor appetite often leads to inadequate dietary calcium intake. Gastrointestinal complaints resulting from required antiinflammatory medications are frequently worsened by supplemental calcium-containing vitamins. These complications may be worsened by involvement of the temporomandibular joint (TMJ). As a result, it is important that parents make sure the child receives adequate vitamin supplementation without calcium and give supplemental calcium separately in children who do not tolerate vitamins with calcium well. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/25/24983?source=see_link&amp;anchor=H7#H7\">",
"       \"Polyarticular onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis\", section on 'Complications'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/10/24743?source=see_link\">",
"       alendronate",
"      </a>",
"      is an option for treating children with JIA and osteoporosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/23\">",
"       23",
"      </a>",
"      ], it is not expected to have any beneficial effect on ameliorating or reversing linear growth retardation. The safety of bisphosphonate use by children remains uncertain. Excessive amounts can lead to osteopetrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/24\">",
"       24",
"      </a>",
"      ]. The decision to use bisphosphonates must be made on a case-by-case basis, since these medications may be teratogenic and have a long half-life, stored in and slowly released from the bone for years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H816152\">",
"    <span class=\"h2\">",
"     Other complications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atypical renal, cardiac, endocrine, and other complications have been reported in a few cases in every large series, but their relevance to systemic onset juvenile arthritis is uncertain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reye syndrome is a toxic encephalopathy that may occur in association with varicella zoster or other viral infections. This illness was widespread when children with fever were treated with aspirin-containing products. It can also occur in children taking other NSAIDs, and has been reported rarely in all subtypes of JIA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/28\">",
"       28",
"      </a>",
"      ]. Whenever a child who is taking an NSAID develops significant fever, vomiting, or diarrhea, the NSAID should be withheld until the symptoms have cleared. If vomiting becomes pernicious, or altered consciousness ensues, prompt and thorough medical evaluation is imperative.",
"     </li>",
"     <li>",
"      Delayed sexual maturation in boys is reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39285/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3173744\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The course and prognosis of systemic onset juvenile idiopathic arthritis (JIA) is highly variable. The systemic manifestations continue for four to six months in most patients, and arthritis resolves in about one-half of patients.",
"     </li>",
"     <li>",
"      A sizeable number of patients will remain ill for a prolonged period of time. Mortality from systemic arthritis has decreased during the past two decades, and disease related morbidity is probably declining significantly as well. (See",
"      <a class=\"local\" href=\"#H815997\">",
"       'Course and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Three patterns of chronic disease activity occur in systemic onset juvenile JIA (See",
"      <a class=\"local\" href=\"#H815997\">",
"       'Course and prognosis'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Systemic manifestations (ie, fever and rash) and no progressive arthritis",
"     </li>",
"     <li>",
"      Persistent systemic manifestations and progressive arthritis",
"     </li>",
"     <li>",
"      Resolution of systemic manifestations and progressive destructive arthritis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Macrophage activation syndrome, severe growth retardation, and osteoporosis are the most common complications of systemic onset JIA or its treatment. (See",
"      <a class=\"local\" href=\"#H816465\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/1\">",
"      Minden K, Niewerth M, Listing J, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/2\">",
"      Schneider R, Lang BA, Reilly BJ, et al. Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. J Pediatr 1992; 120:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/3\">",
"      Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum 2006; 54:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/4\">",
"      Spiegel LR, Schneider R, Lang BA, et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum 2000; 43:2402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/5\">",
"      Oen K, Malleson PN, Cabral DA, et al. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002; 29:1989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/6\">",
"      Svantesson H, Akesson A, Eberhardt K, Elborgh R. Prognosis in juvenile rheumatoid arthritis with systemic onset. A follow-up study. Scand J Rheumatol 1983; 12:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/7\">",
"      Nigrovic PA, Mannion M, Prince FH, et al. Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis. Arthritis Rheum 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/8\">",
"      Goel KM, Shanks RA. Follow-up study of 100 cases of juvenile rheumatoid arthritis. Ann Rheum Dis 1974; 33:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/9\">",
"      Stoeber E. Prognosis in juvenile chronic arthritis. Follow-up of 433 chronic rheumatic children. Eur J Pediatr 1981; 135:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/10\">",
"      French AR, Mason T, Nelson AM, et al. Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study. Arthritis Rheum 2001; 44:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/11\">",
"      Hashkes PJ, Wright BM, Lauer MS, et al. Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum 2010; 62:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/12\">",
"      Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002; 41:1428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/13\">",
"      Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/14\">",
"      Dav&igrave; S, Consolaro A, Guseinova D, et al. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2011; 38:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/15\">",
"      Polito C, Strano CG, Olivieri AN, et al. Growth retardation in non-steroid treated juvenile rheumatoid arthritis. Scand J Rheumatol 1997; 26:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/16\">",
"      Aggarwal B, Bhalla AK, Singh S. Longitudinal growth attainments of Indian boys with juvenile rheumatoid arthritis. Rheumatol Int 2011; 31:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/17\">",
"      Minden K. Adult outcomes of patients with juvenile idiopathic arthritis. Horm Res 2009; 72 Suppl 1:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/18\">",
"      Davies UM, Rooney M, Preece MA, et al. Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. J Rheumatol 1994; 21:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/19\">",
"      Rooney M, Davies UM, Reeve J, et al. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol 2000; 27:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/20\">",
"      Bechtold S, Ripperger P, M&uuml;hlbayer D, et al. GH therapy in juvenile chronic arthritis: results of a two-year controlled study on growth and bone. J Clin Endocrinol Metab 2001; 86:5737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/21\">",
"      Simon D, Lucidarme N, Prieur AM, et al. Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy. J Rheumatol 2003; 30:2492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/22\">",
"      Bechtold S, Ripperger P, Bonfig W, et al. Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years. J Rheumatol 2004; 31:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/23\">",
"      Bianchi ML, Cimaz R, Bardare M, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 2000; 43:1960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/24\">",
"      Whyte MP, Wenkert D, Clements KL, et al. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003; 349:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/25\">",
"      Compston JE. The therapeutic use of bisphosphonates. BMJ 1994; 309:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/26\">",
"      Shaw NJ, Bishop NJ. Bisphosphonate treatment of bone disease. Arch Dis Child 2005; 90:494.",
"     </a>",
"    </li>",
"    <li>",
"     Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: Textbook of Pediatric Rheumatology, 4th ed, Cassidy JT, Petty RE (Eds), WB Saunders Company, Philadelphia 2001. p.218.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/28\">",
"      Rennebohm RM, Heubi JE, Daugherty CC, Daniels SR. Reye syndrome in children receiving salicylate therapy for connective tissue disease. J Pediatr 1985; 107:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39285/abstract/29\">",
"      Aggarwal B, Bhalla AK, Singh S. Sexual maturation in boys with juvenile rheumatoid arthritis. Rheumatol Int 2011; 31:1419.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13512 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-6EBEB1F6CE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39285=[""].join("\n");
var outline_f38_23_39285=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3173744\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H401605\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H815997\">",
"      COURSE AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H816540\">",
"      Arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H816547\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H816554\">",
"      Issues in adulthood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H816465\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H401611\">",
"      Macrophage activation syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H401617\">",
"      Growth retardation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H401623\">",
"      Osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H816152\">",
"      Other complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3173744\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/56/35717?source=related_link\">",
"      Classification of juvenile arthritis (JRA/JIA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/5/41050?source=related_link\">",
"      Hemophagocytic lymphohistiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24056?source=related_link\">",
"      Pauciarticular onset juvenile idiopathic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/25/24983?source=related_link\">",
"      Polyarticular onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21046?source=related_link\">",
"      Systemic onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/9/5274?source=related_link\">",
"      Systemic onset juvenile idiopathic arthritis: Treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_23_39286="Bedbugs";
var content_f38_23_39286=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bedbugs",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39286/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39286/contributors\">",
"     Dirk M Elston, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39286/contributors\">",
"     Stephen Kells, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39286/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39286/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39286/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39286/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/23/39286/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedbugs (also written \"Bed bugs\") are true bugs of the Order Hemiptera. All insects within this order have wings that are half membranous and half sclerotic. In bedbugs, the membranous portion of the wing is vestigial, and only the sclerotic portion of the wing is visible. Bedbugs belong to the family Cimicidae. Cimicids commonly infest human, bird and bat habitats. As parasites they are unique because they are obligate blood feeders but do not remain on the host to complete their lifecycle; rather they move to adjacent areas and hide in the surrounding habitat.",
"   </p>",
"   <p>",
"    Human disease occurs from the direct feeding by one or several species of bedbugs, though it is uncommon for multiple bedbug species to be present in a single case. Bedbugs may feed on the patient within their residence or in sites where the person sleeps or remains quiescent for periods of time. These bugs may be related to birds or bats roosting in or around the house, and when the primary host migrates, the hungry bedbugs range in search of an alternate food source [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     APPEARANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedbugs have flat oval bodies, are reddish brown in color, and similar in size to a dog tick (",
"    <a class=\"graphic graphic_picture graphicRef60747 \" href=\"mobipreview.htm?20/31/20980\">",
"     picture 1",
"    </a>",
"    ). The eyes are widely separated. They have retroverted mouthparts with the labium slender and elongate, forming a three segmented rostellum (rostrum). The wings are reduced to hemelytral pads, with membranous hindwings vestigial or absent. The pronotum has a concave anterior margin that receives the head. Bristles project laterally along the margins of the pronotum, starting behind the eye and continuing along the lateral edge (",
"    <a class=\"graphic graphic_picture graphicRef66148 \" href=\"mobipreview.htm?31/33/32278\">",
"     picture 2",
"    </a>",
"    ). Bristles also can be observed on the dorsal surface. The antennae have four segments, with the distal three antennal segments being long and slender. The abdomen has eleven segments, which expand during feeding, exposing intersegmental membranes.",
"   </p>",
"   <p>",
"    Cimex lectularius and C. hemipterus are the two species of bedbug that most commonly affect humans. Cimex lectularius is found in temperate climates, and C. hemipterus is most prevalent in tropical climates. Adult C. lectularius range in size from 5 to 7 mm, while nymphs (juveniles) may be as small as 1.5 mm. C. hemipterus is somewhat longer than C. lectularius. The ranges of these species overlap, and bugs of different species may interbreed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/2\">",
"     2",
"    </a>",
"    ], though with limited success of viable offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/3\">",
"     3",
"    </a>",
"    ]. Other species exist that use humans as incidental hosts and correct identification is important for determining proper control procedures and the potential vectoring of disease agents.",
"   </p>",
"   <p>",
"    Prior to a blood meal, adult bedbugs are more brown in color. After feeding, the color appears more dull red, and the body of the bedbug elongates and is no longer flat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/4\">",
"     4",
"    </a>",
"    ]. Smaller nymphs are translucent prior to feeding and bright red immediately after feeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HABITS AND DETECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human bedbugs are present throughout the world and tropical bedbugs are limited to equatorial regions. Occasionally, tropical bedbugs may appear in more temperate areas because of international travel. Other species are distributed depending on their primary hosts. Infestations are considered more common in poorer areas, but they can also frequently occur in other areas where people regularly travel, or among people who have used sites frequented by others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/5\">",
"     5",
"    </a>",
"    ]. Within multifamily and institutional facilities, bedbugs will move among rooms from a focal point or may spread as people and effects move within the facility.",
"   </p>",
"   <p>",
"    Bedbugs seldom inhabit the resting surface of beds or chairs. Instead, they hide in cracks and crevices associated with mattresses, cushions, bed frames and other structures. The female deposits her eggs in these areas, gluing them to the surface. The eggs hatch in 4 to 10 days. Bedbugs often feed while the victim sleeps, but feeding also may occur when the victim is quiescent or is preoccupied, such as watching a movie. They are attracted by warmth and carbon dioxide. They inject an anticoagulant to aid with their feeding and usually feed without detection by the host. A complete blood meal is taken in about 5 to 10 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the developing world, bedbugs commonly inhabit the cracks and crevices of mud and daub houses, as well as the thatched roof. In refugee camps, infestations are common. In a refugee camp in Freetown, Sierra Leone, bedbugs were found in 98 percent of rooms evaluated, with many more being recovered during the night when they feed. Eighty-six percent of the residents of the camp demonstrated wheals from bedbug bites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bedbugs move at about the same rate that a ladybug walks. Bedbugs spend the majority of their lives hiding in harborages, especially during the daytime. In the appropriate clinical setting (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Clinical manifestations'",
"    </a>",
"    below), an exterminator or trained bedbug inspector should be called to detect and eradicate infestations, since bedbugs themselves are rarely seen by the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedbugs typically bite at night on exposed areas of skin. Bites typically occur on the face, neck, hands, and arms, and may be noted upon awakening or one to several days after the bites. In some patients, the onset of symptoms may be delayed for up to 10 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/8\">",
"     8",
"    </a>",
"    ]. The bite itself is painless.",
"   </p>",
"   <p>",
"    Not all individuals react to bites, and a bedbug bite most often appears as a small punctum without a surrounding reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/9\">",
"     9",
"    </a>",
"    ]. Some patients may have only asymptomatic purpuric macules. In one questionnaire-based study (n = 474), approximately 30 percent of individuals living in bedbug-infested dwellings reported a lack of bites or skin reactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/10\">",
"     10",
"    </a>",
"    ]. Elderly people may be less likely to develop symptoms than younger individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When a reaction occurs, a bedbug bite can present as a 2 to 5 mm erythematous maculopapular lesion or wheal with a central hemorrhagic punctum (",
"    <a class=\"graphic graphic_picture graphicRef75123 graphicRef79870 \" href=\"mobipreview.htm?34/12/35011\">",
"     picture 3A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/6,9,11\">",
"     6,9,11",
"    </a>",
"    ]. These are frequently pruritic. Other patients may have more severe reactions with bullae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/4,12,13\">",
"     4,12,13",
"    </a>",
"    ]. Antihistamines may suppress the reaction and may interfere with a patient's ability to detect an infestation.",
"   </p>",
"   <p>",
"    Untreated individual lesions usually resolve in one week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/9\">",
"     9",
"    </a>",
"    ]. New lesions typically accumulate as older lesions heal. Occasionally, bedbug bites can become secondarily infected and present with impetigo or cellulitis. Excoriated or impetiginized lesions may take several weeks to resolve.",
"   </p>",
"   <p>",
"    Bedbug bites are also thought to appear as papular urticaria or may mimic conventional urticaria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Patients with papular urticaria may demonstrate IgG against C. lectularius, C. pipiens, and P. irritans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antigens in bedbug feces may play a role in asthma in some countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedbug bites are difficult to distinguish from other bites. A linear series of bites found on awakening is often associated with bedbugs, but does not occur in all cases. The &ldquo;linear feeding&rdquo; may occur as a single bedbug probes multiple times looking for a productive capillary or from multiple bedbugs feeding along a zone of exposed skin. Bedbug feeding tends to cause restlessness in some people during sleep, so bites may be widespread as new areas of skin are exposed. &nbsp;",
"   </p>",
"   <p>",
"    Small infestations of bedbugs are very difficult to detect and an infestation may be suspected if specks of feces or blood are found on linens, mattresses, or behind wallpaper [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/11\">",
"     11",
"    </a>",
"    ]. Caste skins from bedbugs moulting to successive instars also may be found. Additionally, bedbugs produce a pungent odor that is recognizable to those familiar with it [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/6\">",
"     6",
"    </a>",
"    ]. However, this odor typically occurs only with chronic and widespread infestations and so is not helpful in excluding a diagnosis of bedbug bites.",
"   </p>",
"   <p>",
"    The differential diagnosis includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Scabies; however, scabies tends to affect both covered and uncovered skin, and the skin typically shows burrows. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28712?source=see_link&amp;anchor=H5#H5\">",
"       \"Scabies\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other biting arthropods, especially fleas and parasitic mites, can produce bites similar to bedbugs. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/35/28216?source=see_link\">",
"       \"Insect bites\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cheyletiella mites and other mite species (often associated with pet cats, dogs, rabbits, or birds - both domestic and wild) are a common cause of grouped bites.",
"     </li>",
"     <li>",
"      Vesicular disorders unrelated to bites, such as dermatitis herpetiformis, can also have a similar appearance. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/44/40650?source=see_link&amp;anchor=H27#H27\">",
"       \"Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults\", section on 'Dermatitis herpetiformis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Delusional parasitosis can present with symptoms similar to bedbug infestations. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/4/3145?source=see_link\">",
"       \"Delusional parasitosis: Epidemiology, clinical presentation, assessment and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H677471059\">",
"    <span class=\"h1\">",
"     HISTOPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin biopsies of bedbug bites are not typically performed because the diagnosis can usually be made clinically and the histopathologic findings are nonspecific. Urticaria-like lesions often demonstrate variable edema in the upper dermis and a perivascular inflammatory infiltrate that contains lymphocytes, eosinophils, and mast cells. A small number of interstitial eosinophils may also be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bullous bedbug bites may exhibit intraepidermal edema, subepidermal edema, and a mixed dermal inflammatory infiltrate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, histopathologic features consistent with cutaneous vasculitis have been reported in a patient with bullous lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     VECTORS FOR DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human bedbugs have not been proven to be competent vectors for disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/9\">",
"     9",
"    </a>",
"    ]. However, pathogens have been detected on and in these insects, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hepatitis B &mdash; Some studies and experiments have suggested that bedbugs can be a vector for hepatitis B [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/19-21\">",
"       19-21",
"      </a>",
"      ]. Hepatitis B DNA can be detected in bedbugs and their excrement up to six weeks after an infected meal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/22\">",
"       22",
"      </a>",
"      ]. However, a Gambian study of spraying insecticide found a decrease in exposure to bedbugs but no effect on hepatitis B infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chagas' disease &mdash; Bedbugs have been implicated as a possible secondary vector of American trypanosomiasis (Chagas' Disease) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hepatitis C and HIV &mdash; Bedbugs appear unlikely to transmit hepatitis C [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/22\">",
"       22",
"      </a>",
"      ] or HIV [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Wolbachia species have been detected in bedbugs. These bacteria have been found to infest a variety of arthropods and helminths. They are implicated in Mazzotti reactions associated with the treatment of onchocerciasis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/30/20970?source=see_link&amp;anchor=H18#H18\">",
"     \"Onchocerciasis\", section on 'Mazzotti test'",
"    </a>",
"    .) Their significance as pathogens in the setting of bedbug infestation remains to be determined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The swallow bug (Oeciacus vicarious), which is similar in appearance to the bedbug, may be a vector for certain arboviruses. Thus, proper insect identification is important.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedbug bites do not typically require treatment. In patients with severe pruritus, it is reasonable to try symptomatic management with topical corticosteroids",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic antihistamines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/6\">",
"     6",
"    </a>",
"    ]. Patients should be advised to maintain good hygiene and avoid scratching so as to prevent infection. If secondary infection occurs, it should be managed with antibiotics as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antihistamines can suppress the symptoms and signs of bites and so may reduce the patient's ability to detect an ongoing infestation. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PSYCHOSOCIAL ASPECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedbug infestations can produce significant psychosocial stressors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/28\">",
"     28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients may worry about bugs biting them or their family members, and this can disrupt sleep",
"     </li>",
"     <li>",
"      Patients may be avoided by friends or others in the community",
"     </li>",
"     <li>",
"      Patients may self-isolate, avoiding family and friends out of concern for spreading the infestation",
"     </li>",
"     <li>",
"      Patient or employer concerns can lead to the suspension of work",
"     </li>",
"     <li>",
"      Management tactics for infestations are very disruptive to everyday life, and are expensive",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a result, victims of bedbug infestations may experience moderate to severe levels of stress, anxiety, and depression. Clinicians should inquire about symptoms of stress and depression, and in some cases treatment may be required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF INFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4608291\">",
"    <span class=\"h2\">",
"     Developed world",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of bedbug infestation hinges on identification of the bug [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/9\">",
"     9",
"    </a>",
"    ]. If human bedbugs are identified, control requires a combination of nonchemical controls and chemical insecticide applications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/9\">",
"     9",
"    </a>",
"    ]. Inspection of the residence must be carefully performed to find all of the hiding areas. While most bedbug infestations will be located adjacent to the feeding sites, some bedbugs will spread to other areas (and apartments).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4608305\">",
"    <span class=\"h3\">",
"     Human bedbug control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several insecticides are available, and at least three formulations should be used to avoid control failures because of insecticide resistance or missed areas harboring live bugs. Supplemental nonchemical controls include vacuuming, laundering, and freezing articles. Washing and drying items in a dryer on a hot setting is adequate to kill bedbugs in clothing or linens; the dryer should be placed on the hottest setting the fabric can withstand.",
"   </p>",
"   <p>",
"    Heat treatment of living spaces is an alternative to the use of insecticides to eliminate bedbugs from the home. Equipment is available that can heat rooms to a lethal temperature. All stages of bedbugs can be killed at 50&deg;C (122&deg;F). An exposure time of 90 minutes is required for temperatures between 48 and 50&deg;C.",
"   </p>",
"   <p>",
"    Thorough control of human bedbug infestations requires an experienced pest management professional and victims should be advised against attempting control measures themselves [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/29\">",
"     29",
"    </a>",
"    ]. In cases where the patient is destitute and cannot afford a complete treatment, and the landlord is unwilling to help, bedbug numbers can be reduced through thorough removal measures. Removal usually includes using a thin plastic card (or business card) or a thin bladed paint scraper to dig bedbugs out of cracks and crevices. Dislodged bedbugs can be killed manually or removed with tape. If the patient has a vacuum cleaner or hair dryer, these may also remove or kill bedbugs. These practices will reduce bedbug bites, but will not eliminate the population and the practices will have to be repeated. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4608298\">",
"    <span class=\"h3\">",
"     Bat bugs and swallow bugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;If bat bugs or swallow bugs are identified, bat roosts and bird nests should be eliminated and an approved residual insecticide should be applied to control surviving bugs (",
"    <a class=\"graphic graphic_picture graphicRef66148 \" href=\"mobipreview.htm?31/33/32278\">",
"     picture 2",
"    </a>",
"    ). These insects live for prolonged periods without a host, so starvation by host absence from an area is not an effective control method and may result in bug movement to other areas.",
"   </p>",
"   <p>",
"    When a roost cannot be eliminated, such as when the bird or bat is protected by law, an approved residual insecticide can be applied in the area between the roost and the site of human habitation. After the primary host has abandoned its nest, more aggressive measures can be used in vacated areas. The insects may enter the house through cracks in walls and doorways. These can be sealed or treated with an appropriate insecticide. Peeling paint and cracked plaster must be eliminated. However, attempts to seal all openings in a room or house (such as caulking between the walls and baseboards) are unlikely to be successful and may actually prevent insecticide treatments from penetrating into areas where bedbugs hide.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Developing world",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various insecticides have been used in the developing world. Dichlorvos and similar organophosphate insecticides have been shown to be effective in this setting. The residual effect of insecticides varies, and some have reduced efficacy on mud, wood, and fabric.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/22/28004?source=see_link\">",
"     Permethrin",
"    </a>",
"    has only intermediate activity against bedbugs, but can be used to impregnate clothing with residual effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pyrethroid-treated bednets have proved effective in controlling the number of bites, but resistance to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    is emerging as a result of this control method. Where possible, the use of bed nets should be periodically discontinued and replaced with other insecticides that have a different mode of action (such as dichlorvos). A program of rotating insecticides is necessary to manage insecticide resistance. The organic content of mud daub walls has a significant effect on the residual effect of some insecticides [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/31\">",
"     31",
"    </a>",
"    ], and products such as microencapsulated insecticides will counteract these absorptive materials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Insect repellents are not particularly effective against bedbugs. Several repellents have been tried for personal protection. DEET (N,N-diethyl-3-methylbenzamide, previously called N,N-diethyl-m-toluamide) causes bedbugs to take progressively smaller meals in the face of increasing concentrations of the repellent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/33\">",
"     33",
"    </a>",
"    ]. Paradoxically, there is a theoretical concern that this may increase the risk of spreading some diseases, as the bedbugs continue to bite one individual after another in search of a full meal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39286/abstract/34\">",
"     34",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    In general, insect repellants are not recommended for the management of bedbugs. A comprehensive control program that includes insecticide treated bednets, elimination of cracks and crevices, insecticidal sprays of infested sites, and direct removal of bedbugs is more likely to be effective for reducing bites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/13/36049?source=see_link\">",
"       \"Patient information: Bedbugs (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/30/14817?source=see_link\">",
"       \"Patient information: Bedbugs (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adult bedbugs are reddish brown and similar in size to a dog tick (",
"      <a class=\"graphic graphic_picture graphicRef60747 \" href=\"mobipreview.htm?20/31/20980\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Appearance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bedbugs typically bite at night on exposed areas of skin and are noted upon awakening. They often inflict a series of bites in a row, and the most common appearance is of a wheal with a central hemorrhagic punctum. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Habits and detection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If bedbugs are not detected directly, infestation may be suspected when specks of blood containing dung are found on linens, mattresses, or behind wallpaper. Extensive bedbug infestations produce a pungent odor that is recognizable to those familiar with it. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Habits and detection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Human bedbugs have not been convincingly demonstrated to be competent vectors for disease. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Vectors for disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pruritic bites can be managed symptomatically with topical corticosteroids or systemic antihistamines. Patients may require antibiotics if bites become secondarily infected. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of bedbug infestations starts with identification of the bug and thus the primary host (eg, human, bat, bird). If bat bugs or swallow bugs are identified, then roosts or nests should be eliminated whenever possible, with subsequent applications of insecticides. Control of human bedbug infestations requires an experienced pest management professional and victims should be advised against attempting control measures themselves. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Management of infestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/1\">",
"      Whyte AS, Garnett PA, Whittington AE. Bats in the belfry, bugs in the bed? Lancet 2001; 357:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/2\">",
"      Walpole DE, Newberry K. A field study of mating between two species of bedbug in northern KwaZulu, South Africa. Med Vet Entomol 1988; 2:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/3\">",
"      Newberry K. Production of a hybrid between the bedbugs Cimex hemipterus and Cimex lectularius. Med Vet Entomol 1988; 2:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/4\">",
"      Liebold K, Schliemann-Willers S, Wollina U. Disseminated bullous eruption with systemic reaction caused by Cimex lectularius. J Eur Acad Dermatol Venereol 2003; 17:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/5\">",
"      Kells SA. Bed bugs: a systemic pest within society. Am Entomol 2006; 52:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/6\">",
"      Thomas I, Kihiczak GG, Schwartz RA. Bedbug bites: a review. Int J Dermatol 2004; 43:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/7\">",
"      Gbakima AA, Terry BC, Kanja F, et al. High prevalence of bedbugs Cimex hemipterus and Cimex lectularis in camps for internally displaced persons in Freetown, Sierra Leone: a pilot humanitarian investigation. West Afr J Med 2002; 21:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/8\">",
"      Sansom JE, Reynolds NJ, Peachey RD. Delayed reaction to bed bug bites. Arch Dermatol 1992; 128:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/9\">",
"      Goddard J, deShazo R. Bed bugs (Cimex lectularius) and clinical consequences of their bites. JAMA 2009; 301:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/10\">",
"      Potter MF, Haynes KF, Connelly K, et al. The sensitivity spectrum: Human reactions to bed bug bites. Pest Control Technology 2010; 38:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/11\">",
"      Cleary CJ, Buchanan D. Diagnosis and management of bedbugs: an emerging U.S. Infestation. Nurse Pract 2004; 29:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/12\">",
"      Fletcher CL, Ardern-Jones MR, Hay RJ. Widespread bullous eruption due to multiple bed bug bites. Clin Exp Dermatol 2002; 27:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/13\">",
"      deShazo RD, Feldlaufer MF, Mihm MC Jr, Goddard J. Bullous reactions to bedbug bites reflect cutaneous vasculitis. Am J Med 2012; 125:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/14\">",
"      Scarupa MD, Economides A. Bedbug bites masquerading as urticaria. J Allergy Clin Immunol 2006; 117:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/15\">",
"      Abdel-Naser MB, Lotfy RA, Al-Sherbiny MM, Sayed Ali NM. Patients with papular urticaria have IgG antibodies to bedbug (Cimex lectularius) antigens. Parasitol Res 2006; 98:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/16\">",
"      Abou Gamra EM, el Shayed FA, Morsy TA, et al. The relation between Cimex lectularius antigen and bronchial asthma in Egypt. J Egypt Soc Parasitol 1991; 21:735.",
"     </a>",
"    </li>",
"    <li>",
"     Weedon D. Arthropod-induced diseases. In: Weedon's Skin Pathology, 3rd ed, Elsevier Limited, 2010. p.651.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/18\">",
"      Tharakaram S. Bullous eruption due to Cimex lecticularis. Clin Exp Dermatol 1999; 24:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/19\">",
"      Jupp PG, McElligott SE, Lecatsas G. The mechanical transmission of hepatitis B virus by the common bedbug (Cimex lectularius L.) in South Africa. S Afr Med J 1983; 63:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/20\">",
"      Jupp PG, McElligott SE. Transmission experiments with hepatitis B surface antigen and the common bedbug (Cimex lectularius L). S Afr Med J 1979; 56:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/21\">",
"      Ogston CW, Wittenstein FS, London WT, Millman I. Persistence of hepatitis B surface antigen in the bedbug Cimex hemipterus (Fabr.). J Infect Dis 1979; 140:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/22\">",
"      Silverman AL, Qu LH, Blow J, et al. Assessment of hepatitis B virus DNA and hepatitis C virus RNA in the common bedbug (Cimex lectularius L.) and kissing bug (Rodnius prolixus). Am J Gastroenterol 2001; 96:2194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/23\">",
"      Vall Mayans M, Hall AJ, Inskip HM, et al. Do bedbugs transmit hepatitis B? Lancet 1994; 343:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/24\">",
"      J&ouml;rg ME. [Cimex lectularius L. (the common bedbug), the vector of Trypanosoma cruzi]. Rev Soc Bras Med Trop 1992; 25:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/25\">",
"      Webb PA, Happ CM, Maupin GO, et al. Potential for insect transmission of HIV: experimental exposure of Cimex hemipterus and Toxorhynchites amboinensis to human immunodeficiency virus. J Infect Dis 1989; 160:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/26\">",
"      Jupp PG, Lyons SF. Experimental assessment of bedbugs (Cimex lectularius and Cimex hemipterus) and mosquitoes (Aedes aegypti formosus) as vectors of human immunodeficiency virus. AIDS 1987; 1:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/27\">",
"      Brouqui P, Raoult D. Arthropod-borne diseases in homeless. Ann N Y Acad Sci 2006; 1078:223.",
"     </a>",
"    </li>",
"    <li>",
"     www.nytimes.com/2005/11/27/nyregion/27bugs.html (Accessed on February 05, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/29\">",
"      Centers for Disease Control and Prevention (CDC). Acute illnesses associated with insecticides used to control bed bugs--seven states, 2003--2010. MMWR Morb Mortal Wkly Rep 2011; 60:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/30\">",
"      Fletcher MG, Axtell RC. Susceptibility of the bedbug, Cimex lectularius, to selected insecticides and various treated surfaces. Med Vet Entomol 1993; 7:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/31\">",
"      Le Sueur D, Sharp BL, Fraser C, Ngxongo SM. Assessment of the residual efficacy of lambda-cyhalothrin. 1. A laboratory study using Anopheles arabiensis and Cimex lectularius (Hemiptera: Cimicidae) on treated daub wall substrates from Natal, South Africa. J Am Mosq Control Assoc 1993; 9:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/32\">",
"      Gao YT, Shen PY, Wang BH, et al. Controlled release effect of insecticide microcapsules and their results in common household insect pest control. J Microencapsul 1984; 1:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/33\">",
"      Kumar S, Prakash S, Rao KM. Comparative activity of three repellents against bedbugs Cimex hemipterus (Fabr.). Indian J Med Res 1995; 102:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39286/abstract/34\">",
"      Jupp PG, Purcell RH, Phillips JM, et al. Attempts to transmit hepatitis B virus to chimpanzees by arthropods. S Afr Med J 1991; 79:320.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4027 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-188.40.116.55-6D8648E745-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39286=[""].join("\n");
var outline_f38_23_39286=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      APPEARANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HABITS AND DETECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H677471059\">",
"      HISTOPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      VECTORS FOR DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PSYCHOSOCIAL ASPECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MANAGEMENT OF INFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4608291\">",
"      Developed world",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4608305\">",
"      - Human bedbug control",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4608298\">",
"      - Bat bugs and swallow bugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Developing world",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/4027\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/4027|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/31/20980\" title=\"picture 1\">",
"      Bedbugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/33/32278\" title=\"picture 2\">",
"      Bedbug vs bat bug",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/50/35616\" title=\"picture 3A\">",
"      Multiple bedbug bites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/21/38238\" title=\"picture 3B\">",
"      Bedbug bites 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/4/3145?source=related_link\">",
"      Delusional parasitosis: Epidemiology, clinical presentation, assessment and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/35/28216?source=related_link\">",
"      Insect bites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/30/20970?source=related_link\">",
"      Onchocerciasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/44/40650?source=related_link\">",
"      Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/30/14817?source=related_link\">",
"      Patient information: Bedbugs (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/13/36049?source=related_link\">",
"      Patient information: Bedbugs (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_23_39287="Oxycodone: Pediatric drug information";
var content_f38_23_39287=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxycodone: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?10/34/10792?source=see_link\">",
"    see \"Oxycodone: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/3/6198?source=see_link\">",
"    see \"Oxycodone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F204903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Oxecta&trade;;",
"     </li>",
"     <li>",
"      OxyCONTIN&reg;;",
"     </li>",
"     <li>",
"      Roxicodone&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F204904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Oxycodone CR;",
"     </li>",
"     <li>",
"      CO Oxycodone CR;",
"     </li>",
"     <li>",
"      Oxy.IR&reg;;",
"     </li>",
"     <li>",
"      OxyContin&reg;;",
"     </li>",
"     <li>",
"      OxyNEO&trade;;",
"     </li>",
"     <li>",
"      PMS-Oxycodone;",
"     </li>",
"     <li>",
"      PMS-Oxycodone CR;",
"     </li>",
"     <li>",
"      Supeudol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1054606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Narcotic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1054599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/34/10792?source=see_link\">",
"      see \"Oxycodone: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note: Doses should be titrated to appropriate effect:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Analgesic, moderate:",
"     </b>",
"     Oral: Immediate release: 0.1-0.2 mg/kg/dose every 4-6 hours as needed; usual maximum dose: 10 mg/dose (American Pain Society, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Analgesic, severe:",
"     </b>",
"     Oral: Immediate release: Initial dose: 0.2 mg/kg/dose every 4-6 hours as needed; usual maximum dose: 20 mg/dose (American Pain Society, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adolescents &ge; 18 years and Adults:",
"     <b>",
"      Analgesic, moderate to severe:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Immediate release: Initial: 5-15 mg every 4-6 hours as needed; dosing range: 5-20 mg/dose (American Pain Society, 2008). For severe chronic pain, administer on a regularly scheduled basis, every 4-6 hours, at the lowest dose that will achieve adequate analgesia.",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:6em;text-align:justify;\">",
"     Controlled release (OxyContin&reg;):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Opioid-na&iuml;ve: 10 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Concurrent CNS depressants: Reduce usual dose by",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      3",
"     </sub>",
"     to",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Conversion from transdermal fentanyl: For each 25 mcg/hour transdermal dose, 	substitute 10 mg controlled release oxycodone every 12 hours; should be initiated 18 hours after the removal of the transdermal fentanyl patch",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Currently on opioids: Use standard conversion chart to convert daily dose to oxycodone equivalent. Divide daily dose in 2 (for twice-daily dosing, usually every 12 hours) and round down to nearest dosage form.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Dose adjustment:",
"     </b>",
"     Doses may be adjusted by changing the total daily dose (not by changing the dosing interval). Doses may be adjusted every 1-2 days and may be increased by 25% to 50%. Dose should be gradually tapered when no longer required in order to prevent withdrawal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     60 mg and 80 mg strengths, a single dose &gt;40 mg, or a total dose of &gt;80 mg/day are for use only in opioid-tolerant patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Multiplication factors for converting the daily dose of current oral opioid to the daily dose of oral oxycodone:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Current opioid mg/day dose x factor = Oxycodone mg/day dose",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Codeine mg/day oral dose",
"     <b>",
"      x",
"     </b>",
"     0.15 = Oxycodone mg/day dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Hydrocodone mg/day oral dose",
"     <b>",
"      x",
"     </b>",
"     0.9 = Oxycodone mg/day dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Hydromorphone mg/day oral dose",
"     <b>",
"      x",
"     </b>",
"     4 = Oxycodone mg/day dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Levorphanol mg/day oral dose",
"     <b>",
"      x",
"     </b>",
"     7.5 = Oxycodone mg/day dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Meperidine mg/day oral dose",
"     <b>",
"      x",
"     </b>",
"     0.1 = Oxycodone mg/day dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Methadone mg/day oral dose",
"     <b>",
"      x",
"     </b>",
"     1.5 = Oxycodone mg/day dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Morphine mg/day oral dose",
"     <b>",
"      x",
"     </b>",
"     0.5 = Oxycodone mg/day dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Divide the oxycodone mg/day dose into the appropriate dosing interval for the specific form being used.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children and Adolescents: Dosage adjustments are not provided in the manufacturer&rsquo;s labeling; however, the following adjustments have been recommended (Aronoff, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR 10-50 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Administer 75% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR &lt;10 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Administer 50% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hemodialysis: Administer 50% of dose posthemodialysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Peritoneal dialysis: Administer 50% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;60 mL/minute: Initiate doses conservatively and carefully titrate dose to appropriate effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Adults: Controlled release products: Initial:",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      3",
"     </sub>",
"     to",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     of the usual dose; carefully titrate dose to appropriate effect",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F204880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as hydrochloride: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral, as hydrochloride: 5 mg/5 mL (5 mL, 500 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral, as hydrochloride [concentrate]: 20 mg/mL (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oxecta&trade;: 5 mg, 7.5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Roxicodone&reg;: 5 mg [DSC], 15 mg, 30 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, controlled release, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     OxyCONTIN&reg;: 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F204864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes controlled release tablet",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F204937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-II",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11234132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As a requirement of the REMS program, healthcare providers who prescribe OxyContin&reg; need to receive training on the proper use and potential risks of OxyContin&reg;. For training, please refer to file://www.oxycontinrems.com. Prescribers will need retraining every 2 years or following any significant changes to the OxyContin&reg; REMS program.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F10162706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     OxyContin&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM208530.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM208530.pdf",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Oral solution:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM289880.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM289880.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1054610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May administer with food to decrease GI upset",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immediate release (capsule, oral solution, tablets):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral solution: Available in two strengths; 1 mg/mL and a concentrated oral solution (20 mg/mL). Precautions should be taken to avoid confusion between the different concentrations; prescriptions should have the concentration specified as well as the dose clearly represented as milligram (mg) of oxycodone, not volume (mL). The enclosed calibrated oral syringe should always be used to administer the concentrated oral solution to ensure the dose is measured and administered accurately. The concentrated oral solution (20 mg/mL) should only be used in opioid-tolerant patients (taking &ge;30 mg/day of oxycodone or equivalent for &ge;1 week).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tablet (Oxecta&trade;): Swallow whole with adequate water to ensure complete swallowing immediately after placing in the mouth; the formulation uses technology designed to 	discourage common methods of tampering to prevent misuse/abuse. The tablet should not 	be wet prior to placing in the mouth. Do not crush, chew, or dissolve nor administer via feeding tubes (eg, gastric, NG) due to potential for obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Controlled release tablet (OxyContin&reg;): Swallow whole; do not moisten, crush, chew, or break as this would result in rapid release of oxycodone and absorption of a potentially fatal dose of drug. Administer one at a time and follow each with water immediately after placing in the mouth. For oral use only, do not administer rectally; increased risk of adverse events due to better rectal absorption.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1054602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&deg;C (77&deg;F); excursions permitted between 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); protect from light and moisture",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1054609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immediate release formulations (capsules, oral solution, and tablets): Management of moderate to severe pain (FDA approved in ages &ge;18 years and adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Controlled release tablets (OxyContin&reg;): For around-the-clock management of moderate to severe pain when an analgesic is needed for an extended period of time (FDA approved in ages &ge;18 years and adults); immediate postoperative pain management in patients who received OxyContin&reg; prior to surgery or if moderate to severe persistent pain anticipated (FDA approved in ages &ge;18 years and adults)",
"     <b>",
"      Note:",
"     </b>",
"     Not intended for use as a PRN analgesic or for treatment of mild pain, pain that is not expected to persist for an extended period of time, or for immediate postoperative pain (within 12-24 hours after surgery)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F204943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       OxyCODONE may be confused with HYDROcodone, OxyCONTIN&reg;, oxymorphone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       OxyCONTIN&reg; may be confused with MS Contin&reg;, oxybutynin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       OxyFast&reg; may be confused with Roxanol",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Roxicodone&reg; may be confused with Roxanol",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F204941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Orthostatic hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Abnormal dreams, anxiety, chills, confusion, dizziness, dysphoria, euphoria, fever, headache, insomnia, nervousness, somnolence, thought abnormalities",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, constipation, diarrhea, dyspepsia, gastritis, nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Twitching, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, hiccups",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Agitation, amnesia, anaphylactoid reaction, anaphylaxis, chest pain, dehydration, depression, diverticulitis exacerbation, dysphagia, dysuria, edema, emotional lability, eructation, hallucinations, hematuria, histamine release, hyperalgesia, hyperkinesia, hypoesthesia, hyponatremia, hypotonia, ileus, intestinal obstruction, intracranial pressure increased, malaise, paralytic ileus, paresthesia, seizures, SIADH, speech disorder, ST segment depression, stomatitis, stupor, syncope, tablet in stool (some controlled release dosage forms), tremor, urinary retention, vertigo, withdrawal syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1054614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to oxycodone or any component; significant respiratory depression (in settings without resuscitative equipment or without adequate respiratory monitoring); patients with hypercarbia, severe or acute asthma, paralytic ileus (known or suspected)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1054598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hypersensitivity to other phenanthrene derivative opioid agonists (morphine, codeine, hydrocodone, hydromorphone, oxymorphone, levorphanol); discontinue immediately if symptoms of allergic or hypersensitivity reactions occur. Use with caution in patients with adrenal insufficiency (Addison&rsquo;s disease); biliary tract disease; pancreatitis; CNS depression/coma; acute alcoholism; delirium tremens; hypothyroidism (myxedema); severe liver, pulmonary, or renal impairment; urinary stricture; prostatic hypertrophy; or seizures. Use caution when combining with other CNS depressants (eg, centrally acting antiemetics, general anesthetics, phenothiazines, sedative-hypnotics) as there may be additive CNS effects. If combined therapy is needed, consider reducing the dose of one or both agents. Use care in prescribing, dispensing, and administering the oral concentrated solution, inappropriate use may cause overdose.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1054597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oxycodone may cause CNS depression which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Respiratory depression may occur even with therapeutic dosages; use with extreme caution in patients with respiratory diseases including asthma, emphysema, COPD, cor pulmonale, hypoxia, hypercapnia, pre-existing respiratory depression, significantly decreased respiratory reserve, other obstructive pulmonary disease, kyphoscoliosis, or other skeletal disorder which may alter respiratory function. Oxycodone may exaggerate elevated intracranial pressure (ICP); use with extreme caution in patients with head injury, intracranial lesions, or elevated ICP. Hypotension may occur; use with caution in patients with circulatory shock, hypovolemia, impaired myocardial function, or those receiving medications that compromise vasomotor tone or exaggerate hypotensive effects (including phenothiazines or general anesthetics). Orthostatic hypotension may occur in ambulatory patients. Oxycodone may obscure diagnosis or clinical course of patients with acute abdominal conditions; has been shown to decrease gastrointestinal motility; use with caution in postoperative patients especially after intra-abdominal surgery. Physical and psychological dependence may occur; abrupt discontinuation after prolonged use may result in withdrawal symptoms; concurrent use of agonist/antagonist analgesics (eg, pentazocine, nalbuphine, and butorphanol) may precipitate withdrawal symptoms and/or reduce the analgesic efficacy in patients following prolonged therapy with a mu opioid agonist such as oxycodone. Infants born to women physically dependent on opioids will also be physically dependent and may experience respiratory difficulties or opioid withdrawal symptoms (neonatal abstinence syndrome). Symptoms of opiate withdrawal may include excessive crying, diarrhea, fever, hyper-reflexia, irritability, tremors, or vomiting. High potential for abuse; healthcare providers should be alert to problems of abuse, misuse, and diversion.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     OxyContin&reg; is a controlled-release oral formulation indicated for the management of moderate-to-severe pain when continuous analgesia is needed for an extended period of time; OxyContin&reg; is not intended for use as an &ldquo;as needed&rdquo; analgesic or for immediately-postoperative pain management",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Controlled release 60 mg and 80 mg strengths, a single dose &gt;40 mg, or a total dose &gt;80 mg/day are for use only in opioid-tolerant patients",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; administration of these tablet strengths to opioid-na&iuml;ve patients may cause fatal respiratory depression. Tablets may be difficult to swallow and could become lodged in throat; patients with swallowing difficulties may be at increased risk. Cases of intestinal obstruction or diverticulitis exacerbation have also been reported, including cases requiring medical intervention to remove the tablet; patients with an underlying GI disease (eg, esophageal cancer, colon cancer) may be at increased risk. Do not crush, break, or chew controlled-release tablets",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; use of broken, chewed, or crushed tablets may lead to rapid release and absorption of a potentially fatal dose. Healthcare provider should be alert to problems of abuse, misuse, and diversion",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Concomitant use with CYP3A4 inhibitors (eg, macrolides and protease inhibitors) may result in increased oxycodone concentrations and potentially fatal respiratory depression",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     .",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Concentrated oral solution (20 mg/mL) should only be used in opioid-tolerant patients (taking &ge;30 mg/day of oxycodone or equivalent for &ge;1 week). Precautions should be taken to avoid confusion between oxycodone solutions of different concentrations and dosing unit confusion (mg vs mL); the intended dose should be clearly represented as milligram (mg) of oxycodone not volume (mL) and additionally, the intended product concentration to be dispensed should be identified",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Keep oxycodone oral solutions out of the reach of children",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Concentrated oral solution contains sodium benzoate; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; avoid use of oxycodone products containing sodium benzoate in neonates; in vitro and animal studies have shown that benzoate displaces bilirubin from protein binding sites.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F204929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2D6 (minor), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F204873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifampin: May decrease the serum concentration of OxyCODONE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May decrease the serum concentration of OxyCODONE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: May increase the serum concentration of OxyCODONE. Management: A reduced oxycodone dose may be necessary with concurrent voriconazole.  Increased frequency and duration of monitoring for oxycodone-related adverse effects is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1054617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food does not significantly affect absorption of controlled release tablets.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F204875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F204890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Opioids cross the placenta; respiratory depression and withdrawal symptoms may occur in the neonate following use during pregnancy. Controlled release formulations should not be used immediately prior to or during labor.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1054605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pain relief, respiratory rate, mental status, blood pressure; signs of misuse, abuse, and addiction",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1054596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to opiate receptors in the CNS, causing inhibition of ascending pain pathways, altering the perception of and response to pain; produces generalized CNS depression",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1054612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Duration of action: Analgesia:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Immediate release: 4-5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Controlled release (OxyContin&reg;): 12 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1054613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Distributes into skeletal muscle, liver, intestinal tract, lungs, spleen, and brain; V",
"     <sub>",
"      dss",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 2-10 years: 2.1 L/kg (range: 1.2-3.7 L/kg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 2.6 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 38% to 45%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver primarily to noroxycodone (via demethylation) and oxymorphone (via CYP2D6); noroxycodone is the major circulating metabolite, but has much weaker activity than oxycodone; oxymorphone is active, but present in low concentrations; &lt;15% of the dose is metabolized to oxymorphone via CYP2D6; drug and metabolites undergo glucuronide conjugation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 60% to 87%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, apparent:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Immediate release: 3.2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Controlled release (OxyContin&reg;): 4.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 2-10 years: 1.8 hours (range: 1.2-3 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 3.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults with renal dysfunction (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;60 mL/minute): Half-life increases by 1 hour, but peak oxycodone concentrations increase by 50% and AUC increases by 60%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults with mild to moderate hepatic dysfunction: Half-life increases by 2.3 hours, peak oxycodone concentrations increase by 50%, and AUC increases by 95%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: In the urine as unchanged drug (&le;19%) and metabolites: Conjugated oxycodone (&le;50%), conjugated oxymorphone (&le;14%), noroxycodone, and conjugated noroxycodone",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1054604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/3/6198?source=see_link\">",
"      see \"Oxycodone: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause dry mouth; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may cause postural hypotension (use caution when changing positions from lying or sitting to standing). Avoid alcohol; inform healthcare provider of use of other prescription and nonprescription medications. May be habit-forming; do not discontinue abruptly if therapy lasts more than a few weeks; dose should be tapered to prevent withdrawal. Do not moisten, crush, chew, or break controlled release tablets (OxyContin&reg;), as risk of overdose (and possibly death) may occur. Empty controlled release tablets may appear in stool after medication is absorbed (this is normal). Do not share OxyContin&reg; with others (sharing is illegal and may cause severe medical adverse effects, including death).",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1054615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     OxyContin&reg; tablets deliver medication over 12 hours; release is pH independent. Equianalgesic doses: oral oxycodone 30 mg = morphine 10 mg I.M. = single oral dose morphine 60 mg",
"     <b>",
"      or",
"     </b>",
"     chronic dosing oral morphine 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oxecta&trade; utilizes Acura Pharmaceutical&rsquo;s Aversion&reg; technology which may help discourage misuse and abuse potential. Reduced abuse potential of Oxecta&trade; compared to other immediate release oxycodone tablet formulations has not been proven; the FDA is requiring Pfizer to complete a post approval epidemiological study to determine whether the formulation actually results in a decrease of misuse/abuse. In one clinical trial in non dependent recreational opioid users, the &ldquo;drug-liking&rdquo; responses and safety of crushed Oxecta&trade; tablets were compared to crushed immediate-release oxycodone tablets following the self-administered intranasal use. A small difference in &ldquo;drug-liking&rdquo; scores was observed, with lower scores reported in the crushed Oxecta&trade; group. In regards to safety, there was an increased incidence of nasopharyngeal and facial adverse events in the Oxecta&trade; group. In addition, there was decreased ability in the Oxecta&trade; group to completely administer the two crushed Oxecta&trade; tablets intranasally within a set time period. However, whether these differences translate into a significant clinical difference is unknown. Of note, pharmacokinetic studies showed that Oxecta&trade; is bioequivalent with oxycodone immediate release tablets with no differences in T",
"     <sub>",
"      max",
"     </sub>",
"     and half-life when administered in the fasted state.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Olkkola KT, Hamunen K, and Maunuksela EL, &ldquo;Clinical Pharmacokinetics and Pharmacodynamics of Opioid Analgesics in Infants and Children,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1995, 28(5):385-404.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/23/39287/abstract-text/7614777/pubmed\" id=\"7614777\" target=\"_blank\">",
"        7614777",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Olkkola KT, Hamunen K, Seppala T, et al, &ldquo;Pharmacokinetics and Ventilatory Effects of Intravenous Oxycodone in Postoperative Children,&rdquo;",
"      <i>",
"       Br J Clin Pharmacol",
"      </i>",
"      , 1994, 38(1):71-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/23/39287/abstract-text/7605420/pubmed\" id=\"7605420\" target=\"_blank\">",
"        7605420",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,\" 6th ed, Glenview, IL: American Pain Society, 2008.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12666 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-2BB6473422-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39287=[""].join("\n");
var outline_f38_23_39287=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709186\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204903\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204904\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054606\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054599\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204880\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204864\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204937\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11234132\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10162706\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054610\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054602\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054609\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204943\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204941\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054614\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054598\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054597\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204929\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204873\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054617\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204875\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204890\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054605\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054596\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054612\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054613\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054604\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054615\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12666\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12666|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/34/10792?source=related_link\">",
"      Oxycodone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/3/6198?source=related_link\">",
"      Oxycodone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_23_39288="Postinfectious GN EM";
var content_f38_23_39288=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F76739&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F76739&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of postinfectious glomerulonephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 249px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph shows pathognomonic subepithelial deposits (D) with a semilunar, hump-shaped appearance in postinfectious glomerulonephritis. The humps sit on top of the glomerular basement membrane (GBM). A neutrophil is attached to the denuded GBM, contributing to the glomerular inflammation. Neutrophil attraction requires the initial presence of subepithelial immune deposits so that complement chemoattractants have access to the systemic circulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of a normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of a normal glomerular capillary loop showing the fenestrated endothelial cell (Endo), the glomerular basement membrane (GBM), and the epithelial cells with its interdigitating foot processes (arrow). The GBM is thin, and no electron dense deposits are present. Two normal platelets are seen in the capillary lumen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39288=[""].join("\n");
var outline_f38_23_39288=null;
var title_f38_23_39289="Electrophysiologic cardiac mapping: Techniques";
var content_f38_23_39289=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Electrophysiologic cardiac mapping: Techniques",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39289/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39289/contributors\">",
"     Bradley P Knight, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39289/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39289/contributors\">",
"     Brian Olshansky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/23/39289/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/23/39289/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/23/39289/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac mapping during electrophysiologic testing identifies the temporal and spatial distributions of electrical potentials generated by the myocardium during normal and abnormal rhythms. This process allows description of the spread of activation from its initiation to its completion within a region of interest and, in its usual application, is focused toward the identification of the site of origin or a critical site of conduction for an arrhythmia. Although traditionally aimed at detecting myocardial activation, cardiac mapping can also be used to measure repolarization and depict features of the local electrogram such as relative amplitude and degree of fractionation.",
"   </p>",
"   <p>",
"    The development of techniques for intraoperative mapping permitted the first successful surgical division of an accessory pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/1\">",
"     1",
"    </a>",
"    ]. By the late 1970s, mapping techniques were used for surgical ablation of ventricular tachycardia (VT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/2\">",
"     2",
"    </a>",
"    ]. Further refinements in mapping techniques have resulted in the development of highly effective transcatheter techniques for ablation of most types of supraventricular tachycardia as well as different kinds of VT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=see_link\">",
"     \"Catheter ablation of cardiac arrhythmias: Overview and technical aspects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/60/15304?source=see_link\">",
"     \"Catheter ablation for AV nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13129?source=see_link\">",
"     \"Catheter ablation for ventricular arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These transcatheter mapping techniques have essentially replaced intraoperative mapping, which is now rarely performed. The techniques of cardiac mapping will be reviewed here. The application of these various techniques for mapping of specific arrhythmias is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27305?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Use in specific arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MEASUREMENT OF MYOCARDIAL POTENTIAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The amplitude of the extracellular potential generated by myocardial depolarization depends upon a number of factors. The most important are the magnitude of the currents generated by each cell, the number of cells simultaneously generating this current, the proximity of the recording electrode to these cells, and the resistance to current flow between the source in the myocardium and the recording site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recorded electrograms can provide two important pieces of information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The local activation time, ie, the time of activation of myocardium immediately adjacent to the recording electrode relative to a reference",
"     </li>",
"     <li>",
"      The complexity of myocardial activation within the \"field of view\" of the recording electrode",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Recording electrodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recording electrodes may be either unipolar (one pole) or bipolar (two poles); in actuality, both types of recordings are bipolar, except that the two poles are much more widely spaced in unipolar electrodes (",
"    <a class=\"graphic graphic_figure graphicRef51915 \" href=\"mobipreview.htm?29/47/30463\">",
"     figure 1",
"    </a>",
"    ). The greater the interelectrode spacing on a conventional bipolar electrode, the more the recorded electrogram resembles a \"unipolar\" recording. Since extracellular potential decreases inversely with the square of the distance from a point source [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/8\">",
"     8",
"    </a>",
"    ], far-field events generate relatively low amplitude signals compared to electrogram components generated by near-field sources in unipolar recordings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Unipolar electrogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major component of the unipolar electrogram allows determination of the local activation time, although there are exceptions. The morphology of unipolar electrograms is affected by the direction of propagation of the wave front of activation, which is further modified by the underlying fiber orientation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/9\">",
"     9",
"    </a>",
"    ]. Positive deflections (R waves) are generated by propagation toward the recording electrode, and negative deflections (QS complexes) are generated by propagation away from the electrode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/10\">",
"     10",
"    </a>",
"    ]. If a recording electrode is at the source of a focal arrhythmia from which all wave fronts propagate, then the recorded potential is an entirely negative QS deflection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/9,11\">",
"     9,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Bipolar electrogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike unipolar recordings, bipolar electrodes with short interpolar distances are relatively unaffected by far-field events. The bipolar electrogram is simply the sum of the two unipolar electrograms recorded at the two poles. The shape and the amplitude of the bipolar electrograms are determined by the orientation of the bipolar recording axis to the direction of propagation of the activation wave front.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Electrogram criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Establishing electrogram criteria, which permits accurate determination of the moment of myocardial activation at the recording electrode, is critical for construction of an area map of the activation sequence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Unipolar recording",
"    </span>",
"    &nbsp;&mdash;&nbsp;For unipolar recording, the point of maximum amplitude, the zero crossing, the point of maximum slope (maximum first derivative), and the minimum second derivative of the electrogram have been proposed as indicators for underlying myocardial activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Most studies have suggested that local activation is best determined from the unipolar electrogram by the point with maximum slope (maximum change in potential, or",
"    <span class=\"nowrap\">",
"     dV/dt)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Using this fiducial point, errors in determining the local activation time as compared to intracellular recordings have been typically less than 1 msec [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Bipolar recording",
"    </span>",
"    &nbsp;&mdash;&nbsp;Algorithms for detecting local activation time from bipolar electrograms have been more problematic, due in part to generation of the bipolar electrogram by two spatially separated recording poles. Among several options, the absolute maximum electrogram amplitude appears to most consistently correlate with local activation time determined by other means [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/13\">",
"     13",
"    </a>",
"    ]. The result is different with complex multicomponent bipolar electrograms, such as those with marked fractionation and prolonged duration seen in regions with complex conduction patterns (as in regions of slow conduction in atrial flutter or VT). In this setting, determination of local activation time becomes problematic and the decision as to which activation time is most appropriate needs to be made in the context of the particular rhythm being mapped [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/12,14\">",
"     12,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     EQUIPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The necessary equipment for mapping includes special catheters and an appropriate recording device.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Catheters",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large number of multipolar electrode catheters have been developed to facilitate desired catheter positioning and to fulfill various recording requirements. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bipolar or quadripolar electrode catheters advanced to specific sites of interest within the atria or ventricles.",
"     </li>",
"     <li>",
"      Multipolar recording electrode catheters placed within the coronary sinus or along the crista terminalis in the right atrium.",
"     </li>",
"     <li>",
"      A \"halo\" catheter used to map reentrant electrical activity around the tricuspid annulus during right atrial macroreentry.",
"     </li>",
"     <li>",
"      Special small caliber electrode catheters used to record left atrial and left ventricular epicardial activity from the coronary sinus branches.",
"     </li>",
"     <li>",
"      Circular or spiral electrode catheters to record electrical activity from the pulmonary vein ostia.",
"     </li>",
"     <li>",
"      A \"flower\" catheter, which has 20 electrodes on five radiating spines in a branching configuration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/16\">",
"       16",
"      </a>",
"      ]. These spines covered a diameter of 3.5 cm and allow the determination of activation sequences during AF across the covered region. Recording sites that demonstrate radial spread of activation during atrial fibrillation may represent a focal driver that could be an important target site during ablation of persistent atrial fibrillation.",
"     </li>",
"     <li>",
"      Basket electrodes capable of conforming to the chamber size and shape [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Noncontact composite electrodes for simultaneous acquisition of a high number of electrograms from within the chamber of interest [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/19,20\">",
"       19,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Steerable catheters allow deflection of the tip of the catheter in one or two directions in a single plane; these catheters permit precise and detailed mapping to be obtained, which has facilitated the mapping and catheter ablation of many different types of tachyarrhythmias.",
"     </li>",
"     <li>",
"      Electrode catheters used for recording and mapping commonly have electrodes that are 1 to 2 mm in length. Ablation catheters have tip electrodes that are conventionally 4 mm in length, and are available in sizes up to 10 mm in length, to create large ablation lesions. The larger tip electrodes on ablation catheters reduce the resolution of a map obtained using recordings from the distal pair of electrodes. Therefore, in some cases a catheter with small electrodes should be used for mapping and exchanged for a catheter with a larger tip electrode for ablation Specialized catheters are being developed that have small mapping electrodes embedded in a large ablation electrode so that precise mapping can be performed with an ablation catheter that has a large ablation electrode.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Recording equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order to ensure high-quality recordings, direct cardiac electrograms should be recorded with amplifiers that have high-input impedances, in excess of 1010 ohms, to decrease unwanted electrical interference [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For most of the digital systems used today, the data undergo analog to digital",
"    <span class=\"nowrap\">",
"     (A/D)",
"    </span>",
"    conversion after amplification of the data at each channel. During",
"    <span class=\"nowrap\">",
"     A/D",
"    </span>",
"    conversion, the recorded analog signal is converted into points, or samples, at a conversion rate established within the amplifier system, and each sample is encoded by a digital word. A microprocessor transmits each digital word from the memory of the digital amplifier in a linear stream from each amplifier with start and stop codes for each millisecond transmission. The process then repeats itself for the next sampling period. The sequence of digital words (the data stream) describing the signal is decoded by the recording device to regenerate a graphic image.",
"   </p>",
"   <p>",
"    Amplifiers are also used to filter the low- and high-frequency content of the signal. The range of frequencies not filtered out is frequently called the bandpass. The \"high-pass\" filter allows frequencies above a limit to remain in the signal (ie, it filters out lower frequencies) and the \"low-pass\" filter filters out frequencies above a certain limit. Typical bandpass for intracardiac bipolar electrograms is 30 to 300 Hz. The high-pass filter is set at 30 Hz to filter out low-frequency repolarization events and limit baseline drift. Since most of the signal content is less than 300 Hz, the low-pass filter is set from 300 Hz to eliminate high-frequency noise. Unipolar electrograms are typically filtered across a wider bandpass, typically 0.05 to 300 Hz.",
"   </p>",
"   <p>",
"    For digital systems, the sampling rate should be at least twice as fast as the highest frequency component of the signal in order to avoid aliasing (the Nyquist limit) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/21\">",
"     21",
"    </a>",
"    ]. For practical purposes of activation mapping, sampling rates of 1000 Hz are generally adequate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SINGLE CATHETER MAPPING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The simplest form of mapping is achieved by moving the single electrode sequentially to various points of interest on the endocardium in order to measure local activation. Local activation times must be relative to some external fiducial marker, such as the onset of the P wave or QRS complex on the surface ECG or a stable intracardiac electrogram from a reference electrode in the heart. This form of mapping has been used in the assessment of VT (earliest site of ventricular activation), atrial tachycardia (earliest site of atrial activation), atrioventricular reentrant or orthodromic or antidromic atrioventricular nodal reentrant tachycardia (earliest site of retrograde atrial activation), and atrial flutter (earliest atrial site of presystolic activity with prolonged and fractionated electrograms).",
"   </p>",
"   <p>",
"    The success of roving point mapping is predicated upon the sequential beat-by-beat stability of the activation sequence being mapped and the ability of the patient to tolerate the sustained arrhythmia. However, this situation may not be present in certain settings such as mapping of polymorphic VT or a monomorphic VT that has a repetitive sequence of endocardial activation, but is hemodynamically too unstable to allow time for complete roving of the endocavitary catheter in the electrophysiology laboratory. The more sites that are simultaneously mapped, the less roving of a single point is required.",
"   </p>",
"   <p>",
"    In the electrophysiology laboratory, additional data can be obtained by placing a limited number of catheters within the heart in addition to the mapping electrode(s); these catheters are frequently placed at the right ventricular apex, His bundle region, high right atrium, and coronary sinus (",
"    <a class=\"graphic graphic_figure graphicRef64875 \" href=\"mobipreview.htm?21/4/21574\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/2/12326?source=see_link\">",
"     \"Overview of invasive cardiac electrophysiology studies\"",
"    </a>",
"    .) During initial arrhythmia evaluation, recording from this limited number of sites allows rough estimation of the site of interest.",
"   </p>",
"   <p>",
"    Mapping simultaneously from as many sites as possible greatly enhances the precision, detail, and speed of identifying regions of interest. Standard transcatheter endocardial mapping as performed in the electrophysiology laboratory is limited by the number, size, and type of electrodes that can be placed within the heart. Advanced mapping systems have been developed that can rapidly acquire and display recordings from high-density electrode arrays, or baskets, that can be deployed from a single catheter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Activation sequence mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly used method of identifying the site of origin of atrial tachycardia, atypical atrial flutter, or VT is activation mapping to locate the site of earliest endocardial activation during the tachycardia (",
"    <a class=\"graphic graphic_waveform graphicRef81938 graphicRef58120 \" href=\"mobipreview.htm?39/17/40218\">",
"     waveform 1A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/23\">",
"     23",
"    </a>",
"    ]. Such early activation sites precede the inscription of the P wave during atrial tachycardia or QRS during VT and presumably reflect the site from which electrical systole originates; this assumption is true regardless of the mechanism of atrial tachycardia or VT, ie, focal (triggered or automatic) or reentrant.",
"   </p>",
"   <p>",
"    In macro-reentrant VT, a zone of slow conduction over a pathway of possibly quite complex geometry (eg, nonlinear, nonhomogeneously anisotropic) provides the diastolic limb of the reentrant circuit. After emerging from the zone of slow conduction, the wave front propagates rapidly throughout the ventricles to generate the QRS complex. Thus, early or presystolic activation occurs in close proximity to the exit region from the zone of slow conduction.",
"   </p>",
"   <p>",
"    Electrograms in the region of presystolic activation are often complex, with long prepotentials preceding the major deflection on the electrogram that coincides with the onset of the QRS complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Such prepotentials merge into the major deflection, typically without an intervening isoelectric segment. If an intervening isoelectric segment exists, the prepotentials are called mid-diastolic potentials; it has been suggested that they identify the region of slow conduction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/27\">",
"     27",
"    </a>",
"    ]. These prepotentials may precede the major ventricular deflection by tens to hundreds of milliseconds. It is important to demonstrate that during initiation and resetting of the VT, the mid-diastolic potential always precedes all complexes of the tachycardia in a parallel manner and that loss of the mid-diastolic potential is associated with termination of the VT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mid-diastolic potentials that do not dynamically precede the QRS complex of the VT may represent blind-end alleys of late activation or motion artifact [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In one study, almost continuous electrical activity spanning the diastolic segment was frequently seen in patients with VT due to ischemic heart disease or arrhythmogenic right ventricular cardiomyopathy; however, in 85 percent of patients, the episodes of continuous electrical activity could be dissociated from the VT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/24\">",
"     24",
"    </a>",
"    ]. Such behavior presumably is due to slow and fractionated conduction into nonessential areas of diseased myocardium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pace mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pace mapping involves manipulation of the mapping catheter to the region of origin of a focal VT or the site of initial global activation during a macroreentrant VT. Pacing at this site, using the same cycle length as the VT, should generate QRS complexes resembling those during VT (",
"    <a class=\"graphic graphic_waveform graphicRef68142 graphicRef79938 \" href=\"mobipreview.htm?38/21/39258\">",
"     waveform 2A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. The greater the degree of concordance between QRS morphology during pacing and VT, the closer the catheter is to the site of origin of the tachycardia. Concordance should occur in 12 of 12 leads on the surface ECG; however, this is frequently not achievable. One study found that if only major QRS configuration changes were evaluated on the 12-lead ECG, sites as disparate as 15 mm could be similar; if only minor configuration changes were allowed, this decreased to 5 mm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/31\">",
"     31",
"    </a>",
"    ]. However, 83 percent of patients had some QRS configuration change with pacing 5 mm from the index site, and all patients had changes with pacing 10 mm from the index site. These data suggest that detailed pace mapping with allowance of only minor QRS configuration changes could permit identification of the site of origin of the VT.",
"   </p>",
"   <p>",
"    Pace mapping has advantages over activation mapping in that induction of VT is not required; as a result, it allows identification of the site of origin when the induced VT is poorly tolerated or when VT is not inducible by electrophysiologic techniques, but QRS morphology from a 12-lead ECG is available. However, others have argued that pace mapping is not as sensitive as activation mapping and may be more time-consuming.",
"   </p>",
"   <p>",
"    A limitation of pace mapping during post-myocardial infarction VT is that some areas of conduction block are not anatomically determined, but can be functional. Therefore, pacing at the site of origin of VT during sinus rhythm can result in a different pattern of cardiac activation than that occurring during VT. In fact, pacing precisely at a critical portion of the circuit of a reentrant VT can generate a completely different QRS complex than that of the VT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Entrainment mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another technique that has been proposed for identification of the zone of slow conduction in patients with macroreentrant VT or atypical atrial flutter is entrainment mapping [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. The tachycardia circuit can be entrained by pacing during VT at a cycle length slightly shorter than the tachycardia cycle length (ie, a rate slightly faster than the VT rate) within the zone of slow conduction. Since retrograde activation of the zone of slow conduction does not occur fast enough to provide antidromic activation of the ventricles, but does propagate antegradely to activate the ventricles orthodromically, there is no evidence of fusion of the QRS complex on the surface ECG. Thus, the tachycardia accelerates to the rate of pacing without a change in the QRS morphology of the VT. This is known as entrainment with concealed fusion or concealed entrainment, and can be demonstrated in at least 50 percent of patients with ischemic heart disease undergoing mapping for ablation (",
"    <a class=\"graphic graphic_waveform graphicRef80942 \" href=\"mobipreview.htm?19/37/20050\">",
"     waveform 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. When pacing in the zone of slow conduction, there is typically a latency period between the stimulus delivery and the recording of the onset of the QRS or local electrogram at the exit site.",
"   </p>",
"   <p>",
"    The post-pacing interval (PPI) is the time between the last pacing stimulus that entrained the tachycardia and the next recorded electrogram at the pacing site. The PPI should be equal to the tachycardia cycle length (within 20 to 30 msec) if the pacing site is within a critical part of the reentrant circuit. If the pacing site is outside of the circuit the PPI should be equal to the tachycardia cycle length plus the time required for the stimulus to propagate from the pacing site to the tachycardia circuit and back [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/34\">",
"     34",
"    </a>",
"    ]. However, one mapping study of ischemic VT found that post-pacing intervals were not useful for discriminating between sites of concealed entrainment that were within or outside the VT circuit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Fractionated local electrogram, dominant frequency, and voltage mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;During sinus rhythm, endocardial electrograms in and adjacent to the area of infarction or scar frequently have complex morphologic patterns, including fractionation, split potentials, decreased amplitude, and prolonged duration with electrogram components extending beyond the end of the surface QRS complex caused by slow conduction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Similar fractionated electrograms have been seen in patients with arrhythmogenic right ventricular cardiomyopathy and scleroderma, but occur much less often in patients with nonischemic dilated cardiomyopathies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/39\">",
"     39",
"    </a>",
"    ]. Areas with very low amplitude usually represent sites of dense scar.",
"   </p>",
"   <p>",
"    These fractionated, prolonged, and late electrograms are thought to be generated by asynchronous and slow activation of myocardial fibers with interspersed fibrosis. Endocardial mapping for fractionated, prolonged, and late electrograms in sinus rhythm has been suggested as a means of localizing the site of origin of VT in patients with ischemic heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/37\">",
"     37",
"    </a>",
"    ]. However, one problem is the overlap in amplitude and duration measurements between the sites of VT origin and other recording sites. In addition, fractionated, low amplitude, and late electrograms not infrequently occur in other areas, particularly within the infarct zone, but do not participate in VT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/40\">",
"     40",
"    </a>",
"    ]. As a result, the predictive accuracy of fractionated endocardial activity for localizing the site of origin of VT is limited, and other pacing methods provide more direct approaches to mapping.",
"   </p>",
"   <p>",
"    Mapping can be used to identify areas of complex fractionated atrial electrograms (CFAEs) during atrial fibrillation. These sites may represent focal drivers during atrial fibrillation that can be targeted with ablation. Ablation of CFAEs appears to have an incremental benefit over pulmonary vein isolation alone in patients with long-standing persistent atrial fibrillation, but data are conflicting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency distribution and the dominant frequency of a complex electrogram can be determined using signal processing. Frequency gradients have been identified in the atria during atrial fibrillation with high frequencies measured in the posterior left atrium and pulmonary veins. This has been used to support the hypothesis that these regions are important drivers during atrial fibrillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/43\">",
"     43",
"    </a>",
"    ]. Sites of high frequency can be targeted during catheter ablation for termination of persistent atrial fibrillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Limitations of endocardial mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;The site of origin of the tachycardia may not be reachable from the endocardial approach. As an example, animal and human studies have shown that approximately one-third of ventricular tachycardias due to ischemic heart disease are generated within midmyocardial, subepicardial, or intraseptal regions; critical sites of VT origin in patients with inferior infarction without aneurysms are more likely to be located in the subepicardium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/45-48\">",
"     45-48",
"    </a>",
"    ]. Although the general vicinity may be definable with endocardial mapping in these situations, precise localization is not possible.",
"   </p>",
"   <p>",
"    Another limitation is that focal and presumably nonreentrant mechanisms of VT are not infrequent, even in the setting of ischemic heart disease with aneurysms. In such patients, techniques such as searching for mid-diastolic potentials and entrainment mapping aimed at localizing macroreentry will not be applicable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Epicardial ventricular mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epicardial ventricular mapping can be performed with special recording catheters that can be steered in the branches of the coronary sinus. This technique has been used for mapping ischemic VT, idiopathic VT originating in the right ventricular outflow tract, and VT in nonischemic cardiomyopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/49\">",
"     49",
"    </a>",
"    ]. It may be particularly important in identifying right ventricular outflow tract ventricular tachycardias, which may be difficult to ablate with the endocardial approach only. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13129?source=see_link&amp;anchor=H15#H15\">",
"     \"Catheter ablation for ventricular arrhythmias\", section on 'Idiopathic VT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another epicardial mapping technique using a subxiphoid percutaneous approach for accessing the epicardial surface has been used to map VT in patients with Chagas disease and after failed endocardial ablation of other VTs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. A wider application of this technique may be possible, but it is currently performed at only a few centers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     ELECTROANATOMICAL MAPPING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electroanatomical (or electromagnetic) mapping, which is available in many electrophysiology (EP) laboratories, is based upon the use of a special catheter with a locatable sensor tip, connected to a mapping and navigation system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. At this time, these advanced three-dimensional mapping systems do not have all the features found in a standard EP recording system, and are therefore an additional piece of equipment in an EP lab when used. An external magnetic field is created by an ultralow magnetic field emitter, usually located under the table where the patient lies. A miniature magnetic field sensor at the tip of the catheter can determine the location (x, y, z coordinates) and the orientation (roll, pitch, and yaw) of the catheter. The catheter generates an individualized and accurate three-dimensional reconstruction of the chamber size and local geometry in addition to the usual local electrograms. The accuracy and the reproducibility of three-dimensional localization have been validated (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75692 graphicRef65810 graphicRef75508 graphicRef56674 graphicRef72406 \" href=\"mobipreview.htm?31/51/32570\">",
"     image 1A-E",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The system can generate isochrones of electrical activity as color-coded static maps or animated dynamic maps of activation wavefront. These pictures can define reentrant circuits as well as the site of origin or breakthrough of an ectopic activity with centrifugal, monoregional, or asymmetric spread of electrical activity. An additional advantage is local electrogram voltage mapping during sinus, paced, or any other rhythm; this can define anatomically correct regions of no voltage (presumed scar), low voltage, and \"normal\" voltage, although the true range of normal is often difficult to define, especially with bipolar recordings, and different criteria have been used (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63899 graphicRef54163 graphicRef57238 \" href=\"mobipreview.htm?31/55/32634\">",
"     image 2A-C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81609 \" href=\"mobipreview.htm?21/62/22501\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clinical uses and advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the introduction of three-dimensional electroanatomical mapping, many reports have described its use in the mapping of accessory pathways, typical atrial flutter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/54,55\">",
"     54,55",
"    </a>",
"    ], focal atrial tachycardias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/56\">",
"     56",
"    </a>",
"    ], atrial fibrillation due to foci in the pulmonary veins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/57,58\">",
"     57,58",
"    </a>",
"    ], and idiopathic ventricular tachycardias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/59\">",
"     59",
"    </a>",
"    ]. In addition, activation patterns of more complex atrial and ventricular tachyarrhythmias can be defined with the use of propagation maps to identify slowly-conducting critical pathways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/60\">",
"     60",
"    </a>",
"    ] and \"substrate mapping\" to identify the geometry of scars and their relationship to pathways in ischemic VT or postsurgical atrial tachyarrhythmias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/61\">",
"     61",
"    </a>",
"    ]. This technique can also differentiate markedly slow conduction from complete conduction block when effective linear lesions are essential for the success of catheter ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A major advantage of three-dimensional electroanatomical mapping is its ability to allow the catheter to anatomically and accurately \"revisit\" a critically important recording site, identified previously during the study, even if the tachycardia is no longer present or inducible and map-guided catheter navigation is no longer possible. This accurate repositioning can allow pace mapping from or further application of radiofrequency current to critically important sites that otherwise cannot be performed with a high degree of accuracy and reproducibility.",
"   </p>",
"   <p>",
"    Although fluoroscopy is always needed for initial orientation, an experienced operator can usually generate an extensive endocardial activation map with substantially reduced radiation both for him or herself and for the patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     NONCONTACT MAPPING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mathematical methods based upon inverse solution to Laplace's equation have historically been applied to describe cardiac epicardial activation from the changing distribution of the isopotential regions on the skin of the chest wall during the cardiac cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/64\">",
"     64",
"    </a>",
"    ]. Similar mathematical techniques lie behind the generation of endocardial activation maps based upon the electrical field detected by a composite electrode placed in the blood pool in the center of the cardiac chamber of interest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The noncontact catheter available for clinical use is a multielectrode array mounted on a balloon tipped catheter. The balloon can be filled with contrast dye, permitting it to be visualized fluoroscopically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/19,20,66\">",
"     19,20,66",
"    </a>",
"    ]. The location of any conventional mapping catheter with respect to this multielectrode array can be determined by passing a high frequency, low current locator signal by a process described and validated previously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Clinical uses and advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The multielectrode array has been deployed in all four cardiac chambers using a transvenous, transseptal, or retrograde transaortic approach in order to map atrial tachyarrhythmias and VT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/20,67,68\">",
"     20,67,68",
"    </a>",
"    ]. Systemic anticoagulation is critical to avoid thromboembolic complications. Intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is usually given to maintain the activated clotting time between 350 and 400 seconds.",
"   </p>",
"   <p>",
"    The system generates isopotential maps of the endocardial surface at successive cross-sections of time and, when these are animated, the spread of the depolarization wave is visualized. The maps are particularly useful for identifying slowly conducting microreentrant pathways, such as the critical slow pathways in ischemic VT and rapid breakthrough points [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/20,69,70\">",
"     20,69,70",
"    </a>",
"    ] or reentrant atrial tachycardia in patients with surgically corrected congenital heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/71\">",
"     71",
"    </a>",
"    ]. In macroreentrant tachycardias such as typical atrial flutter or VT, the reentry circuit may be fully identifiable along with other aspects such as the slowing, narrowing, and splitting of activation wavefronts in the isthmus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/69,70,72,73\">",
"     69,70,72,73",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13129?source=see_link\">",
"     \"Catheter ablation for ventricular arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This technique has also been used to identify arrhythmogenic pulmonary veins in patients with atrial fibrillation and guide radiofrequency catheter ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/74\">",
"     74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/62/40938?source=see_link\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been argued that the biggest advantage of noncontact endocardial mapping is its ability to recreate the endocardial activation sequence from simultaneously acquired multiple data points over a few (theoretically one) tachycardia beats, obviating the need for prolonged tachycardia episodes that the patient may tolerate poorly. Human pathological data have demonstrated that linear lesions can be created in the left ventricle during sinus rhythm to treat VT using noncontact mapping [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     NEWER MAPPING SYSTEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technology of cardiac mapping systems continues to evolve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Catheter localization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some newer mapping systems are based on similar principles to noncontact and electromagnetic systems but use alternative technologies and energy sources. As an example, one new advanced mapping system uses ultrasound to determine catheter positioning within the heart [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/76\">",
"     76",
"    </a>",
"    ]. Another system emits a high frequency current through three sets of electrode patches placed orthogonally on the skin to localize the catheter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Like electroanatomical systems, these approaches offer the ability to navigate an ablation catheter without the use of fluoroscopy, which represents a significant advance in cardiac mapping.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Integration with other imaging modalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conventional mapping systems construct a model of a cardiac chamber from a large number of data points (50 to 100 or more). Each data point is individually acquired by placing the catheter at a different position on the chamber wall and recording position and electrogram information for that point.",
"   </p>",
"   <p>",
"    In order to reduce the need for point-by-point reconstruction of the cardiac anatomy, systems have been developed to import and merge a three-dimensional computed tomography (CT) or magnetic resonance (MR) image of the heart obtained preprocedurally with the electroanatomic map generated during the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/78\">",
"     78",
"    </a>",
"    ]. Future mapping systems will likely use real time imaging to create an accurate dynamic chamber image during intracardiac mapping [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Robotic catheter manipulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The construction of accurate electrophysiologic maps requires precise catheter manipulation. To facilitate catheter positioning, remotely controlled robotic systems are being developed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/80-84\">",
"     80-84",
"    </a>",
"    ]. The method of catheter manipulation varies in these systems. As an example of one approach, the operator selects a direction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    position for the catheter tip on a fluoroscopic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    reconstructed image of the heart. Computer-controlled magnets on either side of the patient respond to this direction by changing position, altering the vector of the magnetic field. A specialized catheter with a magnetic tip reorients itself within the magnetic field. The redirected catheter can be advanced or withdrawn either manually or via a robot.",
"   </p>",
"   <p>",
"    In preliminary studies, such systems have been used in mapping and ablation for AV nodal reentrant tachycardia, AV reentrant tachycardia, atrial fibrillation, and ventricular tachycardia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/80-84\">",
"     80-84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac mapping during electrophysiologic testing identifies the temporal and spatial distributions of electrical potentials generated by the myocardium during normal and abnormal rhythms. This process allows description of the spread of activation from its initiation to its completion within a region of interest and, in its usual application, is focused toward the identification of the site of origin or a critical site of conduction for an arrhythmia.",
"     </li>",
"     <li>",
"      Most studies have suggested that local activation is best determined from the unipolar electrogram by the point with maximum slope (maximum rate of change in potential, or",
"      <span class=\"nowrap\">",
"       dV/dt).",
"      </span>",
"     </li>",
"     <li>",
"      Algorithms for detecting local activation time from bipolar electrograms have been more problematic, due in part to generation of the bipolar electrogram by two spatially separated recording poles. Among several options, the absolute maximum electrogram amplitude appears to most consistently correlate with local activation time determined by other means.",
"     </li>",
"     <li>",
"      A large number of multipolar electrode catheters have been developed to facilitate desired catheter positioning and to fulfill various recording requirements.",
"     </li>",
"     <li>",
"      The simplest form of mapping is achieved by moving the single electrode sequentially to various points of interest on the endocardium in order to measure local activation.",
"     </li>",
"     <li>",
"      The most commonly used method of identifying the site of origin of a focal arrhythmia, such as an atrial tachycardia or right ventricular outflow tract tachycardia, is activation mapping to locate the site of earliest endocardial activation during the tachycardia. Activation mapping can also be used to determine the circuit used by a macroreentrant arrhythmia.",
"     </li>",
"     <li>",
"      Pace mapping involves manipulation of the mapping catheter to the region of origin of a focal VT or the site of initial global activation during a macroreentrant VT. Pacing at this site during sinus rhythm, using the same cycle length as the VT, should generate QRS complexes resembling those during VT.",
"     </li>",
"     <li>",
"      Another technique that has been proven to be useful for identification of the zone of slow conduction in patients with macroreentrant VT or atypical atrial flutter is entrainment mapping [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/23/39289/abstract/33,34\">",
"       33,34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The tachycardia circuit can be entrained by pacing during VT at a cycle length slightly shorter than the tachycardia cycle length (ie, a rate slightly faster than the VT rate) within the zone of slow conduction.",
"     </li>",
"     <li>",
"      The post-pacing interval (PPI) is the time between the last pacing stimulus that entrained the tachycardia and the next recorded electrogram at the pacing site. The PPI should be equal to the tachycardia cycle length (within 20 to 30 msec) if the pacing site is within a critical part of the reentrant circuit.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During sinus rhythm, endocardial electrograms in and adjacent to the area of infarction or scar frequently have complex morphologic patterns, including fractionation, split potentials, decreased amplitude, and prolonged duration with electrogram components extending beyond the end of the surface QRS complex caused by slow conduction.",
"     </li>",
"     <li>",
"      Electroanatomical mapping, which is available in almost all modern electrophysiology laboratories, is based upon the use of a special catheter with a locatable sensor tip, connected to a mapping and navigation system. The catheter generates an individualized and accurate three-dimensional reconstruction of the chamber size and local geometry in addition to the relative timing of local electrograms.",
"     </li>",
"     <li>",
"      In order to reduce the need for point-by-point reconstruction of the cardiac anatomy, systems have been developed to import and merge a three-dimensional computed tomography (CT) or magnetic resonance (MR) image of the heart obtained preprocedurally with the electroanatomic map generated during the procedure.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/1\">",
"      Cobb FR, Blumenschein SD, Sealy WC, et al. Successful surgical interruption of the bundle of Kent in a patient with Wolff-Parkinson-White syndrome. Circulation 1968; 38:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/2\">",
"      Wittig JH, Boineau JP. Surgical treatment of ventricular arrhythmias using epicardial, transmural, and endocardial mapping. Ann Thorac Surg 1975; 20:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/3\">",
"      Lesh MD, Van Hare GF, Epstein LM, et al. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation 1994; 89:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/4\">",
"      Schilling RJ, Davies DW, Peters NS. Clinical developments in cardiac activation mapping. Eur Heart J 2000; 21:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/5\">",
"      Breithardt G, Borggrefe M, Wichter T. Catheter ablation of idiopathic right ventricular tachycardia. Circulation 1990; 82:2273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/6\">",
"      Calkins H, Sousa J, el-Atassi R, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med 1991; 324:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/7\">",
"      Calkins H, Kalbfleisch SJ, el-Atassi R, et al. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol 1993; 71:827.",
"     </a>",
"    </li>",
"    <li>",
"     Plonsey R. Bioelectric Phenomenon, McGraw-Hill, New York 1969.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/9\">",
"      Spach MS, Miller WT 3rd, Geselowitz DB, et al. The discontinuous nature of propagation in normal canine cardiac muscle. Evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents. Circ Res 1981; 48:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/10\">",
"      Gallagher JJ, Kasell J, Sealy WC, et al. Epicardial mapping in the Wolff-Parkinson-White syndrome. Circulation 1978; 57:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/11\">",
"      Haissaguerre M, Warin JF, Le Metayer P, et al. Catheter ablation of Mahaim fibers with preservation of atrioventricular nodal conduction. Circulation 1990; 82:418.",
"     </a>",
"    </li>",
"    <li>",
"     Biermann M, Shenasa M, Borggrefe M, et al. The interpretation of cardiac electrograms. In: Cardiac mapping, Shenasa M, Borggrefe M, Breithardt G (Eds), Futura, Mount Kisco, NY 1993. p.11.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/13\">",
"      Anderson KP, Walker R, Fuller M, et al. Criteria for local myocardial electrical activation: effects of electrogram characteristics. IEEE Trans Biomed Eng 1993; 40:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/14\">",
"      Damiano RJ Jr, Blanchard SM, Asano T, et al. Effects of distant potentials on unipolar electrograms in an animal model utilizing the right ventricular isolation procedure. J Am Coll Cardiol 1988; 11:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/15\">",
"      Claydon FJ 3rd, Pilkington TC, Ideker RE. Classification of heart tissue from bipolar and unipolar intramural potentials. IEEE Trans Biomed Eng 1985; 32:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/16\">",
"      Ha&iuml;ssaguerre M, Hocini M, Sanders P, et al. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation 2006; 113:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/17\">",
"      Rodriguez E, Man DC, Coyne RF, et al. Type I atrial flutter ablation guided by a basket catheter. J Cardiovasc Electrophysiol 1998; 9:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/18\">",
"      Schmitt C, Zrenner B, Schneider M, et al. Clinical experience with a novel multielectrode basket catheter in right atrial tachycardias. Circulation 1999; 99:2414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/19\">",
"      Schilling RJ, Peters NS, Davies DW. Simultaneous endocardial mapping in the human left ventricle using a noncontact catheter: comparison of contact and reconstructed electrograms during sinus rhythm. Circulation 1998; 98:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/20\">",
"      Schilling RJ, Peters NS, Davies DW. Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia. Circulation 1999; 99:2543.",
"     </a>",
"    </li>",
"    <li>",
"     Ziemer RE, Tranter WH. Principles of Communications. Systems, Modulation, and Noise, Houghton Mifflin, Boston 1976. p.68.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/22\">",
"      Barr RC, Spach MS. Sampling rates required for digital recording of intracellular and extracellular cardiac potentials. Circulation 1977; 55:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/23\">",
"      Josephson ME, Horowitz LN, Spielman SR, et al. Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia. Circulation 1980; 61:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/24\">",
"      Brugada P, Abdollah H, Wellens HJ. Continuous electrical activity during sustained monomorphic ventricular tachycardia. Observations on its dynamic behavior during the arrhythmia. Am J Cardiol 1985; 55:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/25\">",
"      Fitzgerald DM, Friday KJ, Wah JA, et al. Electrogram patterns predicting successful catheter ablation of ventricular tachycardia. Circulation 1988; 77:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/26\">",
"      Josephson ME, Horowitz LN, Farshidi A. Continuous local electrical activity. A mechanism of recurrent ventricular tachycardia. Circulation 1978; 57:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/27\">",
"      Morady F, Frank R, Kou WH, et al. Identification and catheter ablation of a zone of slow conduction in the reentrant circuit of ventricular tachycardia in humans. J Am Coll Cardiol 1988; 11:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/28\">",
"      Stevenson WG, Weiss JN, Wiener I, et al. Resetting of ventricular tachycardia: implications for localizing the area of slow conduction. J Am Coll Cardiol 1988; 11:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/29\">",
"      Ideker RE, Lofland GK, Bardy GH, et al. Late fractionated potentials and continuous electrical activity caused by electrode motion. Pacing Clin Electrophysiol 1983; 6:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/30\">",
"      Kuchar DL, Ruskin JN, Garan H. Electrocardiographic localization of the site of origin of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol 1989; 13:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/31\">",
"      Kadish AH, Childs K, Schmaltz S, Morady F. Differences in QRS configuration during unipolar pacing from adjacent sites: implications for the spatial resolution of pace-mapping. J Am Coll Cardiol 1991; 17:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/32\">",
"      SippensGroenewegen A, Spekhorst H, van Hemel NM, et al. Localization of the site of origin of postinfarction ventricular tachycardia by endocardial pace mapping. Body surface mapping compared with the 12-lead electrocardiogram. Circulation 1993; 88:2290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/33\">",
"      Morady F, Kadish A, Rosenheck S, et al. Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol 1991; 17:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/34\">",
"      Stevenson WG, Sager PT, Friedman PL. Entrainment techniques for mapping atrial and ventricular tachycardias. J Cardiovasc Electrophysiol 1995; 6:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/35\">",
"      Hadjis TA, Harada T, Stevenson WG, Friedman PL. Effect of recording site on postpacing interval measurement during catheter mapping and entrainment of postinfarction ventricular tachycardia. J Cardiovasc Electrophysiol 1997; 8:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/36\">",
"      Bogun F, Knight B, Goyal R, et al. Clinical value of the postpacing interval for mapping of ventricular tachycardia in patients with prior myocardial infarction. J Cardiovasc Electrophysiol 1999; 10:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/37\">",
"      Cassidy DM, Vassallo JA, Buxton AE, et al. The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia. Circulation 1984; 69:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/38\">",
"      Cassidy DM, Vassallo JA, Miller JM, et al. Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. Circulation 1986; 73:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/39\">",
"      Rankin AC, Osswald S, McGovern BA, et al. Mechanism of sustained monomorphic ventricular tachycardia in systemic sclerosis. Am J Cardiol 1999; 83:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/40\">",
"      Kienzle MG, Miller J, Falcone RA, et al. Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation 1984; 70:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/41\">",
"      Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43:2044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/42\">",
"      Oral H, Chugh A, Yoshida K, et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2009; 53:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/43\">",
"      Lazar S, Dixit S, Marchlinski FE, et al. Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. Circulation 2004; 110:3181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/44\">",
"      Sanders P, Berenfeld O, Hocini M, et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005; 112:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/45\">",
"      Downar E, Harris L, Mickleborough LL, et al. Endocardial mapping of ventricular tachycardia in the intact human ventricle: evidence for reentrant mechanisms. J Am Coll Cardiol 1988; 11:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/46\">",
"      Downar E, Kimber S, Harris L, et al. Endocardial mapping of ventricular tachycardia in the intact human heart. II. Evidence for multiuse reentry in a functional sheet of surviving myocardium. J Am Coll Cardiol 1992; 20:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/47\">",
"      Garan H, Fallon JT, Rosenthal S, Ruskin JN. Endocardial, intramural, and epicardial activation patterns during sustained monomorphic ventricular tachycardia in late canine myocardial infarction. Circ Res 1987; 60:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/48\">",
"      Kramer JB, Saffitz JE, Witkowski FX, Corr PB. Intramural reentry as a mechanism of ventricular tachycardia during evolving canine myocardial infarction. Circ Res 1985; 56:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/49\">",
"      Littmann L, Svenson RH, Gallagher JJ, et al. Functional role of the epicardium in postinfarction ventricular tachycardia. Observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation. Circulation 1991; 83:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/50\">",
"      Sosa E, Scanavacca M, D'Avila A, et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol 1998; 9:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/51\">",
"      Schweikert RA, Saliba WI, Tomassoni G, et al. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation 2003; 108:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/52\">",
"      Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation 1997; 95:1611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/53\">",
"      Ben-Haim SA, Osadchy D, Schuster I, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 1996; 2:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/54\">",
"      Shah DC, Ja&iuml;s P, Ha&iuml;ssaguerre M, et al. Three-dimensional mapping of the common atrial flutter circuit in the right atrium. Circulation 1997; 96:3904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/55\">",
"      Ja&iuml;s P, Shah DC, Ha&iuml;ssaguerre M, et al. Mapping and ablation of left atrial flutters. Circulation 2000; 101:2928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/56\">",
"      Hoffmann E, Nimmermann P, Reithmann C, et al. New mapping technology for atrial tachycardias. J Interv Card Electrophysiol 2000; 4 Suppl 1:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/57\">",
"      Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000; 102:2619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/58\">",
"      Tse HF, Lee KL, Fan K, Lau CP. Nonfluoroscopic magnetic electroanatomic mapping to facilitate focal pulmonary veins ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2002; 25:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/59\">",
"      Friedman PA, Packer DL, Hammill SC. Catheter ablation of mitral isthmus ventricular tachycardia using electroanatomically guided linear lesions. J Cardiovasc Electrophysiol 2000; 11:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/60\">",
"      Delacretaz E, Ganz LI, Soejima K, et al. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol 2001; 37:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/61\">",
"      Dorostkar PC, Cheng J, Scheinman MM. Electroanatomical mapping and ablation of the substrate supporting intraatrial reentrant tachycardia after palliation for complex congenital heart disease. Pacing Clin Electrophysiol 1998; 21:1810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/62\">",
"      Shah D, Ha&iuml;ssaguerre M, Ja&iuml;s P, et al. High-density mapping of activation through an incomplete isthmus ablation line. Circulation 1999; 99:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/63\">",
"      Kottkamp H, H&uuml;gl B, Krauss B, et al. Electromagnetic versus fluoroscopic mapping of the inferior isthmus for ablation of typical atrial flutter: A prospective randomized study. Circulation 2000; 102:2082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/64\">",
"      Rudy Y, Messinger-Rapport BJ. The inverse problem in electrocardiography: solutions in terms of epicardial potentials. Crit Rev Biomed Eng 1988; 16:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/65\">",
"      Khoury DS, Rudy Y. A model study of volume conductor effects on endocardial and intracavitary potentials. Circ Res 1992; 71:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/66\">",
"      Schilling RJ, Peters NS, Davies DW. Noncontact mapping of cardiac arrhythmias. J Electrocardiol 1999; 32 Suppl:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/67\">",
"      Schneider MA, Ndrepepa G, Zrenner B, et al. Noncontact mapping-guided catheter ablation of atrial fibrillation associated with left atrial ectopy. J Cardiovasc Electrophysiol 2000; 11:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/68\">",
"      Schilling RJ, Kadish AH, Peters NS, et al. Endocardial mapping of atrial fibrillation in the human right atrium using a non-contact catheter. Eur Heart J 2000; 21:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/69\">",
"      Strickberger SA, Knight BP, Michaud GF, et al. Mapping and ablation of ventricular tachycardia guided by virtual electrograms using a noncontact, computerized mapping system. J Am Coll Cardiol 2000; 35:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/70\">",
"      Klemm HU, Ventura R, Steven D, et al. Catheter ablation of multiple ventricular tachycardias after myocardial infarction guided by combined contact and noncontact mapping. Circulation 2007; 115:2697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/71\">",
"      Paul T, Windhagen-Mahnert B, Kriebel T, et al. Atrial reentrant tachycardia after surgery for congenital heart disease: endocardial mapping and radiofrequency catheter ablation using a novel, noncontact mapping system. Circulation 2001; 103:2266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/72\">",
"      Schmitt H, Weber S, Tillmanns H, Waldecker B. Diagnosis and ablation of atrial flutter using a high resolution, noncontact mapping system. Pacing Clin Electrophysiol 2000; 23:2057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/73\">",
"      Schilling RJ, Peters NS, Goldberger J, et al. Characterization of the anatomy and conduction velocities of the human right atrial flutter circuit determined by noncontact mapping. J Am Coll Cardiol 2001; 38:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/74\">",
"      Hindricks G, Kottkamp H. Simultaneous noncontact mapping of left atrium in patients with paroxysmal atrial fibrillation. Circulation 2001; 104:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/75\">",
"      Knight BP, Bogner P, Wasmer K, Morady F. Human pathologic validation of left ventricular linear lesion formation guided by noncontact mapping. J Cardiovasc Electrophysiol 2002; 13:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/76\">",
"      Packer DL, Stevens CL, Curley MG, et al. Intracardiac phased-array imaging: methods and initial clinical experience with high resolution, under blood visualization: initial experience with intracardiac phased-array ultrasound. J Am Coll Cardiol 2002; 39:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/77\">",
"      Wittkampf FH, Wever EF, Derksen R, et al. LocaLisa: new technique for real-time 3-dimensional localization of regular intracardiac electrodes. Circulation 1999; 99:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/78\">",
"      P&eacute;rez-Castellano N, Villacast&iacute;n J, Moreno J, et al. Errors in pulmonary vein identification and ostia location in the absence of pulmonary vein imaging. Heart Rhythm 2005; 2:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/79\">",
"      Packer DL. Evolution of mapping and anatomic imaging of cardiac arrhythmias. J Cardiovasc Electrophysiol 2004; 15:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/80\">",
"      Faddis MN, Chen J, Osborn J, et al. Magnetic guidance system for cardiac electrophysiology: a prospective trial of safety and efficacy in humans. J Am Coll Cardiol 2003; 42:1952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/81\">",
"      Ernst S, Ouyang F, Linder C, et al. Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation 2004; 109:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/82\">",
"      Pappone C, Vicedomini G, Manguso F, et al. Robotic magnetic navigation for atrial fibrillation ablation. J Am Coll Cardiol 2006; 47:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/83\">",
"      Aryana A, d'Avila A, Heist EK, et al. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation 2007; 115:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/23/39289/abstract/84\">",
"      Reddy VY, Neuzil P, Malchano ZJ, et al. View-synchronized robotic image-guided therapy for atrial fibrillation ablation: experimental validation and clinical feasibility. Circulation 2007; 115:2705.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1023 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-59BD6D52C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39289=[""].join("\n");
var outline_f38_23_39289=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MEASUREMENT OF MYOCARDIAL POTENTIAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Recording electrodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Unipolar electrogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Bipolar electrogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Electrogram criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Unipolar recording",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Bipolar recording",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      EQUIPMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Catheters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Recording equipment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SINGLE CATHETER MAPPING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Activation sequence mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pace mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Entrainment mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Fractionated local electrogram, dominant frequency, and voltage mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Limitations of endocardial mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Epicardial ventricular mapping",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      ELECTROANATOMICAL MAPPING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clinical uses and advantages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      NONCONTACT MAPPING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Clinical uses and advantages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      NEWER MAPPING SYSTEMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Catheter localization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Integration with other imaging modalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Robotic catheter manipulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1023\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1023|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/3/28735\" title=\"diagnostic image 1A\">",
"      Electroanatomic mapping NSR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?7/21/7508\" title=\"diagnostic image 1B\">",
"      Electroanatomic atrial tachy I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?8/15/8433\" title=\"diagnostic image 1C\">",
"      Electroanatomic atrial tachy II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/60/29632\" title=\"diagnostic image 1D\">",
"      Electroanatomic mapping VT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?21/44/22208\" title=\"diagnostic image 1E\">",
"      LA ablation map",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?4/59/5045\" title=\"diagnostic image 2A\">",
"      Electroanatomic mapping normal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?11/20/11590\" title=\"diagnostic image 2B\">",
"      Electroanatomic mapping ARVD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?15/20/15683\" title=\"diagnostic image 2C\">",
"      Electroanatomic map MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?21/62/22501\" title=\"diagnostic image 3\">",
"      Pathology electroanatomic map",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1023|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/47/30463\" title=\"figure 1\">",
"      Bipolar unipolar electrograms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/4/21574\" title=\"figure 2\">",
"      Normal intracardiac electrograms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1023|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?31/52/32585\" title=\"waveform 1A\">",
"      EPS tracing AVRT initiation termination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?16/49/17176\" title=\"waveform 1B\">",
"      EP study tracings during atrial tachycardia mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?18/4/18503\" title=\"waveform 2A\">",
"      ECG pace mapping RVOT tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?40/26/41385\" title=\"waveform 2B\">",
"      ECG pace map ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?19/37/20050\" title=\"waveform 3\">",
"      EP study tracings entrainment concealed fusion VT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/60/15304?source=related_link\">",
"      Catheter ablation for AV nodal reentrant tachycardia (junctional reciprocating tachycardia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13129?source=related_link\">",
"      Catheter ablation for ventricular arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=related_link\">",
"      Catheter ablation of cardiac arrhythmias: Overview and technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27305?source=related_link\">",
"      Electrophysiologic cardiac mapping: Use in specific arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/2/12326?source=related_link\">",
"      Overview of invasive cardiac electrophysiology studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/62/40938?source=related_link\">",
"      Radiofrequency catheter ablation to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_23_39290="Pseudofolliculitis barbae 2";
var content_f38_23_39290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69365%7EDERM%2F76686%7EPC%2F58129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69365%7EDERM%2F76686%7EPC%2F58129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudofolliculitis barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tight, curly hairs that have been sharpened by shaving penetrate the skin. Inflammatory papules and pustules that resemble acne are evident.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudofolliculitis barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pseudofolliculitis barbae. A loop of hair exiting and entering the skin is visible at the site of the erythematous papule.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acne keloidalis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hypertrophic scarring and flesh-colored papules are seen in this patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39290=[""].join("\n");
var outline_f38_23_39290=null;
var title_f38_23_39291="Pedi needs med attention PI";
var content_f38_23_39291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F52493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F52493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    When to take your child or infant to the doctor",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Your child should be seen as soon as possible if he or she:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does not respond to you, has trouble waking up, or is limp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has trouble breathing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has blue lips, tongue, or nails",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Starts to lean forward and drool",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is an infant, and the soft spot on his or her head seems to be bulging or caving in",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has a stiff neck",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has a severe headache",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has severe belly pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has a rash or purple spots that look like bruises on the skin (that were not there before he or she got sick)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Refuses to drink anything or seems too sick to drink enough",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Will not stop crying",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is very cranky or irritable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Call or visit your child's doctor or nurse if your child:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has diarrhea that lasts more than two to three days or seems to be getting worse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has vomiting that goes on for more than one day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seems to be dehydrated (signs include urinating less than usual, not having tears when crying, being less alert and less active than usual)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has a specific symptom, such as a sore throat or ear pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has pain when he or she urinates",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39291=[""].join("\n");
var outline_f38_23_39291=null;
var title_f38_23_39292="Manifestations of OA";
var content_f38_23_39292=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of osteoarthritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Age of onset",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Usually after age 40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Commonly affected joints",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical and lumbar spine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First carpometacarpal joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Proximal interphalangeal joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Distal interphalangeal joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hip",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Knee",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subtalar joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First metarsophalangeal joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Uncommonly affected joints",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shoulder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wrist",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elbow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metacarpophalangeal joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stiffness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gelling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Findings on physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crepitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bony enlargement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased range of motion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malalignment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness to palpation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Synovial fluid analysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clear fluid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        WBC &lt;2000/mm3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal viscosity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Radiographic features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Joint space narrowing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subchondral sclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marginal osteophytes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subchondral cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Patterns of presentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monoarticular in young adult",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pauciarticular, large-joint in middle age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polyarticular generalized",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rapidly progressive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Secondary to trauma, congenital abnormality, or systemic disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Prognosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Variable, generally slowly progressive",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39292=[""].join("\n");
var outline_f38_23_39292=null;
var title_f38_23_39293="Etiology acute UGI bleeding in adults";
var content_f38_23_39293=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of acute upper gastrointestinal bleeding in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Ulcerative or erosive",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Peptic ulcer disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Idiopathic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Drug induced",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Aspirin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Nonsteroidal anti-inflammatory drugs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Infectious",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Helicobacter pylori",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Cytomegalovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Herpes simplex virus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Stress-induced ulcer",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Zollinger-Ellison syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Esophagitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Peptic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Infectious",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Candida albicans",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Herpes simplex virus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Cytomegalovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Pill-induced",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Alendronate",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Tetracycline",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Quinidine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Potassium chloride",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Aspirin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Nonsteroidal anti-inflammatory drugs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Portal hypertension",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Esophageal varices",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gastric varices",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Duodenal varices",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Portal hypertensive gastropathy",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Arterial, venous, or other vascular malformations",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Idiopathic angiomas",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hereditary hemorrhagic telangectasia (Osler-Weber-Rendu syndrome)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dieulafoy's lesion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Watermelon stomach (gastric antral vascular ectasia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Radiation-induced telangiectasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Blue rubber bleb nevus syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Traumatic or post-surgical",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mallory-Weiss tear",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Foreign body ingestion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Post-surgical anastomosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aortoenteric fistula",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Post gastric/duodenal polypectomy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Tumors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Benign",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Leiomyoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Lipoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Polyp (hyperplastic, adenomatous, hamartomatous)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Malignant",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Adenocarcinoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Mesenchymal neoplasm",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Lymphoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Kaposi's sarcoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Carcinoid",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Melanoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Metastatic tumor",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Hemobilia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Hemosuccus pancreaticus",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39293=[""].join("\n");
var outline_f38_23_39293=null;
var title_f38_23_39294="TNM staging prostate CA";
var content_f38_23_39294=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F75565%7EONC%2F67222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F75565%7EONC%2F67222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tumor node metastasis (TNM) stage definitions for prostate cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Primary tumor (T)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Clinical (cT)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        TX",
"       </td>",
"       <td>",
"        Primary tumor cannot be assessed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T0",
"       </td>",
"       <td>",
"        No evidence of primary tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        T1",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Clinically inapparent tumor neither palpable nor visible by imaging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T1a",
"       </td>",
"       <td class=\"sublist_other\">",
"        Tumor incidental histologic finding in 5 percent or less of tissue resected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T1b",
"       </td>",
"       <td class=\"sublist_other\">",
"        Tumor incidental histologic finding in more than 5 percent of tissue resected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T1c",
"       </td>",
"       <td class=\"sublist_other\">",
"        Tumor identified by needle biopsy (eg, because of elevated PSA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        T2",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Tumor confined within prostate*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T2a",
"       </td>",
"       <td class=\"sublist_other\">",
"        Tumor involves one-half of one lobe or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T2b",
"       </td>",
"       <td class=\"sublist_other\">",
"        Tumor involves more than one-half of one lobe but not both lobes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T2c",
"       </td>",
"       <td class=\"sublist_other\">",
"        Tumor involves both lobes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        T3",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Tumor extends through the prostate capsule&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T3a",
"       </td>",
"       <td class=\"sublist_other\">",
"        Extracapsular extension (unilateral or bilateral)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T3b",
"       </td>",
"       <td class=\"sublist_other\">",
"        Tumor invades seminal vesicle(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T4",
"       </td>",
"       <td>",
"        Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Pathologic (pT)&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        pT2",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Organ confined",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        pT2a",
"       </td>",
"       <td class=\"sublist_other\">",
"        Unilateral, one-half of one side or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        pT2b",
"       </td>",
"       <td class=\"sublist_other\">",
"        Unilateral, involving more than one-half of side but not both sides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        pT2c",
"       </td>",
"       <td class=\"sublist_other\">",
"        Bilateral disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        pT3",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Extraprostatic extension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        pT3a",
"       </td>",
"       <td class=\"sublist_other\">",
"        Extraprostatic extension or microscopic invasion of bladder neck&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        pT3b",
"       </td>",
"       <td class=\"sublist_other\">",
"        Seminal vesicle invasion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pT4",
"       </td>",
"       <td>",
"        Invasion of rectum, levator muscles, and/or pelvic wall",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Regional lymph nodes (N)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Clinical",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        NX",
"       </td>",
"       <td>",
"        Regional lymph nodes were not assessed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        N0",
"       </td>",
"       <td>",
"        No regional lymph node metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        N1",
"       </td>",
"       <td>",
"        Metastasis in regional lymph node(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Pathologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pNX",
"       </td>",
"       <td>",
"        Regional nodes not sampled",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pN0",
"       </td>",
"       <td>",
"        No positive regional nodes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        pN1",
"       </td>",
"       <td>",
"        Metastases in regional node(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Distant metastasis (M)&sect;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        No distant metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        M1",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Distant metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        M1a",
"       </td>",
"       <td class=\"sublist_other\">",
"        Nonregional lymph node(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        M1b",
"       </td>",
"       <td class=\"sublist_other\">",
"        Bone(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        M1c",
"       </td>",
"       <td class=\"sublist_other\">",
"        Other site(s) with or without bone disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Tumor found in one or both lobes by needle biopsy, but not palpable or reliably visible by imaging, is classified as T1c.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Invasion into the prostatic apex or into (but not beyond) the prostatic capsule is classified not as T3 but as T2.",
"      <br>",
"       &Delta; There is no pathologic T1 classification.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Positive surgical margin should be indicated by an R1 descriptor (residual microscopic disease).",
"        <br>",
"         &sect; When more than one site of metastasis is present, the most advanced category is used. pM1c is most advanced.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TNM anatomic stage prognostic groups for prostate cancer*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary tumor (T)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Regional lymph nodes (N)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Distant metastasis (M)",
"       </td>",
"       <td class=\"subtitle1\">",
"        PSA",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        I",
"       </td>",
"       <td>",
"        T1a-c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;10",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;10",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1-2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA X",
"       </td>",
"       <td>",
"        Gleason X",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        IIA",
"       </td>",
"       <td>",
"        T1a-c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;20",
"       </td>",
"       <td>",
"        Gleason 7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1a-c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &ge;10&lt;20",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &ge;10&lt;20",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;20",
"       </td>",
"       <td>",
"        Gleason 7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;20",
"       </td>",
"       <td>",
"        Gleason &le;7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA X",
"       </td>",
"       <td>",
"        Gleason X",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        IIB",
"       </td>",
"       <td>",
"        T2c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1-2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &ge;20",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1-2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Gleason &ge;8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        T3a-b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        IV",
"       </td>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"     * When either PSA or Gleason is not available, grouping should be determined by T stage and/or either PSA or Gleason as available.",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39294=[""].join("\n");
var outline_f38_23_39294=null;
var title_f38_23_39295="Pseudoclaw metacarpal fx";
var content_f38_23_39295=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81613&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81613&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudoclawing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 428px; height: 163px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCACjAawDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAM8470UVDdRNPC8ayyQlhgPHjcvuM5H6UATUVyGoeCpb5yZfFXidFI6QXiQ/wDoEYrNHwvtSTu8V+OG9/7fnH8iKAPQaK83k+EemOSf+Ej8ZB8cP/bk+R+tUn+DYLZj+InxGjH91dcOB/45QB6rRXl8fwq1G3/49PiT43AA/wCW97HN/wChJWjD4I8TQQ7IfiRr2R0MlpZyfziz+tAHf0V5zN4R8fKym1+JsuAclbjQrWQH2+XYaneL4n2V1D5Vz4Q1ezUfvRLDcWMzfQhpVH5UAd/RXCL411mwjZ/EngjWrRA+PO0549Qjx64jIlx/2zrT0Tx/4U1mVYdP1+wa6YkC0mkENwCOoML7XH4igDqKKQHIzS0AFFFFABRRRQAUUUUAFFFFABRRRQAUVXvruCytZbm7lihtol3ySyuEVB6kngfia5IeOv7UlaLwbpN1rwVgGvVPkWXXBKzsMSAf9Mw9AHa1Dd3UFnCZrqeKCIdXlcIo/E1yVtpPi/Ul3a3r1rpce4/6NosAZtp6Bp5wxY47rGhqbT/h94ctpkuLqwbVbtW3C51WZ72QH1BlJ2/8BxQBInj3w9canLp2nXr6lexDMkdhby3IT/eeNSq/iRU1r4h1C7Z/J8L6xHGv3ZLl7eIP9B5pb06qK6JVCgBQABwAK5/U/GWiWDtGLpr65V/LNtp0TXcwb0KRBiv1bA96AOT1uTx5qWshJvtOg+H2dY1bSY4Lq7II+ZpHkJEY548tHIwea2tN+HWk2qRNdX3iDUbqPpd3ms3LS555G1wqn/dAqPV/FWuJJ5Gn+H47aWVMwNql6kfmMewji8xz9Pl78iuY07xP4/uZzDPJoHmQjdcva6fPJApOdsUMjzKZ5Dg5CDapyCxIClAdnpngHw7ZWr28+mWmoqzEmS/t45pWyc4ZyuX5PVsn3qOfwRa2bCbwtdXOgXStvC2jbraQ4xiS3Y7CvTO0K3HDCsPUtG+KMmnQCw8V6Et0GO/fppTK7hgltzDcQDkBQMk47GutufESabIBrtrLp8LSeWlyT5kB4zlnH+rHbLhR70wM/wAJ+LVvbq50bxA1lY+JrKUQz2sc4KzZUMksIJ3FGUg8jIIZTnbk9dXIa54B8M+Jbi+uda0611F7+JFE0kSl4VVcAxSgbl65GD1JxWHpetap4DvLbR/Gd619okrrBpuvy/fJJ+WG79H7CXhWwN2GPIB6XRSKMDnJPrS0AFFFFABRRRQAUUUUAFFFFABRRRQAUUV5l4m+K1vDql5o/g3SbvxPrVoCtwlsRHbWrcgLLM3ygk5wBnoRxQB6bRXjV1rPxbvIbaSyHg7T2cBpIZluJDHx90sCQSO+FHPc9au6R4i+Jttcf8TrTPCWpW//AE4XU9s4HqfMRgfpx9aAPWKKy7fWrZoYDdMLeaXjy2OcH0yOK01YMoKkEHuKAFooooAKCQoJJAA6k0VXv7yGwtJLm5LiGMZYojOR+CgmgDOufFPh+1k2XOu6VE+cbZLuNTn6E1mTfEjwXDK0cnijR9ynBxdIQD6ZBxTrLxj4dvHkW1+1OyqXf/iWXA4HU8x1Zm8YaNbtHHI96pcAqBp9wRg9OkdAFOP4ieFp2Is9UF6wGdtnBLcE/gimpP8AhO9FAy6azGuM7pNGvFH5mKrDeMtCQZku5Y/m2/vLaVOfxWql38Q/C1ru87VVLL1WOGR2/JVJpAVm+KfguNyk+v28D/3Z0eI/+PKKuWnxD8HXcix2/ijRXkY4VftkYJ/Ami38eaFOjPE2psi9WOk3YH6xU6Dxt4cvQ0f2xsHgrPayxj/x9BTA24NU0+dwkF/ayOeipMrE/kara94c0XxDCseu6RYaii/dF1bpLt+m4HH4Vy93a/DGSRkvLfwd5rfOVmjtgxz3wefxrT0vwn4Z8gPpUCxwOPlNneSIpHtsYAfhQBjwfCPwvp6zf8I9/a2gSStuZ9L1O4hGf9wuU7f3auS+FPElvEF0jx7qgYYwNSsra6T8dqRuf++q07jwfp0sYSO71u3x0MOr3S/+1MVWuvDGsRxqNG8X6tashBVLqKC7jb1DbkEh/CQUAVUb4haeX3xeGdbQdNkk+nufwImH6ioP+FijTJhD4x0DVfDwC5a9lQXFiDnGDcR5C/8AAwlayP4xtLkCWDQ9TtivLxSS2cgPshEoI/4EKiHjCOC2Y+JNH1PRyH8tjND58J9/Mi3KFPT5tvuKAOotpEmhSWFxJE4DI6nIZSMgg9xUlebaR4P0uYS3vgDxfqmnW6qY47ayvEurKFsknEEgdVznlRt9sHJrXOvazoGE8V2H2qy+Y/2ppUTuiADrNB8zp35Xeo7laAOyorkbj4keCrOEPc+LdDXIDBftsZcg9DtBz+lLpvxF8J6nIsdnrtpudljQykxBmY8KpcAEnnAHXBoA62iuOv8A4h6HDczWmmG813UIeGtdIt2uSDnGGcfu0PrvdcVj3fjjxgLad9P+GmsSMF/dfaL+1jyf9oB2IHfjJoA9A1G7t7Czmu724jtrWJC0ksrhEQDuS3A+prkY/EOseJBJH4PtFgsgwH9s6lGwicEA7oIsh5hg/eJRM9Cw4rn47HSLa4s9c+J2u219qpkD29rcbobOylAJ2w27EguMn94+W4BGK0U+IOs36zHw94D1y9RCVSe4mgtonIOCQWckjPoCf1AANiHwFpE15FfeIBNr+pRghZ9SIlWPOMlIcCJOR1VQfUmtnVtd0fQYkOralZWKHAQTyrGW7DAPXp0FYR0LxJqzhtc8RGztmQK1lo0ZhBbPOZ33SYx/cEZ961dB8KaHoNxLcaXpsMV5N/rbtsyXEvu8rku34k0AUv8AhLJLy9lttE0HV74ogcXMkP2W2bOeBJLgt65RW61akGuzJDcXl3p+kW8a77mOMG4IAzn9621QMYOShxg+tdBXnnjvUX1zVI/DOnM7x71+3NC5Vsn5lhDDoxALE/wqCeu0MAZVrpi/Eqd/t/2uXwzbyn5pp5Va9IP3QqFECjo3DdNuQwkA6LxRd3ulW/8AZnhA6db3hU+Tbi1G1CAD83zqFXlSTg4X3Kgz+LNfs/COjwWNj9mguPK228bDEcCKMb2GemcADOWJx6keT/ELX9P8JaGLTXFE1xfsZk0tvnnvSzHMs8WeVJYlYiFXKtvJPyhAcZ41fxzrV9eL4Vvby7+3QlLjVHlhhW9jBRS8ACAw26kMNxfaw5JJ+9k2Xwf+Kn2iTU01G6vHDkpJbao8TycAF1L7SVK8DpkDggYp3h74oeO316WPS/D2k6/ez7bkxqJLloGAITeyvt3gKSB0XkKF6D1Gy+KvxRt5EXU/hh9oG0MTa3ewc9OTvGfbrTsB5Tq2pfFnwboWo6lNrXiG2ghmMYh1COaRlUkbWV2EkZ4zn95xjv0r1XwZ8Wb+y+H2h+JPF+pWGq2GploDAkHk3yTIWVwsa5SZcgHpHgOM54B1rL4/aXaXf2bxr4c17wuwzma6tmlhHoNyjccn0Uj3qzqngD4ZfEy3kk0wW8N6uZvN0yQ288Jfku8PABbA5dMkUAb+kwxJpEOvfDq4g1DRbndM2mRyYhlBJ3GA/wDLGUN/CflJBUhCSw37O40rxv4WlSSH7TYXStb3VpdRFHjYcPG6NyrKex9iDjBrgPhf4M174UfbdOEv9v8Ahi6mE8TWsXl3FnI3DkxljujwE+6xbI4Xk11y6pYRanLrWj3CTWszJFqkKEBoj91J3QkFCANrZGSgXtGBSAw7PVL74a3MOl+JJZLnwfI6w2GsMQWsc4Cw3Z7LnhZfoGOTmvTIyCuQdwPIPtUV5bQ3lrPa3kMc9rPGYpYpFDLIrDDKwPBBBxivNwl/8MA7x/bdS8B5UeWoaW50ZAOSo5aS3GOR95B0BA4YHp9FVtOvbbUbGG8sbiO5tZ1EkU0ThkdT0KkcEVZoAKKKKACiiigAooooAKDRSN0P+GaAPDviH8QPEHiPxDqHgz4Y/Z/tFtCV1LVpCdtsxONkZ6BhzlueTgYYVm/Bzwj4g8AeHr6wubCO8kuJ1ud4vEA37AHzwSNpHUZyc4BGCZfgB4bPhe28Q6bqs5fxcb3ztSWRyWZAT5ci5+8jbi2/1Yg9K9aETBsbuBxx0/CnEGcdpPi2G41f+yr6zvba+j+/iB2jiYjK7iAGXPX5gBgiuqCDA2kbe205Hvg9+c0t/pVlqHk/2ha2115JLxieIOEPGSAfwrL0fR7vTrW9m8ye5vpWZhazXWLdAGO1YwM+UMHOQpJz9KoRqBDnIOPUHvVNNOhge6lsZrmwnnQr5tvL0bswjbKE+5Q9q0rSOc20ZvIY47kjMiRMWRT1wCVUkdOoFWEiPYYoYI5C7v8A4h6fMi2Mmg6zZBf9ZcRPbXA932sUJ+ir9BV4eJ/FqBFbwvaudo3Fb4gA+w8vpXReWe5xThEMc7j9KkZy83i3xVGXMnhW0jt1QHzpNRfJYk4UIkDNj/a7VHa+NfEUsxSTw9p0UeMhzeXQye/BtAa60RDPGfxqTYR0oA5oeL9W6Ppunq3oJ7pv/bWnSeKfEmGMXh/THUIWBOpzIWx2wbb+tdKFbHXFLtYnoT7igDyzWvi/rek3xtJ/BiNIACSNVGAD/wBss1VHx0ufNEb+Fikjfd/0qVwx9Bst2P6V7EqOBxvB6D2PrT4o5lRVd3Yjq3rRYDyKT4ya0mAPh/q8rdcQpdEY+pthSL8adZeSNU+Gnigh227mgkVceuTHXsSxsD95qPKDA7vm9m6UgPFdW+Mc63v2PUPAsixsuHa9u0QAehUoSRXEaj8XfCFjOEs/htpFxeP/AKxbPCupyepFuCa+mG0mwc7nsrVn9TCpP6ipRY2wgaEQxiJuqhQAfwFID58bxlFd2kVzp/w111534VE1Ge1KnjhnwMA8+3HFakPifxYt1DNaeF/ElhbqATu1hbhH4yVKzRNjB4yWTp96vdkjCKFT5VAwAO1YXjfXtP8ADPh291LVru1t4I4X2/anKpI+DhDgFjn0UE4zwaAMfRPEes6ro91qGiDS9cSKV4hGHa0cOvDRlv3iEg/xAgHPbGa2rHX7j7LbNrOi6hp08oO9AouUjIHd4i3HuQKw/gtpl7pfw/sEv5LbZNme2trUEw2sDYKRIxJZ1x825jn5vQCqXjzxPrF3rL+FPBcEL6kvlf2je3G1orGGQMR8hOXdlQ4G0r60wN5tC8K+IpZ7yC3s5Ll2/e3VlIYZyR2eSMh8+xNJJ4VvobsT6V4p1m1TI3W87R3UZA/66KXH4NXhK6L4vsria1vLG9lJaFLQ7kvoZAF4cyMoZP8AeTbnsBXVzaT420WSxntr7Wr6B9v2kabfqGgHqkV35ofHfG2kB1+leBb7RfE1zrWlr4fiurkETvDZy25nzz+8AkZScknIUZNdBfWGuanZzWepwaBc2kwAeGWKSRGXuGU8Htz29DXP2M+tXt1HaW/i65sb1lEi2uqaRF5jjnoVKK/TnYeK159L8cSAiPxVokI9U0JyR+dyR+lMBvhrw3rejW81nFrFtDpvH2e2W3eVrb1VZJJCWXPQMOMnGBgDWtNClUOdT1jUtRLDaVd1hQDnosSr6989K8K+KPjRPDF2dE1Hxx4k1rxAWUPaaUsFokYPO0+XGZN2CCF38juKxtDn8R3/AIcOp6hffabKSTEq65fyLDDk4VQshZWwAd2714JpqNwPSPFdtY+CbOSPQru1vNLs4i19odyBdy2lu3D3EG7c428sY3JRgrAbTydv4e6/r2qWdxaR6MIYbV2iF5dXJKh1Yq0YXG9grBsFsZXbzk14/wCNviBqOheGY7bStU0uIzlXma0hxEkfKAoRGnm4AU4I5C45Ga6X9kXxGdZ0HV7eS53tbtAvkMMGIiMxrg5OQUhT8VP1qdmB68/ht765afXNVvLyM4xZxv5FsmOvyphnHs7MPat20toLO2jt7SGOGCMbUjjQKqj0AHAqaimBg+M9bTRNGll82OO5lVo4DITgNtJLtwflUAsx9AepwDxsd7afDnwfPr3iGVzeTDy4o53AeSRjkA4Gd7kBmwDtChRkIM3Tc29/eXvirxBN9l0LSyywCUYUhGILkf7wHA5JVfQA8hL4Z1H4reKpdR1ye803R7AvDaQQMFkt88HJOQJ2GC5A/drhB8+5kQHg3jD4ha3J4kufJuvt/iW5vGMOIyq6cAcIqoSQZcAEbiwi7fvMsnS+Efhdq1n4istV8U6Tr/ifULhWkuQgKxwluD5kkpBmbDEkKR06tX1F4R8EeGvCVusXh3RbOx2gr5qR5lYf7UjZdvxJrpKa0A8n8I/2QulN/YEEUVss8iyRpAImSUN86uoAwwPHPOAK2y+0FiflALE/d4HPU9B61ta94N0jWZpLiWO4tbxwA11Y3D20rAf3mQjd+Oaxrf4X+HkuftOrSajrOwh1TVLtpo12g4ynCkDJPIPU10fWGkQ4XZ5j4kuYPGcsWofYGvPB2lyKY5lQj+3LvzB5drEG6w7wu5yCvyt0wWBB8KrXUtWl8R+K9S1OTxXeN509zY3LQLbPjAjh2gsAowoJJ4UHjNeg+L9ZiPgfTvEUsRg0mzuxcf6OplBsyHjWRlUA7cOshC5wAPSltbmG9tIbmzmiuLaUbo5YyHVwechh1B65p00qnvSCV1scxB4o8aeAnC6jb3PjLw2p5uYVX+0bZf8AaA+WYADrwc5yRiuq0jVfAnxRja90PUIZtRjiKme1ka2vYU5GG6PsyTwwKEnoaalxC87QpPG0y8siOC6jt8vUD36Vx3jD4faRrk51GwjfSPEMbGSLUtNf7PKrdySOG984PuvdSoP7IKT6naaUfEfgO0js9RW58SaBEzkajFzeWkechZIeTKozjdH82B9ziu10TVbHXNKttS0m6iu7K4XfFNEchhnB+hByCDyCMHnNeHeG/itr/g2cab8VLYz2KfLFr1pEffb58Y9Rn5kB6Dhslq9EuNDFzIvij4eajawXV2pmkjBL2OqZHBkA+6+QP3y/NjIIYYA52rOzLK134W1Pwlfy6l4Cj8zT5Dm78OGQRwS5PMlsxIEEnJJH3G/2TzXV+F/EmneJLN59PaVJYm8u4tbiMxT20mASkiHlWGR7HIIJBBqLQfEcepTfYr61m0zWEQNJY3GN2OhaNh8siZH3l/EA8Cr4m8IwapfR6tplzJpXiCEbY7+EZ8xRz5c6ZAlj/wBk4I/hKnmgDqQKK5rwl4il1SS703WLQWGv2O37VbBt6OrZ2zRN/FG2DgkAgqVIBBrpR7UAFFFFABRRRQAUUUUAcv438H6d4pS1kuTcWepWb+ZZ6nYv5d1bHBzsfHKkcFSCDnpkAji/At/4k0zxZqPg/wAayw386QfbdP1CGMQpdW4ITZsHG8E8j+H3GCfXK5/xOwtb7Rb53RIUuvs0u5c5WYbFGe37zy+aAJ2Ch0VigLk446nvj8aXZ3J57j0q2kWeinjjk5/WphD7YpgUUi3VKkPPTJ/l7+9XBEBWT4tinbw9fraNqKzNEVVtO2faFz3j3/Lu+v50AQxatp8+l3OoWdwtza2+8Sm23SMrIPmXavO4dkHOSMdau6VPbalp8F7Y3CT20yho5IsYI/Hn6g8g8Gvlbx1o2vTXwt/GAs7m6RBLbaneqNKnfB+QPKpMMhXBypZHBHDgE57v4Z61q1pfmx1i51QXEgQQPIiz3agKQXuAMGaFmyRIiyYBH73GDSA94jWN9/lssm1trYbofQ4qtqS3cNqX0+1iuZsj9083lZHf5tprz+LQ2tdRl1jQGl067vplM11pi/abO5P3maWDO5GJ3AkZxnOSTXV6Jqk+n6bZQaxFcyMYyTfxK00TgfxMwG5cjBywA9zQBzOpeNfFOkzCW9+G+tyaYo/eS2F3b3c27JxshVtzDGOeD7cUTfETwdrMcGnatcazpgvGURm6tbuxBkBzgS4UKQR2fB6c16TbTxXMCTW8iSwuNyujBlYeoNE8MVxE8U8aSxsMMjqGUj3BoAxLNJLi0Muka39tVFYxs7I6s+OAzKPu+vGffPXhtZ8R+L/Dt7Y3GqWkEEEruLoGczWsjlFCCGXaDCMqxIlCqc8OOtddH4E0WzuTcaPHPpExdpGNhIY1ckAHKcrjgcY7VasZ7yHyNN1q1nuy5KLeLErRvjoXAJ2n3IAoA8s8S6z4/wBV0iMt4asNStRbvI99pJWSe2k6xyRRSNhxt+UiN23c7XUjFcxb/FfxHpmmQ/bNTswrfuWkvYiI3IVuIZWAaKUlT+6u1GcZEm0g16xr2lSaFfXeoaRpmowLIFeSfQ2VnY5I+e0f5HwMZZQXI4AGAaWwg0Xx7a3FtqjaVqs0cXkz3FsvlSjkgxywPl4/91ieeeDjCAxfDPxchbTrO58TQpDZ3Mjwrqlsp+ziQMQsUq5YxOQODueNj92Qg8enaRf2up2KXNjKJYGJ2uOhHY/iMHPfOa+c/E/wg1zwFqd7qPw4k+1eHb9fK1DR7iNrlliJ+bbH1mUAkgAiQdATk15W/iXWdHk0ryLtZkhmUT+UQbKWPcNzxsVJt8fJuXaNhP3Y87WAPu2uJ+Klx4cXSrOx8R2NlqF1qM32TTrW4hjlZ7hxhSofgYOMt2yPWuL0+1+J15p8E9gukPDKvmRzPr00qSIwBUgpFyMdweabqPg74ja8/h7+3I/CJfR9Ti1GKeO8u3YlM/KQyc5yP4gMgdeQWB2XinWJPCOheG9F05z/AGhqM0WlW1zc7pliYISZJD1Y4Q9erHJ4zR4Z8KWPh+W6ubQ3U97diJbi6vLh5pZRGu1QWPIH3jtHy/NgfLiodKaw8UeM9V1CWO1nn0K4bT7WOW1ZZ7RyAZHy2eHyu1lAygzk114hGMgE57k5J+p6/nQgOb07wzY6dePc2oljZjkorER5/wCuf3FIGBleeK3FjyCd3U1Brd62kWT3Zs7i5t4wXmFuoaRVHcIfvfQc1JpOs6bq0Kvp19bSggEokq70yM4ZeoPPQ0wMXx5pdpf+HJXvY71xbETLLYnE9vgjMieuByR3Ge+Kz/h74qufHPg3VdOubuOw8UWgmsLloWG6N9uEuEUHO0hlYdBnIHSu3uLcT200QmaNZI2XzY2wy5H3gR3HBB7V8T+NfEGp+D/HT6zYajNa3jCONZI4wHXyxtAeJjhkZRx0wCBngikwL2gaA3hiXUo9cs1h8Q7njuGlTaoUbVChgcDdyxbILKyuDzkfSml2tudHtYDBGsXlhGiMYUA4w4KgAZyTuBA5zkZzXC3PjLRvGnw+i8bRPawa1pheC5szL5f24xDzDFHnJJyVkjO1iGOD1Y1q+Fr3xHrOg2lr4W8HXehxJEITP4gIiSE4X5ljGZJj1O5tmTyT2relOMVqS1c4X44T+F/CejyxQaFJFqN46yyygukdyMNiMHuisEYopUAspwxyK5b9lOC6g8UX2oXSOqwTNPP8uHGyC4Vhj/elHHqBV74nLYeDtavNb1jxE+ueL7cmC2mngiK28oRWBhtlYqmC2d8h+XqI3JDDS/Zg0aS71JZ3nu5ruVP7Q1N5oyVKvIGiTe3JdmiSTPdc+tYN32KSPqLSYriHToEvJvOucbpHxjLE5IA9BnA9hWT4ivhM0mnxzJHAsZkvpt2DHFz8in+++CPYBj121s37SJaStCIy4HHmNtUe7H0HU/SvBddudR8d+L4/CnhaSRdJtJWn1fUi2Gck7WYY53feVB0JUqfkRwQDq5hN4x8TwWmiTyx6RYpHvdG2RWi7TtMYXgzsrApniNMP1aOvTNJsrXTtOgs9PhSC1hXYkadBj+uc5J5J681B4d0iz0LR7fT9NTZbRDgk7mcnlnZurMxJYk8kkmtKgAooqhrWsadodi97rF9bWNomAZriRY0z6ZJHPt1NAF+uB+Jmu2zmHwtb6ollfakv+lTiRVNlZ7gJJWLcKW4iTPO6TK/dNJJrviHxaTD4StptH00nD61qdsVd1xnNtbMMt1GHkCqP7r1s+HfBei6FpN3p8dv9sW+YvezXx8+W9c9WlZvvfTGB2AoAfN4k0jTvEmk+GFmtVu7qJ/KtkkXdGiJuGU7AqGx/u1UsvCvg7W7GG/ttC0uS3uEZo3W1VMhupAx39e9VZfhd4PTRLjSbDSItNiuJkuTLYkwzLIjbkdZB8wKk8c8ZPrVb4PXRsNEl8I6g7DWNAka2kWT700G4mGdc8lWQjnswYdqQGBrHwA8KtdLf+FWuvDmqpuKT2sjSJkjHKOTx/ulT7isqC38beDbJovE2ny+INPt4sjUdN/ey/e43xsd5wMZIVsc5OOnutFXGbjsJq545b32ieK9PmgSSK5ikUiSItiRCcEjg5UgEZI5Gea45fBviLwVqMmpfDPVDbwSNun0q4Gbd+R1j7ZC/eQ78dPvce0eKvAOheI5zdXMElrqO3aL2zkMUo5DDOPlfBHG8HHOMVyc0F34WEVn4hu3uIpXKQ6ky4STnhH4wjnOBuJDdjngbKcamkiWmtjD0L4seGfFog0P4iWR8O68hAjkkkMcXm4yWhuFIMTcdCVIyFyxzXoTX2reFxv1eSXWdCVc/2hFFm5txnkzRpxIvT541BA6rjL1yHinwppPie18jWLNJZACFl6tGSP1HQEHOD0x1rjNC1zxD8GLqZNU83Vfhu8wSB1cPcaZuJ2jaTkpnjaT6EYOQ2c6Thr0KTue2+I9I/t2ztNW0O4hj1m1Uy6fdq+Y3DDmOQrndC/AYDPZl+ZVI0vDOrR61o8V7HHJA7M8c0En34ZUYq8be6sCOODjIyMGuL1Kb/hHFh8Y+GbkXXhK5X7RqdjH80Yjf5jeW4A+VhlmkXo6lmwGHzVJIbrwn4+TxNa35vvDPiu6hguokbKWsrRxx288fXcHYFWIIH7yM87c1mM9UopFGBiloAKKKKACiiigArF8Z6c2q+FtTtIohLcGEyQITgGZPnj/8fVTW1SMcY79qAM/w5qdvrWh2Op2ZU295Cs6EHPDDP8ya0a8u1XU734Y6tf3NzYXuo+DNQna6EtlGZZNJlY5lDp18hjmTcvKtvBB3LVm6+Mfgx7BZdL8QaXe3TbDHbm4ETSZIHRhkEZztODxigD0diFGWIAHc15n42+KWn6Oxj0ub7fcDcphtkBKMr4LSOx2qgxgjBY7hjFcp4s1PW9X8NxX3jO+h8NaLvO+H5o7mdRgN5cbDcWOGwzbQA2dnyhzyfhTwpD48t21TVLW28M/Dy3wtupl8qS/RCTuZ2AIUnkyNzgEKBksqATSvHHjj4kaxNa6LZwSuEVJp7KEC3t18xW2STMxDELv+UZzuIA4aujt/gFczXmq3cmvDR1u2Z7bTdOtxLa2rHGXAfGGyAfk2FedrAYx0C/Ffwto0Ft4d+HOlPrssCFILbT8Q26BcE/vX4bqSSgc9c81THxL8Z6x5b6RolpaRHIOzT7/UixHGFdY4Yuv+2RQBct9X8ceAzEviCyGsaOOJr2DdMyADC4YDzOgGfNVsd5j1ruvDvjfRNdEYt7owSy8RpOAolPfy5ATHL/wBmxg1wNnJ8U5xLNcNqLKw/dQR2thZAH3Z5LhsfVa4jxL4H+LL35vNAstPtrmf/j6kW4tv9IwePNRYo45Op++jfhQB9NoqpnaoXJycDvTq+eNFvfiV4bhg/wCEg8I6nBaWzsWn8OahBIjIQPl+ySlxjIz8hjAzwBzW74f+NYtGuI/GOgeJbC2SQ+XqEujNHGsWBgyhXchs56AgjBpge1UVxel/FTwJqiobTxZo2XOFWW6WJj/wF8H9K6uy1Czv032N3b3K+sMiuP0NAFmsfWvDml6xNHcXlsBexY8q7hJjnjxnhZFwwHJ4zg9xWxRQBk2y32mQMLy7N/br/wAt3RUlQZOS+AFYAegHToa5XXvBXhHx7I+oxyRTSSDyp7mwkRvN28AOcHDrnhhhwMjO0sp9ArKvNB0+5uftKwm2vQpAubYmOTB7Ej7w9jke1AHhq2njD4J640ljBdeIvAt3MzPaWkY820JG4tHGAAhLFyVUBD22EgD23wj4n0fxdosOq+Hr2K8s5OMocMjd1ZeqsPQ04/2tZMcbNTt+MDiKdR35+656f3O/WvGtY8OsPEkvin4V3Enh7xZMHkvNB1OFrePUsNzmNsDJOfnU7STnKklqAL3iTxda+Ef2k7CweURWev6ZGt6SPlEqmURN9TtC/iK9tRAB2/Cvgb4p+NdQv/ihqWqarpd5o12YbaN9Ou13eW8ew9CBuXIZlOBkkGvtDwF430zxloWn6lYMVF2CArDo4GWX6jn/AL5NAG5qovtif2dDaTEsBLHcuUVkOc4IDc9Oowa8L8dWGiW2oX39oeBr2OVnV5nMPmrKCOXt5gHGRj7pCAdwK+g68c+M3i+wvLb/AIRrT/L1G+upPJjjtL5UcyqxEkTcYUgckZzz0HBKYFLweP8AhKNBa00vxJ4k0exiJtZ7W9gtTI3XBBkUqBjH3Bj8c1Xsvgp4Ev7h7jXLjXdYZQAHvrgxjnsixqp7VpfCrV7/AE+M6XqeieILKO3AhtoolFxFbxknG4pI+SO24ZHXkEAeif8ACV+H45rqFtftJ5YG2SxpMjtGw4IITkHIPB70AUPBHh/QtGDL4d0Ky0yNPlEkVk0buv8AtSOFZiePXp1PSqXiX4m+HtHguUbU1ea3IS4MAEggYnBQv9zeOfkG5uM7TWdqvxBurrbJ4U0y7uYZJwj3csTCNI1++3zlEXpgZbOSDtPFeLeO/Fev+M/EKeE9AlXUtQjuXn22kiC1sUVcIzsFKjYTuZtx+bgEHAoAo+PbeHx/4tguZJIIrWKM3lxEqSKnkh2CqN2PnnYgYUAnazkAAV9GfCHwkvhfw0zzxBNU1BxcXROdw4wiHJJG1MDHYlqyfhl8NdP0GytWlL30kci3Ml9OCJby4VdokPpGgJWNO3J5zk7/AIt1eS5jubKwneCyg+XUb2INvQHgQQY+9OxIXg5XcP4iooA5vx94ivNaK6V4eDSxXUxs4pYuRcSD/WFTgjYmGy3QFXyDtCv2HgDwpZeENBSwswryljJPMFK+Y59ASSFAwoGTgKOT1Mfg7w+bFjqN7aw217JGsMVpFgpY26/chTHGeSWYdWJxwBXUAYzTAWqOtapp+jadNfaveQWVlENzzzyBEX8T39u9cjrfxBibWG0LwdZHxFri5E6wyBLWy5x/pE+CEPDYUBmO3GBkGnaL4Ikn1O21vxrff25rcABgHliO0sTnJ8iLnDdAZGJY7RgryKAIR4m8ReK1X/hCdPFhpj4zrOswOoZT3gtuHfjkFyi/71aWh+B9L0/U/wC1NRe41rXD/wAxLUWWSROvESgBIh14jC++etdZGcgnBHJ4OfpTqAEA6+9LRRQAVxvxA8IT68bXVNCvTpnibTlb7Fdj/VyBvvQTrzviYhcjGQQCO4PZUUAef+HviPaNqSaB4ui/4R7xOAB9mumAhuycDfbS52yKScAZ3AggjINegDpzWT4k8P6T4m06TTtf0+3v7J+scyZweeVPVT7jBHrXBL4I8ReChHL8PdZmvdOjzu8P61OZISg2/JbzffiOFIAbcuTk47gHqdV9Rs4NQsbizvIlmtriNopI3AIdWGCCD7VxvhT4laVrN+NG1WKbw/4mXhtK1LCO55GYW+7MpIbBU54zgV3DMqKWdgFHUk0AeIeHNSj0KYeEtdkurfVdMgB8+9OEu4QwVZYpTw3LKMHkbiDyDXS3rWf9nXH9pNbrp7xMJ2lcLEYypyWP3cEZHPTORW38Uz4ebwqy+JtMtdVhmkWG1tJtgMszAhQjN9w43EsD8qhj0Br581D4cWk15Df6V8OYUuJSGKahr/mWsODyTGBvfjnGcDjIPIPRGrJqyVyXE6L9nzUr3wlKbK8nV/BGuatcWmhSM5/dyLllK7sExygMoPPzx9BvyfTJ/D1xdeDvFXg3BVIYpP7LlEnKxyZeDHdfKkBRf9mNTXk/iXwjeaV4Ovdc1K//ALU8VWxtHhuQnlR2cUdxEwit4wAkaqBk4/IZNfQRt1j8arcoWElxpxjcZyCI5AV47Y81vrn2rCcHF6oadyTwdrEfiDwrpWrRMWF3bJK2V2kMQNwI5wQcgjtitiuW8JRR6ZrniPR0uJ5cXI1ONJF4hS5ySqnuPNSdvbdjtXUjpSGFFFFABRRRQAUUUUAFZPiHQ7TXLMW90ZoijiWKe2laKWJ+zKykEHr7HuCK1qKAPNNQ+D+h6xrY1XxJdX+u3S7SiXzIIMrnYXiiVFfGcYPBGc9TnZuvAOm61HaDxb/xPWtTmOKdBHbof9mFeOnHzbuldlRQBV0zT7PS7KO0020t7O1jHyQwRrGi/RRwKtUUUAFVryxtr1St1F5qEYKsTtP4dKs0UAeZeJPhf4KZjNc+Fmv5JWJ228Clh+Jxj86wLb4N+C2zv+Hd2AT1mvkB+uFlr2ysfxBYavfqkelayNKjI+eRLRZpf+AlyVH4o1AHmrfs/wDw7uBvfwzcwMP4Ev5Of/H8Vz2pfCLwz4XN3qlhp+s+HYoE2DUrPxAIHAJxnLZAycDBP4V65pvha4tWZ7nxP4gvZGOSZ5olH4BI1A/AVdu9BadCI9X1a3Y/xRTjI/76UigD5800+OtLsXNh8TZxucts1AWV2kY6APPJLkdOy49q2bD4peLdF0rdrGr/AA3126iJBSDXo7Wdx77h5efpj6V6jJ4K1A3Amh8c+KomAwFD2rL+KtAQaD4Y8ShSo8aTzg/8/emWz5HodipSA8psv2o9Fil8nxFoN5aSZxu0+8gvk9yWBXj6Zr1Xw58U/BHiG3gk07xNpe+Y4WCe4WGbPp5bkN+lY+q/DrUb5Vzd+Ey38bS+GVcyfU+cOKzbX4RWjoBq2geCrqWNy6SW+mvbBuOjIHYfqR7dywPXgQQCCCD0IqpqumWOr2T2eq2dve2j43Q3EYdDjocHuK8I8Q+CPGHhp4P+Ff6E1mrSb3fRtcZFXHGHt7n90R3G0fl3l0r4l/E7wy0cHjz4eX9/aggNfaSokkCjq7pGXQt34ZBQB1vxK+E1j4wtNPj88BbJ2dUul85sEY2pKcugGM4O9D3Q14na+A/Hfwu8Sifw3eodIuJ/9IivB5UI2EMJG27lHQYcYIyQVC7hXtOn/H34c3bBH182k/8AFFdWs0ZU9wTt25/Guw0vxn4V16JU07XtJvlmBXy47lHJ46Fc5H0IoA+WvHHxd8cXWn+Tdw2mgjcPJuFmeaG4BXEqI6hoJF4zh9xXOAa5jQdQ8L+LNRjm1LSPEF7q5jU3X2MWYWSQdWUlVIzjPHNfVniD4ReF9UVPsVr/AGTtkMjRWIEcMpOPvxj5T09q4GX9nWJNQmmi1TS7i1kzthn0hY3TntJE6knr2pAc1HPoU5W6utH8ZQaNAXaa91fVAIoyUyqbfMO4cccjrzxXS2XxU8F6dor6ZoUVymoEYt7TTIEu7uQs2W2tCdmef7+fY9K1rD9nLwbDqNte3KTyGMhnthtMLtjoQwLYznjNeiGbwj4IjWCGPSNG884S3tYUjeY+ixoNzn2ANAHimp6V47+IbTveaJJ4b8O+UI3n1VpLm8kUPkEQJhiw/uYVTnktgCu68G+D9D8E6BC93bxaRpL4LWco825vZcZRrhh99+GIhQFQScZ4xva54q1Fbaa7SOHw9oUADTatrK7WYHI2xQZDbs7cGTHJwEbpWXoWl6pqV2LvTYrqAqjRrr2vx+ZfODuBNvbkKsK89Sq54yjACgBmreLNTvpbee5hvdC0WV2W2sBETq2sED7scYOYEywyxw+OSYhzW54S0DUWeG/1+KC0ihUf2folrgw6eMYyWGBJL/tYwuSF6ljXaTwz4GvcTveal4muoNzMsb3uo3MYIBOEBKx5A4AWMEdqqS+IviBrM3leH/B8Gj28gVk1DX7xGwueR9ngZm3YzjLDoMmmB2HifxHpHhfSm1HxBfw2VqGCh5Ccu+MhUUZZmOD8qgk4PvXDRQeKPiLIs2pfb/CvhM9NPBMeoX6/9NnU5t06Dap3EbtxAIrR8M/De2tNSg1zxVqNx4n8SwktHe3oAitySP8AUQj5Iug5AJznnsO/XkA0AZ3h3RNO8PaRBpmjWUFlYwjCQwrtA9SfUk8knk960qKKACiiigAooooAKKKKACiiigDA8ZeENC8Z6b9g8S6bBf26ncm/IeM+qsCGU/QivMNU+GlpY+OPDGn3OueJtU0C9efzdK1PUpJ7QtFGHjXacZAIztYtkL6A59urh/i5aXp0Cx1rS/Pe78P30eq+RABvuYkDLNEPdonkx6kAUAbfjTw3beK/C97ot3JJElwo2Tx/ehkUhkdfcMAcdD06GvKPCGr6zbXsvh7xxCkHiG1k2QzKP3WoRhAfOQ992Mn3yCAQQPadJ1C01bTLTUNNnSeyuolmhlTo6MMg/lXHfGDwnP4k8N/atHZ4vEGluLywlj+8zpz5foQw4weM4zxmrhPkYmroy72ziv7KWzueYJUEbc4O3v7Z4FVPA/jS/wDE3xdutPlsprK107SJBJDOB5nmtcqFckdmjVWx71T8F67Jr2gR3dxBLDcozRXClMfvVHzFV7Lk/p65qx4EsrbSPjJrE28+Zr2mJcBS2VR7d1R1X2xIhx7Gtq6uuYmD6HXag5tPi3ouxiF1DR7uOVc8MYZrcxn8POlH/Aq7GvEPidpN/r3x18MW9hqMmnXenaNcX+nygZV7gSBSj/7DLgNg5xmvXPDWrx65oltqEaeUZQVkiLbjDIrFXjJ6Eq6spxxkGuYs06KKKACiiigAooooAKKKKACiiigAooooAKKKKACmyFgjFF3MBkDOMmnUUAcrNL4xu1AtrfQ9MO4fNPLJeELnn5FWMDIx/Gayn8MeOrnVGnuPiF9msixP2Ww0SBCB2AeVpT+YNd/RQB51efDO7vHL3HxC8cgk8iC9hhH5JCKjg+FCQ5/4rrx/IT/f1tj/AOy16TRQBxdt4De2R1Txb4sbcc5kvlcj6Eoawn+E10Hle3+I/j1HkJJD6krqPoNnH4V6jRQB5nbeBfGtinlWPxP1IwjGBeaZb3De+XIBP510C6V4whm3ReKNOmiyDsudIyenPzJMv8q6yigDynxNoPia9My6h4I8E6/A5/5+Xgkcdsh4mAP/AAI4rze58G6JpdnNLrHw68XeFJJ5Mm50C/S9SPbzyUYkL/vIR6YNfT1FAHyDaWPwxyyW/wAUtbtr9yc+fDJAAx/vb4+O3OasweHPEUcI/sH42eHY7GMnldTVGUHuxUcn69K+spoY542jmjSSNhgq6ggj3BqnBoulwALBptlEAdwCQKvPrwKVgPnLw5pvg7Rbs3XxH+Kdv4scw+ULE30lzHG7MPmG12LdMYK9/pXrOlarY2Vp5Pw/8GXUjOgKStZ/2db8ngu8oVyO+VR69BSNI8hEVfoMU6mBx2jeEppNXh1zxbejVtYiA8iNU2WdiecmCM5O7nBkYljjgqPlGd4m8YX+p6zN4U8BLHPrcZC3+pSJvtdJQ9Wfn55sfdiHfliApBxvH/i/UvE2rz+B/hxOBqoAGq6wOYtLiJwQD3mPICjkc4xglfQPBnhvTfCfhyz0bRoRHaWy7d3G6Vv4ncjqxPJPrQBV8FeEdO8LWcq2nnXF/cHfd6hdN5lzdv8A3pJOp9h0A4FdInT/AOtilooAKKKKACiiigAooooAKKKKACiiigAooooAKaxO4DsetOooA810/Pw+8Wrpsr48J69dsbA8r9hvZCWa3x08uU7mTHRty4+ZTXpPbis/xDpFjr2j3elatbJdWN3GYpYXBwwPuOQR1BHIIBHIFcr8PtRvtNu7jwdr8k0+padEJbK9mcMdQst21JCevmIcJICOu1uQ4oA462uXtfil400Z3CWoaDUbaGQfMFkRfNZB3UyAnP8ACST3rF+J2qzeFtU8MeLI/NNvp17i+8qLzG8lgQfpkNIufVhXffFfwzql5eaL4h8LWcN5remM8UlrJKsX2y0kGHj3HjcGCMpYgAhj1ODiWmp2OtWjW1zbzRS3ELedpuoQeXPtyQRJE/3l4OSMrjHJGK6abU48pL01NX4qtbWMvhP4g27iS20S5/0mSMsQ1jcqI3fCjLBS0b49A1b2iyHSvH+p6XHE32HVbcavbycbfNBWOdB+cL/WRq8z8A2Y8L/EKfwajvN4P17T5HhtJ5GkFvP826KMkfcaMOdv+zntzN8P73UF1jwj4d1Wxvkbw9qd9p0OqXaiJLyOOGZI0iHLSHywpLEKo2dSxArmasyrnu1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRXMa34evtY1Kb7Vr+o22lNGqpaae32ZtwYlmaZfn5GBgFeh654AKvi/4h6B4Zu4rGeeW+1mYhYdL09PPuZCTj7gPyj3Yge9cekniH4laje6VqGsQ+HNMtI0N9pmkXHn3r+ZvCrJchfLQHZkpHuOM5IDCvI5dJvtS+Kd1B4X0K00p4rlYNJBTCSwxGWSS5fJ3F5GgQLIw5B4JK5r3n4LeCZPBeh3tvfBpL+a4WSWdm3eYfJiVtp/u7lYAegFIDrfCvhzSPCujRaV4esYbKwiJIjjycsepZiSWPuSTxWvRRTAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArlvHfhltdt7S80ySG28R6WzT6XdyA7Y3IwyPjkxuPlcehyOQK6migDjvBPjaz1tm0zUYpNI8SW+VudKvCBKpHBeM9JYyc7ZF4Yc+tafjHwxYeK9LNlqBniIO6G6tX8ue3f+9G/O0/h9al8TeGdG8T20UGu6fDdrC/mQu2Vkhb+8jqQyHgcqQa5VfB3i/Tp2j0Dx9crp20hLfVtPW/eMkk5E29HYDIADlunWgC34b+HWmaHrket3l/qWtapBCYLe61ORHNuh+9sCIqgkdXILEcZwSDmadeHx58QdK1jSlb/hGfD5uRDf8A8GoXToYj5PHzRIpcGQcM/AyFyZrfwBrOpxPB478YXmvWLMD9it7SOwhkGCCsvl5d15+7vCnAyDXoFpbxWltFb20SQ28SiOOONQqooGAABwABwAKAJaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACkZQykHODxwcH86WigDG8MeHbLw5ZyQWXmSPNIZp55iDJM5wMsQAOAAoAAAVQAAABWzRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pseudoclawing stems from an imbalance of metacarpophalangeal joint hyperextension and proximal interphalangeal joint flexion that occurs when the patient attempts finger extension. It occurs in proportion to the degree of apex dorsal angulation at the metacarpal fracture site. This condition represents one indication for surgery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Henry MH. Upper extremity: Hand fractures and dislocations. In: Rockwood and Green's Fractures in Adults,&nbsp;7th ed, Bucholz RW, Court-Brown CM, Heckman JD, Tornetta P (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_23_39295=[""].join("\n");
var outline_f38_23_39295=null;
